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Riassunto 
 
Il mio progetto di dottorato riguarda processi neurodegenerativi del midollo spinale, 
con una particolare attenzione verso la sclerosi laterale amiotrofica (SLA). Durante il 
mio dottorato ho usato come modello le fettine organotipiche di midollo spinale e ho 
concentrato i miei studi su: cambiamenti precoci nell’eccitabilità del tessuto spinale 
in un modello genetico di SLA; cambiamenti nell’attività del network spinale indotti 
da stress ossidativo in wild type (WT) e cambiamenti nell’attività sinaptica dei 
circuiti premotori sottoposti ad uno stress infiammatorio in WT. 
Il fine principale del mio lavoro era quello di capire il dialogo tra una condizione di 
stress generale ad il network spinale premotorio. A questo scopo, ho unito tecniche 
elettrofisiologiche e analisi di immunofluorescenza per caratterizzare gli interneuroni 
ventrali localizzati nel microcircuito spinale. Per raggiungere questo obiettivo ho 
sfruttato le colture organotipiche derivate dal midollo spinale di embrioni di topo che 
sono generalmente accettate come un buon modello per studiare l’attività premotoria 
neuronale e garantiscono un facile accesso sperimentale agli interneuroni (Avossa et 
al., 2003). 
Nella prima parte della mia ricerca ho confrontato colture WT con colture 
transgeniche SOD1G93A, uno dei modelli di SLA maggiormente studiati. Nei network 
spinali in coltura, come già descritto in preparazioni acute ottenute a diversi stadi di 
sviluppo, c’è una progressiva velocizzazione delle correnti glicinergiche, 
rappresentata dalla riduzione del decay time constant (valore di tau) delle correnti 
sinaptiche durante la crescita delle fettine. Le colture WT e SOD1G93A presentano un 
diverso profilo di maturazione dato che nelle colture transgeniche questo processo di 
sviluppo è significativamente più marcato non solo nelle correnti postsinaptiche 
(PSCs) ma anche negli eventi in miniatura (mPSCs). Questa differenza nelle 
proprietà cinetiche delle correnti glicinergiche può essere fortemente ridotta dalla 
presenza di TBOA che diminuisce la sintesi del GABA. Questi risultati supportano 
l’ipotesi che nelle colture SOD1G93A ci sia un aumento del co-rilascio GABA/glicina 
portando alla conclusione che il rilascio sinaptico sia condizionato dalla presenza 
della mutazione ad uno stadio precoce dello sviluppo, prima di qualsiasi 
degenerazione neuronale evidente. Inoltre, ho supportato questo dato anche con 
risultati preliminari riguardanti la marcatura di GlyT2 e GAD65 (due marker per la 
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glicina ed il GABA presinaptici rispettivamente). Infatti, le fettine spinali 
organotipiche SOD1G93A sembrano caratterizzate da un aumento delle sinapsi miste. 
Successivamente, ho testato altri processi di stress del tessuto che potrebbero 
interferire con l’attività sinaptica e, conseguentemente, alterare l’attività del network.  
Dato che le fettine spinali sono preparazioni a lungo termine, ho testato incubazioni 
croniche con molecole chiave nei processi di stress: perossido di idrogeno (H2O2) per 
creare uno stress ossidativo e lipopolisaccaride (LPS) o una miscela di citochine 
(CKs: TNF-α, IL-1β and GM-CSF) per mimare uno stato infiammatorio. Per questo 
set di esperimenti ho usato un altro ceppo di topi privo di manipolazione genetica. 
Tutti questi trattamenti cronici aumentano la frequenza delle correnti mediate dai 
recettori AMPA; inoltre, uno stato infiammatorio è in grado di incrementare l’attività 
globale del network; il trattamento con LPS aumenta anche l’ampiezza delle correnti 
sinaptiche AMPA-mediate, sia spontanee che in miniatura, mentre le CKs accelerano 
il ritmo dei burst indotto dall’eliminazione farmacologica dell’inibizione sinaptica 
che accende il centro ritmogenico presente nel network spinale. Riassumendo, ho 
dimostrato che i trattamenti con questi fattori ambientali alterano la componente 
sinaptica, in questo caso eccitatoria, del network premotorio. 
Nel complesso il mio lavoro ha evidenziato che una predisposizione genetica (nel 
caso della SLA familiare) e fattori ambientali di varia natura (ossidativi, 
infiammatori o di alterata SOD1) inducono cambiamenti nella trasmissione sinaptica 
e possiamo speculare sul fatto che queste alterazioni nel circuito premotorio possono 
cooperare in sinergia causando lo sviluppo di network inefficienti che concorrono a 
determinare la neurodegenerazione motoneuronale. 
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Abstract 
 
My PhD project concerns neurodegenerative processes in the mouse spinal cord, 
with a particular attention to amyotrophic lateral sclerosis (ALS). During my PhD I 
have used as a model the organotypic spinal slice cultures and I have focused my 
studies on: early changes in spinal tissue excitability in an ALS genetic model; spinal 
network activity changes induced by oxidative stress in wild type (WT) and synaptic 
activity in premotor circuits when challenged by neuroinflammation in WT. The 
principal aim of my work was to understand the dialogue between a general stress 
condition and the spinal premotor network. To this aim, I combined 
electrophysiological techniques and immunofluorescence analysis to characterized 
the ventral interneurones located in spinal microcircuits. For that purpose I exploited 
the organotypic cultures developed from embryonic mouse spinal cord that are 
generally accepted as a good model to study the neuronal premotor activity and 
provide high experimental access to interneurones (Avossa et al., 2003). 
In the first part of my research I compared WT cultures with SOD1G93A transgenic 
cultures, one of the more investigated ALS model. In cultured spinal networks, as 
described in acute preparation collected at different stages of development, there is a 
progressive fastening of glycinergic currents, represented by the reduction of the 
decay time constant (tau value) of synaptic currents along with the slices growth. WT 
and SOD1G93A cultures display a different maturation profile since in transgenic 
slices this developmental process is significantly steeper not only in glycinergic post 
synaptic currents (PSCs) but also in miniature PSCs (mPSCs). This difference in the 
glycinergic PSCs kinetic properties can be strongly reduced by the presence of 
TBOA that lowers the GABA synthesis. These results support the hypothesis that in 
SOD1G93A cultures there is an increase amount of glycine and GABA co-release 
leading to the conclusion that the synaptic release is conditioned by the presence of 
the mutation at an early stage of development, before any evident neuronal 
degeneration. Moreover, I supported this data also with preliminary results regarding 
the co-staining of GlyT2 and GAD65 (markers for presynaptic glycine and GABA, 
respectively). In fact, SOD1G93A spinal organotypic slices seem to display an higher 
amount of mixed synapses. 
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Next, I tested other stress processes of the tissue that could potentially affect synaptic 
activity and, ultimately, alter network activity. I tested chronic incubations of the 
spinal slices, since they are long-term preparations, with stress key players: hydrogen 
peroxide (H2O2) to create an oxidative stress and lipopolysaccharide (LPS) or a 
mixture of cytokines (CKs: TNF-α, IL-1β and GM-CSF) to mimic 
neuroinflammation. For these sets of experiments I have used another strain of mice 
with no genetic manipulation. All these chronic treatments increase the AMPA 
receptor mediated PSCs frequency; moreover, a neuroinflammation state is able to 
enhance the overall network activity; LPS treatment increases also the amplitude of 
AMPA-mediated synaptic currents in both spontaneous and miniature events, while 
CKs accelerate the disinhibited burst rhythm induced by the pharmacological 
removal of the synaptic inhibition that switch on the rhythmogenic centre contained 
in the spinal network. Summarizing, I detected that the treatments with these 
environmental cues affected the synaptic component, in this case the excitatory one, 
of the premotor network. 
Altogether, my work highlighted that a genetic predisposition (in the case of familial 
ALS) and environmental factors of different kind (oxidative and inflammatory 
factors or an alterate SOD1) trigger changes in synaptic transmission and we may 
speculate that these alterations in the premotor circuit could cooperate in synergy 
leading to the development of misconnected networks that contribute to induce 
motoneuronal neurodegeneration. 
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Introduction 
 
1. Spinal cord core networks 
The spinal cord is considered a multifaceted central nervous system (CNS) structure: 
it is in fact the gateway for information transfer between the sensory and motor 
periphery and the cortex and it contains neuronal circuits that integrate and 
coordinate complex sensory, motor and autonomic functions (Hockman, 2007). 
The spinal cord has a segmental organization (Fig. 1): each segment is associated 
with a pair of ganglia, called dorsal root ganglia (DRG), which are situated just 
outside of the spinal cord, that contain cell bodies of sensory neurons; their axons 
travel into the spinal cord via the dorsal roots. The white matter surrounds the cord 
and comprises the axon tracts that relay signals to and from the brain and between 
spinal segments and consists almost totally of myelinated motor and sensory axons. 
The gray matter, in the center of the cord, is shaped like a butterfly and involved the 
dorsal and ventral horns that consists of sites of termination of primary afferent 
neurons and neurons descending from the brain, interneurons and ascending tract 
cells projecting to higher CNS levels. It also contains neuroglia cells and 
unmyelinated axons (Hockman, 2007). 
 
 
Figure 1. The segmental organization of the spinal cord. Primary sensory neurons located in DRG 
project via dorsal roots onto spinal neurons largely within the dorsal horn. The spinal cord is divided 
into several layers of laminae (dorsal horn: laminae I-VI; ventral horn: laminae VII-IX). Lamina IX 
contains motoneurons whose axons exit via ventral roots. Sensory information is transmitted to brain 
through two principal axon tracts, the dorsal column and anterolateral system (Hockman, 2007). 
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The several hundred thousand neurons per segment are housed within 
cytoarchitectonically defined anatomical layers called laminae (I – X) that can 
broadly be divided into the sensory dorsal horn (laminae I – VI), the intermediate 
gray (lamina VII) and the ventral horn (VII – IX). Motoneurons (MNs) are located in 
lamina IX (Hockman, 2007) (Fig.1). 
MNs are the largest neurons in the CNS with extensive dendritic arbors that receive 
20.000–50.000 synapses; their role is to produce the appropriate muscle contractions. 
Nearly 100 years ago Graham-Brown, using a set of experiments in spinal cats, 
demonstrated that circuitry within the spinal cord is sufficient to produce coordinated 
rhythmic movements of the hindlimbs without the need of descending connections 
(Graham-Brown, 1911). The term central pattern generator (CPG) has been coined to 
describe the intrinsic spinal circuits that can generate motor output (Whelan, 2003). 
In mammals, the locomotor CPG network is located throughout the ventromedial 
portion of the lower thoracic and lumbar spinal cord (Kjaerulff and Kiehn, 1996; 
Cowley and Schmidt, 1997; Kremer and Lev-Tov, 1997). 
The “intentions” of the brain must be aligned with MNs movement drive at every 
given time and place. The neuronal circuits upstream of MNs, the CPG, control this 
demanding task. Therefore, movement deficits are not only caused by MNs 
degeneration, but also by impairment of the network that converge its output on MNs. 
In the years since the Graham-Brown discoveries, there has been a great deal of 
investigation into the detailed structure and mechanism of function of mammalian 
CPG, in particular the relevance of understanding how the building blocks of the 
network interact to produce the behaviour emerged. This implies the understanding 
of the connectivity between the building blocks of the network (Whelan, 2010). 
Given that MNs are well known final common pathway for motor processing, to 
build a realistic model of networks requires to identify the classes of premotor 
ventral interneurons along with their connections as well as their intrinsic and 
synaptic properties (Whelan, 2010). In mammals, an additional complexity is 
provided by the requirement of spinal control over 80 muscles to produce fluid 
stepping behaviour. The spinal network is constructed in such a way that the output 
is both robust yet modifiable so that it accommodates volitional and reflexive 
changes to the basic pattern. Furthermore, during development, as limbs and muscles 
grow and the animal gets heavier, spinal networks are capable of adjusting to the 
changing biomechanics of the system (Whelan, 2010). 
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This scenario has been dominated by two theories for CPG function. The first one is 
the unit oscillator hypothesis: a unit oscillator is a simple network controlling 
movement around a single joint; this model could account for complex behaviours 
such as walking by connecting multiple unit oscillators through excitatory and 
inhibitory connections. The advantage of this system is that it is extremely flexible: 
different behaviours may be generated by simply altering unit oscillators coupling 
(Grillner, 1981). 
The second one is the three-layer model: the first layer is proposed to consist of a 
distributed network composed of excitatory interneurons interconnected that 
represent the rhythm generator whose drive is than propagated to the pattern 
formation layer, which provides the specific drive that is sent to a population of MNs 
innervating  particular muscles. The third layer is a set of mutually inhibitory classes 
of Ia inhibitory interneurons that also receive input from Renshaw cells that 
contribute to the shaping of overall motoneuronal output (Lafreniere-Roula and 
McCrea, 2005; Rybak et al., 2006; McCrea and Rybak, 2008). 
To elucidate CPG functions, one should be able to experimentally and reversibly 
silence sets of neurons to examine whether they are necessary for specific network 
function and behaviour. In this way we would be able to identify a single class of 
conditional pacemaker cells that form the kernel of the network (Marder and Bucher, 
2001). These pacemaker cells would be responsible for generating the timing of the 
rhythm and would project to pattern-generating interneurons that sculpt the pattern 
before in turn projecting onto MNs (McCrea and Rybak, 2008). 
Rather than a single pacemaker class within the spinal cord, a more likely scenario 
picture the presence of multiple classes of genetically identified interneurons form 
the kernel of the CPG (Whelan, 2010). The presence of distributed networks is 
sustained by the observation that there are no classes of interneurons that can be 
reversibly inactivated and found to be necessary for the rhythm generation. More 
likely, what occurs is graceful degradation of the rhythm. Graceful degradation is a 
term commonly used in the design of distributed computer networks (Randell et al., 
1978) and it refers to the ability of the network to maintain limited functionality even 
if large portions of it are destroyed or inactivated.  
Another logical approach to identify components of the locomotor CPG, as well as 
their connectivity, is to identify “first-order” spinal interneurons that receive inputs 
from command centers in the brain that are known to initiate locomotor activity. The 
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connectivity of these cells once identified, can track downstream components 
(Gosgnach, 2011). The most prominent descending system activating the CPG is the 
reticulospinal tract that originates from the reticular formation and is crucial in 
generating locomotor activity when evoked by brainstem stimulation (Shik et al., 
1966; Grillner, 1975; Garcia-Rill and Skinner, 1987; Grillner and Dubuc, 1988). In 
mammals, activation of the reticulospinal tract is necessary and sufficient for the 
initiation of locomotion (Steeves and Jordan, 1980; Shefchyk et al., 1984; Drew et 
al., 1986) and locomotor-initiating centers in the midbrain/pontine tegmentum (Jones 
and Yang, 1985; Garcia-Rill and Skinner, 1987) and cerebellum (Noga et al., 1995) 
converge in the reticular nucleus before descending to the spinal cord. Thus, 
identifying spinal interneurons that are monosynaptically activated by the 
reticulospinal tract will be a significant step forward in our understanding of the 
structure and mechanism of function of the locomotor CPG. Some progress has been 
made in this regard. Several studies have shown that reticulospinal tract cells make 
monosynaptic contacts onto interneurons located in the ventro-medial region (lamina 
VII-VIII) of the lumbar spinal cord (Bannatyne et al., 2003; Jankowska et al., 2003; 
Matsuyama et al., 2004; Szokol et al., 2011) and many of these cells are 
rhythmically active during locomotor activity (Matsuyama et al., 2004). Despite 
knowledge of the presence of these neurons, there has been no conclusive data 
detailing their role during locomotion or determining whether they project to other 
components of the locomotor CPG. This is primarily due to the fact that only 
restricted lamina VII-VIII neurons receive projections from the reticulospinal tract 
and they are densely intermingled with cells that do not. This makes the task of 
identifying, tracing and recording from a substantial number of them extremely 
difficult (Gosgnach, 2011). 
Recently, thanks to optogenetic methods, Hägglund and colleagues observed that in 
mice locomotor-like bursting can be induced unilaterally without any activity on the 
controlateral side. This ability to evoke rhythmic activity in a limited population of 
the hindlimb MNs pools, support the idea that basic units of the locomotor CPG are 
independent rhythmogenic modules finely interconnected during locomotion to 
ensure a coordinated output (Hägglund et al., 2013). 
Molecular genetic experiments have shown that neurons could be clustered into 
distinct classes based on the expression of transcription factors in progenitor cells 
(Jessell and Sanes, 2000). Each of these classes has unique anatomical and 
 15 
 
transmitter phenotypes. Since the transcriptional profile directs cell fate (Bang and 
Goulding, 1996; Goulding and Lamar, 2000; Goulding and Pfaff, 2005), pattern of 
axonal projection (Betley et al., 2009) and neurotransmitter phenotypes (Cheng et al., 
2005; Mizuguchi et al., 2006; Pillai et al., 2007), it is possible that neurons with a 
similar genetic background will have similar characteristics and a similar function in 
locomotor activity. Understanding the diversification of spinal interneurons at early 
developmental stages is essential since this process establishes functional spinal 
circuits that are needed to generate and maintain rhythmic motor output. This means 
that, alterations in any of the steps involved in network assemblies, lead to impaired 
connections within the spinal circuit and, consequently, to motor output malfunction. 
Therefore, each spinal neurons developmental stage should be investigated to 
determine which one is the responsible of network dysfunction. 
 
1.1. Spinal neurons development 
Precise spatiotemporal gene regulation governs nervous system development by 
controlling cell proliferation, migration and patterning as well as later events such as 
neuronal circuit formation and specificity in synaptogenesis (Salie et al., 2005). 
Neurons with cell bodies positioned in the spinal cord are derived from local 
progenitors. Spinal progenitors are arrayed at conserved dorsoventral positions along 
the midline and proliferate to give rise to postmitotic neurons during temporally 
restricted periods (Arber, 2012). Early action of ventral sonic hedgehog (Shh) and 
dorsal bone morphogenetic protein (BMP) signalling sources leads to spatial 
subdivision of progenitor domain territory along the dorsoventral axis (Jessell, 2000). 
This process is accompanied by the acquisition of a combinatorial transcription 
factor code allowing distinction of 11 progenitor domains based on molecular and 
genetic criteria that divide postmitotic neuronal discendants into 6 dorsal and 5 
ventral cardinal populations (Jessell, 2000; Goulding, 2009; Alaynick et al., 2011; 
Kiehn, 2011) (Fig.2). With the exception of the progenitor domain-generating MNs, 
the other domains give rise to more than one generic neuronal type. 
Members of the BMP and Hedgehog gene families also contribute to the guidance of 
axons toward the floor plate (FP) (Fig. 2). Once generated, neurons in the dorsal 
spinal cord extend axons toward and across the FP. The molecular mechanisms 
involved in these guidance decisions are well understood and classical guidance 
molecules such as Netrins and Slits play major role in this process (Tessier-Lavigne 
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and Goodman, 1996; Yu and Bargmann, 2001). Interestingly, the roof plate (RP) and 
selected members of the BMP family possess repulsive activity capable of directing 
axons ventrally (Augsburger et al., 1999; Butler and Dodd, 2003). The establishment 
of the further trajectory of axons toward the ventral midline is influenced by 
attractive cues derived from the FP and at least part of the signalling cascade 
responsible for interacting with the cytoskeleton to mediate chemoattraction is most 
likely conserved between patterning and guidance activities downstream of Shh 
(Salie et al., 2005). 
Apart from their well-characterized roles in influencing cell proliferation, Wnts were 
also shown to be involved in specification of DRG sensory neurons at early 
developmental stages (Lee et al., 2004). Moreover, several studies have addressed 
the role of Wnt signaling in axon guidance, neurite outgrowth and synaptogenesis 
(Packard et al., 2003). In particular, Wnts are involved in the axons direction in the 
rostrocaudal axis. In vertebrates, axons turn rostrally after crossing the FP, projecting 
toward their targets in the brain. Wnt signaling has been implicated in controlling 
this decision (Lyuksyutova et al., 2003). Wnt4 is expressed in a high-anterior 
(rostral) to low-posterior (caudal) gradient along the spinal cord in the FP throughout 
the time window when neurons make the decision to turn toward the brain. Wnt4 can 
induce postcrossing axons to turn either anteriorly or posteriorly, depending on the 
position these cells are placed. Interestingly, the observed activity of Wnt4 
selectively affects postcrossing but not precrossing axons (Salie et al., 2005). 
The spatial overlap between axons entering the spinal cord and dendritic territory of 
spinal neurons represents an important parameter in defining possible synaptic 
connections. The migratory routes taken by neurons derived from different spinal 
progenitor domains are highly stereotyped such that the final target destination of 
each neuronal subpopulation is spatially confined and follows a laminar organization 
pattern (Arber, 2012), as described previously. In the mammalian spinal cord axons 
of spinal origin or descending axons project along the surrounding white matter and 
enter the cell body-rich grey matter area at subpopulation-specific sites. Axons 
derived from DRG sensory neurons enter the spinal cord dorsally. The observed 
spatial stereotypy in spinal neuronal subtype positioning and axonal trajectories has 
important consequences for how neuronal circuits connect and function (Arber, 
2012). For example, Renshaw cells are located in an extreme ventral position near 
the ventral root exit point of motor axons. Renshaw cells receive direct synaptic 
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input from locally projecting motor axon collaterals providing a main source of 
synaptic input and in turn connect to motoneurons through a spatially confined 
feedback inhibitory loop (Renshaw, 1941; Windhorst, 1990; Alvarez and Fyffe, 
2007). 
 
 
Figure 2. Neuronal populations based on developmental progenitor domain origin and control of axon 
guidance by patterning molecules. Left: at early stages, BMPs (purple) from the roof plate (RP) 
control the generation of distinct neuronal subtypes in the dorsal spinal cord (DL1-DL6), whereas Shh 
(green) from the floor plate (FP) acts to pattern the ventral spinal cord (V0-V3, MN). Right: at later 
stages, axon guidance is influenced sequentially by (1) BMPs (purple) from the RP to direct axons 
ventrally, (2) combinatorial activities of Netrin-1 and Shh (green) to attract axons to the FP and (3) 
Wnt4 (yellow) expression in a caudal-low rostral-high gradient to control rostral turning toward the 
brain. Wnt1 signals (blue) derived from the RP act to instruct neural crest (NC) cells to acquire DRG 
sensory neuron identity. Dorsoventral and rostrocaudal axes are indicated by black arrows (Salie et al., 
2005).  
 
Apart from the spatial organization, also the role of sequential generation of defined 
neuronal subpopulation and their integration into neuronal circuits is an important 
aspect to understand when considering mechanisms controlling emergence of circuit 
function (Ladle et al., 2007) (Fig. 3). For instance, within the ventral spinal cord, 
MNs are among the earliest born neurons (Hollyday and Hamburger, 1977; Nornes 
and Carry, 1978) and are followed in short succession by the four classes of ventral 
interneurons. 
MNs and local spinal interneurons begin to interact functionally long before DRG 
sensory axons or descending inputs reach the spinal cord. As early as E11.5 in the 
mouse, when motor axons are still on their way to muscle targets, patterned 
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spontaneous activity can readily be observed when recording from outgrowing 
peripheral nerves (Hanson and Landmesser, 2003). Throughout embryonic 
development MNs, grouped within pools and projecting to individual muscles, are 
electrically coupled via gap junctions (Chang et al., 1999; Milner and Landmesser, 
1999; Kiehn and Tresch, 2002; Hanson and Landmesser, 2003). Focusing on 
chemical transmission, the motor circuit activation can be at large divided in two 
distinct phases (Kudo and Nishimaru, 1998; Milner and Landmesser, 1999; Myers et 
al., 2005) (Fig. 3). 
 
 
Figure 3. Sequential assembly of local spinal circuits in the mouse lumbar spinal cord. (A) 
Approximate time line of events observed. (B) Dominant excitatory connections during phase I are 
derived from MNs (neurotransmitter Ach) and GABA/Glycinergic interneurons. At this stage, the role 
for glutamatergic interneurons input for circuit function and connectivity is ambiguous. (C) Phase II is 
characterized by a gradual switch of GABA/Glycinergic inputs from excitation to inhibition and 
activation of glutamatergic inputs. Moreover, excitatory (Glu) Ia proprioceptive afferent connections 
to MNs are formed at late embryonic stages (red). In B and C, ventral horn are shown (Ladle et al., 
2007). 
 
The first phase (E12.5-E14.5 in the mouse) begins shortly after MNs generation. 
Acetylcholine (ACh) is the major MNs neurotransmitter and provides important 
excitatory drive for MNs activation through connections to other MNs and 
interneurons. Moreover glycine and/or GABA provided by interneurons act as 
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excitatory neurotransmitters at this early stage. The second phase (E15.5-E18.5 in the 
mouse) is dominated by upregulation of glutamatergic excitatory neurotransmission 
and paralleled by a gradual shift of glycinergic/GABAergic neurotransmission from 
excitation to inhibition (Kudo and Nishimaru, 1998; Milner and Landmesser, 1999; 
Myers et al., 2005). It is well established that this switch from excitation to inhibition 
is due to a progressive lowering of intracellular calcium concentration [Cl-]i, during 
development, that results in the shift of chloride reversal potential. This transition is 
principally mediated by the different expression of two co-transporters: NKCC1 
(highly expressed in immature neurons) raises [Cl-]i, while KCC2 (whose expression 
increases from the first postnatal week) decreases [Cl-]i (Hubner et al., 2001; 
Fiumelli and Woodin, 2007; Ben-Ari et al., 2012). 
Thus MNs and at least some glycinergic/GABAergic interneurons are functionally 
interconnected at early developmental stages, but it is difficult to judge which types 
of interneurons are already in place in the appropriate mature location (Ladle et al., 
2007). Spinal interneuron diversification during development is provided by 
progenitor domain origin, time of neurogenesis, migratory path and acquisition of 
distinct transcriptional profiles. These are generated via a tight interaction between 
programs of genetic predetermination and experience-driven processes, leading to 
functional motor outputs. These features are translated in the mature spinal cord, into 
neuronal subpopulations exhibiting differential spatial distribution patterns, 
neurotransmitter profiles, connectivity matrices including synaptic input and output 
and functional properties (Arber, 2012). The commonly used terminology “spinal 
interneurons” embraces an incredibly vast array of functionally distinct neuronal 
subtypes charged with local as well as long-distance computations in the spinal cord 
(Arber, 2012). 
 
1.2. Activity-dependent mechanisms in developing neuronal 
networks 
The assembly of functional synaptic circuits in the brain was previously thought to 
be divided in two stages. An early activity-independent phase in which neurons 
develop distinct phenotypes, migrate to their specific location and establish an initial 
set of connections. And a later activity-dependent phase characterized by refinement 
and remodelling of circuits connectivity mediated by neuronal activity (Shatz, 1990; 
Goodman and Shatz, 1993). 
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It is now widely accepted that electrical activity plays essential roles in early 
development of the nervous system. The complexity of the brains renders the number 
of genes in the genome insufficient to program the organization of the nervous 
system directly on a single-gene-to-single-component basis. Local communication is 
required to specify developmental choices in a temporally and spatially appropriate 
manner. Thus the extensive involvement of activity is required at all developmental 
stages (proliferation, migration, differentiation) as a necessary partner with genetic 
programs (Spitzer, 2006) (Fig. 4).  
 
 
Figure 4. Role of electrical activity during spinal cord development. Electrical activity regulates 
important events of spinal cord development starting at the early stages of neuronal generation and 
extending to later stages of circuit formation and synaptic plasticity (Borodinsky et al., 2012). 
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Although revising neuronal numbers or respecifying neurotransmitter identity after 
the genetic program has dictated their “fate” may seem counterintuitive and 
inefficient, electrical activity may allow adaptability of the developing system 
according to the environment that surrounds it (Borodinsky et al., 2012). 
Proliferation from stem cells give rise to neurones at a prodigious rate and this 
process is regulated by electrical signalling. Neurotransmitters release at early stages, 
before synapse formation, has different effects on neurogenesis in different regions. 
Regarding the spinal cord, glycine is essential for specifically interneurons 
differentiation: perturbing glycinergic transmission in vivo reduced the number of 
spinal interneurons without affecting MNs and sensory neurons. Moreover, it 
disrupted rhythm-generating networks and reduced the frequency of spontaneous 
glycinergic and glutamatergic events in the zebrafish (McDearmid et al., 2006). 
Since neurons are generated in a restricted set of locations, they further need to 
migrate to specific sites from which they extend processes to establish synaptic 
connections. Both the rate and the extent of migration are regulated by 
neurotransmitters released at this early point of development (Spitzer, 2006). 
Neuronal differentiation is constituted by many components and electrical activity is 
still a full partner of gene expression also in these phases. For example, spontaneous 
electrical activity can regulate the level of excitability of cells by controlling the 
expression of ion channels generating it (Spitzer, 2006). Another feature of neuronal 
differentiation is the specification of neurotransmitter phenotype mediated mainly by 
Ca2+ spike activity: altering the distinct patterns of Ca2+ spike activity spontaneously 
generated by different classes of embryonic spinal neurons in vivo changes the 
transmitter that neurons express without affecting the expression of markers of cell 
identity. This regulation is likely homeostatic: suppression of activity leads to an 
increased number of neurons expressing excitatory transmitters and a decreased 
number of neurons expressing inhibitory transmitters, while the reverse occurs when 
activity in enhanced in the Xenopus laevis embryos (Borodinsky et al., 2004). 
An important aspect of neuronal differentiation is the targeting of axons that neurons 
extend to synapse with other neurons, muscles and glands. Axons turn in response to 
different substrates and to diffusible guidance molecules both of which require 
expression of appropriate receptors. Interestingly, receptor expression is activity-
dependent (Hanson and Landmesser, 2004; Hanson and Landmesser, 2006). 
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Also the formation of dendrites, which are generally shorter than axons, more 
extensively branched and specialised for the receipt instead of transmission of 
synaptic signals, is activity-dependent. Their growth and stability depend on 
activation of neurotransmitter receptors and Ca2+ elevation (Spitzer, 2006). 
Once cells differentiate and extend their axons, the next step towards establishing 
spinal circuitry consists of formation of synapses. Synaptogenesis and maturation of 
newly formed synapses are processes strongly governed by interactions with target 
tissues, neighboring cells and by electrical activity and neurotransmitter signalling. 
Spontaneous activity in the emerging circuitry produces simple motor behaviours 
and reinforces functional synaptic connectivity within CPG. In addition to the role of 
spontaneous electrical activity in synapse formation and elimination, this activity 
also regulates synaptic strength during spinal cord development (Borodinsky et al., 
2012). 
 
2. The role of synaptic activity on neuronal health 
The concept of neuronal health involves considering a dynamic spectrum of 
physiological states ranging from protected and fully functional to vulnerable and 
dysfunctional cells (Isacson, 1993) (Fig. 5).  
 
 
Figure 5. Neurons spectrum of health. A neuron’s position in the dynamic spectrum of health is 
constantly influenced by a multitude of both beneficial and detrimental cues. In (a) the weight of an 
insult compromises the neuron health, while in (b) neuronal activity is able to boost neuronal health, 
enabling the neuron to withstand the same insult burden (Bell and Hardingham, 2011). 
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The concept that electrical activity promotes neuronal health, originated from studies 
in which activity blockade caused death in the disconnected target neurons 
(Mennerick and Zorumski, 2000). 
The myriad routes by which neuronal activity influences neuronal health are now 
becoming clearer (Fig. 6). Synaptic activity and resultant Ca2+ influx is an important 
mechanism of dialogue between the synapse and nucleus, enabling both activation of 
second messengers and gene transcription. Neuronal activity is also intimately 
involved in regulating the expression, processing, transport and release of 
neurotrophic factors, many of which have well-characterised neuroprotective effects, 
such as BDNF (Bell and Hardingham, 2011). In addition to pro-survival gene 
induction, synaptic activity results in the transcriptional suppression of core 
components of the intrinsic apoptotic cascade, leading to an enhanced resistance to 
apoptotic insults (Lau and Bading, 2009; Leveille et al., 2010). 
 
 
Figure 6. Mechanisms through which synaptic activity boosts neuronal health (Bell and Hardingham, 
2011). 
 
As well as restricting the apoptotic potential of neurons, synaptic activity also boosts 
neuronal health through an enhancement of intrinsic antioxidant defences (Bell and 
Hardingham, 2011). 
Moreover, synaptic activity is able to localize mitochondria where energy demands 
are high: by regulating mitochondrial fission/fusion and intracellular trafficking, 
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neuronal activity triggers events that balance energy demands with localized 
availability (MacAskill and Kittler, 2010). 
Synaptic activity is essential in guiding CNS maturation and this knowledge raises 
the question about its possible involvement in the born at early developmental stages 
of neurodegenerative diseases (Ben-Ari, 2008). Obviously, disorders like 
Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and 
amyotrophic lateral sclerosis (ALS) are late-onset neurodegenerative diseases, but 
we cannot exclude an impairment in the developing brain as the cause, or at least one 
of the causes, of these fatal disorders. It is difficult to imagine that an organ as 
complex and plastic as the brain could suffer an insult at an early stage without an 
electrical and/or architectural trace of this event and without alterations of 
developmental programs (Ben-Ari, 2008). 
Because several processes including proliferation or migration occur primarily in the 
developing but not the adult brain, it comes as no surprise that a wide range of agents 
and procedures produce brain malformations in the former but not the latter (Ben-Ari, 
2008). 
An additional theory about the role of synaptic activity at the earlier stages is that it 
operates as a checkpoint controlling the correct implementation of the genetic 
programme (Ben-Ari and Spitzer, 2010). Neurons and networks operate with 
feedback controls that act as homeostatic devices and serve as useful sources of 
information during the implementation of the programme (Dehorter et al., 2012). For 
example, if a neuron meant to shift from current A to B when it has performed a 
given developmental step it will remain with current A if this step fails. These 
observations imply that an insult occurring at an early developmental stage will 
disrupt the normal sequence of activity maturation, leading to a clinical syndrome 
with a variable delay, that is the onset of the disease does not coincide with this 
initial insult (Ben-Ari, 2008). Studies on a variety of disorders have shown important 
brain malformations well before the first clinical signs (Dehorter et al., 2012), 
hopefully allowing us to intervene at the proper time. 
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3. Organotypic cultures 
Until now the vast majority of FDA approved therapeutics are symptomatic and there 
is little evidence to support a neuroprotective effect for any current medications. This 
failure underscores the fact that identifying novel therapeutics remains challenging 
due to undetermined etiology, a variable disease course marked by a prolonged 
subclinical phase and the paucity of validated targets (Ravikumar et al., 2012). The 
failures of current screening systems to translate candidate molecules to real-time 
clinically effective neuroprotective agents underlie the absolute need to develop 
relevant model systems able to recapitulate as close as possible the in vivo brain 
structure and, at the same time, allowing manipulations and an easy access to 
individual neurons. Furthermore, due to the essential role of synaptic activity during 
all the phases of brain development and how its impairment could be responsible also 
of late-onset disorders, a possible strategy is to focus more on the properties on 
immature neuronal circuits. 
Efforts in developing valuable model system to study brain network connectivity in 
both healthy and disease conditions should not be underestimated. An in vitro cell 
culture assay obviously fails to account for the complex interplay between cell types 
in the CNS, while animal based studies that demonstrate disease phenotypes may not 
adequately recapitulate the pathophysiology of the disease in its entirety and are 
difficult to manipulate experimentally in a high throughput manner (Cho et al., 2007; 
Polikov et al., 2008; Jarjour et al., 2012). They are also expensive and increasingly 
unpopular on ethical grounds. Clearly what is needed now is the development of 
intermediary models based on living cells with the potential to assess biological 
function but also including sufficient throughput. The closer in vitro models parallel 
in vivo models and reflect pathophysiological mechanisms related to human disease 
conditions, the more likely they are to be of value as interfaces between drug 
discovery and development (Walker et al., 2004). 
The use of an ex vivo brain slice culture system offers an alternative to these assays. 
Slice cultures maintain the tissue architecture and neuronal connections at the 
synaptic level. This allows one to account for the complexity of cellular interactions 
and allow several modifications of variables (Haydar et al., 1999; Mielke et al., 
2005; Mingorance et al., 2006). Ex vivo CNS slice culture system partly models the 
in vivo environment and allows the development of specific disease models 
(Ravikumar et al., 2012). Although slices are by definition de-afferented explants, 
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intrinsic connections between neurons are maintained throughout the culturing 
process, thus electrophysiological approaches can be used to study the neural 
network activity gaining information on the structure-activity relationship with 
respect to function (Sundstrom et al., 2005). 
Freshly isolated brain slices, termed acute slices, have been used primarily for 
recording electrophysiological activity. The limitation of this technique relies on the 
fact that slices can only be maintained ex vivo for limited amount of hours, while 
CNS slices  are maintained in organotypic tissue cultures for several weeks enabling 
to design studies in vitro over a period of days to weeks in a context that reflects 
organ features (Sundstrom et al., 2005). Progressive standardization of the methods 
to generate these cultures has allowed the development of organotypic slice cultures 
from different CNS regions (in particular: hippocampal, thalamic, cerebellar, cortical, 
retinal and spinal slices are the best characterized). 
We can distinguish between three major techniques: 
- roller-tube cultures (dynamic): the tissue is embedded in a plasma clot on glass 
coverslips and then undergoes slow rotation that assured oxygenation thanks to 
the continuous changing of the liquid-gas interface (Gähwiler et al., 1997); 
- interface cultures (static): slices are placed on semiporous membranes and kept 
stationary during the entire culturing process obtaining oxygen from above and 
medium from below (Stoppini et al., 1991); 
- culture dishes: tissue is placed directly on collagen-coated dishes or embedded in 
three-dimensional collagen gels without taking special measures to facilitate 
oxygenation (Tucker et al., 1996). 
All techniques yield cultures that retain the basic characteristic cytoarchitecture of 
the tissue of origin and that display excellent cellular differentiation. The major 
differences between these techniques are the final slice thickness and the survival in 
culture (Gähwiler et al., 1997). Roller-tube cultures turn out to be the thinner ones 
(from 100-200 µm to cell monolayers, depending on the CNS region of origin), 
while slices grown on culture dishes result to be the thicker ones. Roller-tube and 
interface cultures survive for several weeks or even months in vitro, instead slices 
can be cultured on dishes only for a few days. 
For all these reasons, roller-tube cultures are preferable for experiments that require 
optimal optical conditions and easy access to neurons. Interface cultures offer 
advantages when a semi-three-dimensional structure is desired. Culture dishes are 
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well suited for short-term studies and have advantages for example for multi-site 
recording of electrical activity (Gähwiler et al., 1997). 
Tissue flattening depends also on the age of the animal used for the explants. 
Organotypic slice cultures can be prepared from both late embryonic and early 
postnatal animals because the essentials of the cytoarchitecture are already 
established in most CNS areas and they do not suffer of necrotic events as often 
happens with more aged animals (Gähwiler et al., 1997). 
 
3.1. Organotypic spinal cultures developed from embryonic mouse 
spinal cord 
Organotypic spinal slices are a suitable in vitro model to investigate the dynamics of 
maturation processes that rely on neuronal network activity. Our laboratory has 
developed since more than a decade the spinal slice organotypic cultures and we 
reported that these long term cultures preserve the basic spinal tissue cytoarchitecture, 
synaptic connections and the dorsal-ventral orientation of the spinal segment from 
which they are derived (Avossa et al., 2003; Rosato-Siri et al., 2004; Furlan et al., 
2005; Furlan et al., 2007). 
In the mouse spinal cord, spontaneous rhythmic activity can be observed early in 
embryogenesis (Suzue, 1996; Branchereau et al., 2000; Hanson and Landmesser, 
2003), before the innervations of muscle is complete. This early spontaneous activity 
differs from late alternating locomotor-like activity in at least three aspects: 
- early spontaneous activity is composed of episodic periods of bursts that are 
synchronized across the rostrocaudal extent of the spinal cord; 
- glutamate is not involved in generating spontaneous activity, rather the excitatory 
drive is supplied by GABAergic, glycinergic and cholinergic transmission 
(Hanson and Landmesser, 2003); 
- chemical and electrical transmission are critical for generating spontaneous 
activity at early embryonic ages (Hanson and Landmesser, 2003), whereas in 
neonatal rodents chemical transmission appears to predominate (Tresch and 
Kiehn, 2000). 
This spontaneous rhythmic activity is present because of two crucial features. The 
first is the predominantly excitatory nature of developing synaptic connections, since 
at this stage GABA and glycine depolarize spinal neurons. The second is the 
presence of activity-dependent depression of neuronal and network excitability 
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during which neurons recover to be ready for the following episode (O’Donovan et 
al., 1998). 
Although bursts are highly synchronized, the firing of individual neurons is not 
completely synchronized throughout the network. Discharges persist significantly 
longer in some neurons than others, and this delayed firing could retrigger the 
network (O’Donovan et al., 1998). 
Since neural activity is involved in the establishment of the adult connectivity pattern, 
synchrony may have evolved to maximize the number of neurons exposed to 
spontaneous activity. Synchronization will serve as an amplifier of neuronal activity 
by increasing both the depolarization of individual neurons and the number of active 
neurons by temporal and spatial facilitation of their synaptic inputs (O’Donovan et 
al., 1998). 
During spinal network development progressive changes in network properties are 
required to allow the generation of mature motor behaviour and some of these 
changes occur also during the in vitro development of organotypic spinal cord 
explants (Rosato-Siri et al., 2004). 
At early stage of development in vitro (1 week of in vitro growth, 1WIV), that 
corresponds to the late embryonic stage, ventral interneurons display a synchronous 
bursting activity which is very effective in driving muscle contractions. At later 
stages (2 and 3 WIV), representing the early postnatal phase, this activity is 
drastically reduced as well as its correlation with motor responses (Rosato-Siri et al., 
2004).  
Another important feature of the spinal circuit development is the role played by the 
two major inhibitory neurotransmitters in the adult: GABA and glycine. During early 
foetal periods, the immature high intracellular chloride concentration results in 
depolarizing response upon GABA and glycine synaptic receptors activation (Wu et 
al., 1992). Such depolarizations lead to transient elevation in the cytoplasmatic 
calcium concentration (Cherubini et al., 1991; Ziskind-Conhaim, 1998) relevant to 
neuronal growth and differentiation (Mattson and Kater, 1987). This suggests that 
GABA and glycine might promote neuronal development (Gao et al., 2001). Such a 
control might be crucial for establishing the required inhibitory pathways between 
the rhythm-generating networks. The depolarizing effect brought by inhibitory 
aminoacids diminishes over time as neurons mature and synaptogenesis subsides. 
This developmental switch from depolarizing to hyperpolarizing action also 
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coincides with the developmental transition between different isoforms of 
glycinergic receptors (GlyRs): the excitatory GlyRs in embryonic neurons are of the  
α2 subtype, combining in homomeric receptors and characterized by long mean open 
time, while, after birth, the α1 subunit replaces the previous one, underlying 
developmental shortening in the life time of native GlyRs channels (Takahashi et al., 
1992). The majority of adult glycinergic neurotransmission is mediated by 
heteromeric α1β GlyRs (Lynch, 2009). 
There is another fundamental characteristic regarding GABA and glycine interplay: 
during the period when synaptic inhibition starts to succeed, a transition from 
GABAergic to glycinergic synapses on MNs takes place. This occurrence has been 
observed by both immunohistochemical analysis (Allain et al., 2004; Allain et al., 
2006) and physiological data (Kotak et al., 1998; Gao et al., 2001; Nabekura et al., 
2004). The functional implication is connected to the currents kinetic mediated by 
the two neurotransmitters: the long lasting GABAergic currents might control the 
level of neuronal excitation during foetal period, while the postnatal shorter 
glycinergic currents allow the generation of faster and larger amplitude APs (Gao et 
al., 2001). 
In the embryonic spinal cord, glycine progressively becomes the dominant force in 
driving motor patterns of activity, such as coordinated locomotor-like bursts (Bonnot 
et al., 1998; Whelan et al., 2000). One of the major role of spinal glycinergic 
neurotransmission is the shaping of MNs output via a number of glycinergic 
interneurons in the ventral horn of the spinal cord (Gao and Ziskind-Conhaim, 1995). 
Apart from controlling movement execution, glycine is also involved in representing 
or mediating responses to sensory perception, since it is widespread also in the dorsal 
horn (Betz, 1991; Kuhse et al., 1995). 
These considerations highlighted that the evolution of the locomotor-like activity 
during spinal network maturation reflects two fundamental developmental steps 
regarding GABA and glycine neurotransmitters: the switch of GABA function from 
excitatory to inhibitory (Wu et al., 1992) and the subsequent shift in the spinal cord 
from GABA receptor-mediated to glycine receptor-mediated synaptic transmission 
(Gao et al., 2001). 
These functional transitions have been well described also in cultured slices: the 
pharmacological block of GABA and glycine receptor activity (mediated by the 
application of SR-95531 and strychnine respectively), has different outcomes based 
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on the age of in vitro growth of the organotypic spinal cultures. At 1 WIV 
GABAergic and glycinergic systems did not appear to limit burst duration and 
frequency, while at later stages (2 WIV) their presumed inhibitory role controls the 
emergence of synchronous bursting in preparations that did not burst spontaneously 
and prolonged the duration of spontaneous bursts in the minority of preparation 
where bursting was still present (Rosato-Siri et al., 2004). Interestingly, these 
developmental changes are associated with a progressive decrease in glutamic acid 
decarboxylase (GAD) immunoreactivity, the enzyme responsible of GABA synthesis. 
At 1 WIV GAD-labeled neurons were numerous and display a widespread 
distribution, instead at 2-3 WIV there was a significant decrease in their number and 
moreover they were localized principally in the dorsal horn regions (Avossa et al., 
2003). 
Taken together these results indicate that the organotypic cultures developed from 
embryonic mouse spinal cord preserved the minimal circuit that replicate some of the 
basic patterns of activity generated by the entire spinal cord in vitro, and this circuit 
undergoes appropriate maturational processes (at least during the first 3 WIV) 
regarding both neuronal and glial cells (Avossa et al., 2003; Rosato-Siri et al., 2004) 
(see Methods 1.7. Spinal slice morphology, for detailed cell phenotypes present 
within organotypic spinal slices). These considerations support these cultures as a 
valuable in vitro model system to study the mechanisms of neurogenesis, glial 
differentiation, myelination, muscle formation and synaptogenesis (Avossa et al., 
2003).  
For these reasons, organotypic embryonic mouse spinal slices represent an ideal 
experimental tool to investigate the cross-talk between the spinal network activity 
and stress conditions, ranging from transgenic models of neurodegenerative diseases 
to the manipulation of the microenvironment and of defence mechanisms such as the 
inflammatory system and antioxidant strategies. 
 
4. Amyotrophic lateral sclerosis 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, whose 
primary hallmark is the selective killing of MNs in the motor cortex, brain stem and 
spinal cord, which initiates a progressive paralysis in mid-life. 
The clinical features of ALS are muscle weakness, atrophy and spasticity each of 
which reflects the degeneration of upper and lower MNs in the brain and spinal cord. 
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It is recognized that at least 30% of interneurons in the motor cortex and spinal cord 
also degenerate (Cleveland and Rothstein, 2001). 
ALS has a prevalence of 2-3 per 100.000 people, with an average age onset between 
50 and 60 years, with a male to female ratio of approximately 1.6/1 and it is 
generally fatal within 1-5 years of onset (Yoshida et al., 1986), usually caused by 
denervation of the respiratory muscles and diaphragm. 
Since its description by the famous French neurobiologist and physician Jean-Martin 
Charcot (Charcot and Joffory, 1869), more than 140 years ago, the causes of this 
disorder and the mechanisms underlying the characteristic selective degeneration of 
MNs, remain unknown thus contributing to the lack of appropriate target 
identification and effective mechanism-based therapies. 
 
4.1. Genetic factors 
In 90-95% of patients, there is no apparent genetic linkage, a form of the disease 
referred to as sporadic ALS (sALS), but in the remaining 5-10% of cases, the disease 
is inherited in a dominant manner, a form referred to as familial ALS (fALS). 
The clinical phenotype of fALS patients is indistinguishable from sALS, but it 
displays an equal male to female ratio, an earlier age of onset and longer disease 
duration (Ticozzi et al., 2011). 
The first mutated gene identified in fALS encodes the enzyme Cu/Zn superoxide 
dismutase 1 (SOD1) (Rosen et al., 1993) and since this discovery, over 150 
pathogenic mutations in SOD1 have been identified in ALS patients (Andersen, 
2006). Recently, mutations in other genes have also been found to be causative for 
fALS (Table 1). 
 
 
Table 1. Currently known genetic causes of fALS. Source: http://alsod.iop.kcl.ac.uk.  
 
The observation of pathogenic mutations in the TARDBP gene which encodes Tar 
DNA binding protein 43 (TDP-43), a DNA and RNA binding protein (Kabashi et al., 
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2008; Sreedharan et al., 2008), has strengthened the possibility that aberrant RNA 
processing may play a significant role in ALS pathogenesis. This association was 
further confirmed by the identification of mutations in the DNA and RNA binding 
protein fused in sarcoma/translocated in liposarcoma (FUS/TLS) as a cause of fALS 
(Kwiatkowski et al., 2009; Vance et al., 2009). Strikingly, in the autumn of 2011, 
two groups simultaneously reported the finding of a noncoding GGGGCC 
hexanucleotide repeat expansion in C9ORF72 gene (DeJesus-Hernandez et al., 2011; 
Renton et al., 2011) that seems to have an RNA binding function, in a substantial 
proportion of the remainder of cases of fALS. The last gene identified to be mutated 
in fALS patients is Profilin 1 (PFN1) (Wu et al., 2012); even though it has already 
been demonstrated that its mutations are not a common and prominent cause of 
neurodegeneration (Lattante et al., 2013), PFN1 is crucial for the conversion of 
monomeric (G)-actin to filamentous (F)-actin, shedding light on a new potential 
mechanism in the pathogenesis of ALS that is disruption of neurons cytoskeletal 
architecture (Renton et al., 2014). 
These recent genetic breakthroughs further reinforces the concept that ALS 
pathogenesis involves multiple pathways (Rothstein, 2009) and that probably is not 
only a monogenetic, but often a digenetic or polygenetic disease with a variable 
penetrance (Andersen and Al-Chalabi, 2011). In addition, discovering such 
mutations has provided the basis for the development of experimental animal models 
of the disease. Genetic disease models, crucial to investigate fALS biology, are also 
useful for studying sALS due to the clinical similarities and common pathogenic 
pathways of the two forms of disease (Bosco et al., 2010). Recently, reports hints at 
the vanishing boundary between fALS and sALS: gene mutations responsible of 
fALS are also detectable in a small but significant proportion of apparently sALS 
reporting no family history (Fig. 7); for example, SOD1 mutations are reported in up 
to 7% of sALS cases (Andersen, 2006). 
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Figure 7. The current macrogenetic landscape in ALS. At present, at least two-thirds of fALS cases 
can be linked to one of four major genes whose mutations can be detectable also in a small but 
significant proportion of sALS (Turner et al., 2013). 
 
These discoveries strengthen the hypothesis of an interplay between ALS and 
frontotemporal dementia (FTD) since these mutations had already been linked to 
FTD. In ALS patients it has been recognized an impairment of frontotemporal 
functions such as cognition and behaviour in up to 50% (Lomen-Hoerth et al., 2003; 
Phukan et al., 2007; Giordana et al., 2011). Similarly, as many as half of FTD 
patients develop clinical symptoms of MNs dysfunction (Lomen-Hoerth et al., 2002). 
The genetic link by pathogenic mutations in TARDBP, FUS and most recently 
C9ORF72 supports the close relation between these two entities (Ludolph et al., 
2012). 
 
4.2. SOD1 mutations 
Even though, thanks to the recent discoveries of gene mutations linked to ALS, 
alternative disease models are developed, the SOD1 models have been the mostly 
investigated until now and substantially contributed to our current knowledge in the 
pathogenesis of ALS, in particular transgenic rodent overexpressing the mutated 
human SOD1 protein (McGoldrick et al., 2013). These animals develop ALS in a 
clinical and pathological fashion reminiscent of the human counterpart (Rothstein, 
2003). Some ALS models exploiting TDP-43 and FUS mutations have already been 
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tested, but in large part these first attempts do not recapitulate ALS-like phenotypes 
to the extent that SOD1 transgenic mice do (McGoldrick et al., 2013). 
SOD1 is an ubiquitous cytoplasmic and mitochondrial enzyme responsible for the 
catabolism of superoxide radicals to hydrogen peroxide and molecular oxygen, 
thereby preventing oxidative stress. Due to the damaging effects of reactive oxygen 
species (ROS) and their association with neurodegenerative diseases, it was 
originally proposed that pathogenic mutations in SOD1 may cause ALS as a result of 
a loss of dismutase activity (Rosen et al., 1993). It has now been demonstrated that 
SOD1-mediated toxicity in ALS is not due to the loss of its catalytic activity but 
instead to a gain of function which confers toxic properties that are independent of 
the levels of dismutase activity (Brown, 1995). The main arguments supporting this 
theory are that SOD1 knockout mice do not develop MNs disease (Reaume et al., 
1996) and that levels of SOD1 activity do not correlate with disease in mice or 
humans. In fact, some mutant enzymes retain full dismutase activity (Borchelt et al., 
1994; Bowling et al., 1995), and chronic increase in the levels of wild-type SOD1 
(and consequently dismutase activity) has no effect on the disease (Bruijn et al., 
1998) or even accelerates it (Jaarsma et al., 2000). 
At present, 12 different human SOD1 mutations have been expressed in mice (Turner 
and Talbot, 2008) and among them transgenic SOD1G93A mice are largely used in 
ALS research.  
In my PhD work involving ALS genetic models, I have used mice carrying 
SOD1G93A mutation and I will focus on its characterization regardless the existence 
of other valuable ALS models. 
 
SOD1G93A mice 
Shortly after the discovery of SOD1 mutations in fALS (Rosen et al., 1993) the 
transgenic mouse model SOD1G93A was developed, expressing approximately 20-24 
copies of the human coding sequence with the G93A mutation, under control of the 
human SOD1 promoter (Gurney et al., 1994). 
The disease in these mice begins with hindlimbs tremor and weakness around 3 
months detected by locomotor deficits progressively leading to complete paralysis of 
the limbs followed in 4 months by death (Gurney et al., 1994). Pathologically, 
neuromuscular junctions degenerate around 47 days (Fisher et al., 2004; Pun et al., 
2006) while loss of proximal axons is prominent at 80 days coinciding with motor 
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impairment and a severe 50% dropout of lower MNs is evident at 100 days (Fischer 
et al., 2004). This retrograde sequence of neurodegeneration has led to the proposal 
that ALS may be a distal axonopathy (Fischer et al., 2004). Importantly, pathology is 
not restricted to lower MNs in transgenic SOD1G93A mice, involving a regression of 
descending corticospinal, bulbospinal and rubrospinal tracts in this model (Zang and 
Cheema, 2002). 
MNs cellular alterations are mainly characterized by mitochondrial vacuolisation 
(Dal Canto and Gurney, 1995), Golgi apparatus fragmentation (Mourelatos et al., 
1996), neurofilament-positive inclusions (Tu et al., 1996) and cytoplasmic SOD1-
immunoreactive aggregates (Johnston et al., 2000). These alterations bring to 
neuronal loss and atrophy of the ventral horns in the spinal cord, but the medulla, 
pons and midbrain are affected as well (Dal Canto and Gurney, 1995). 
Spinal cord are also characterized by substantial astrocytosis and microgliosis around 
disease-onset (Hall et al., 1998). 
Several lines of transgenic SOD1G93A mice were originally obtained and they 
principally differentiate for their transgene copy number with slightly variable 
phenotypes, basically mice carrying the lower transgene copy number develop latent 
disease of longer duration (Gurney et al., 1994; Chiu et al., 1995; Dal Canto and 
Gurney, 1995; Dal Canto and Gurney, 1997; Gurney, 1997a). 
 
4.3. Mechanisms of MNs degeneration in SOD1G93A ALS 
ALS is a complex and multifactorial disease (Fig. 8) where probably distinct 
molecular pathways converge to the same final result that is MNs death (Gurney, 
1997b). Hereafter I will briefly summarize the major mechanisms though to be 
involved in ALS disease. Oxidative stress and neuroinflammation will be considered 
more in details separately. 
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Figure 8. Cellular and molecular processes mediating MNs degeneration in ALS. Neurodegeneration 
might result from a complex interplay of glutamate excitotoxicity, mitochondrial dysfunction, 
impaired axonal transport, protein and neurofilament aggregation, generation of free radicals and 
inflammatory dysfunction. A genetic component is also involved (Kiernan et al., 2011). 
 
Excitotoxicity 
Excitotoxicity is the pathological process by which neurons are damaged and killed 
by excessive glutamate stimulation that result in a massive calcium influx. This is 
undoubtedly one of the more robust pathogenic mechanisms in ALS (Heath and 
Shaw, 2002). Noteworthy, MNs are particularly susceptible to toxicity through 
activation of cell surface glutamate AMPA receptors (Carriedo et al., 1996). 
Glutamate levels are elevated in the cerebrospinal fluid (CSF) of ALS patients 
(Rothstein et al., 1990; Shaw et al., 1995). A follow-up study reported that increased 
CSF glutamate levels were apparent in approximately 40% of nearly 400 ALS 
patients and correlated with disease severity (Spreux-Varoquaux et al., 2002).  
In other studies, reducing excitatory sensory input delayed disease onset in 
SOD1G93A mice (Ilieva et al., 2008). 
Glutamate clearance from the synaptic cleft is critical in preventing repetitive firing 
and subsequent excitotoxicity (Cleveland and Rothstein, 2001). Fast removal of 
synaptic glutamate is accomplished primarily by the astrocytic glutamate transporter 
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EAAT2 (Rothstein et al., 1996). Analysis of motor cortex and spinal cord extracts 
from ALS patients demonstrated a nearly complete loss of EAAT2 protein in 25% of 
patients and abnormality in EAAT2 protein expression in up to 80% patients 
(Rothstein et al., 1995). 
In SOD1G93A transgenic rats, EAAT2 expression in the ventral horn is reduced 
presymptomatically and almost completely abolished by end-stage disease (Howland 
et al., 2002). Another study reported that overexpression of EAAT2 in mutant 
SOD1G93A mice delayed the onset of motor deficits and partially increased 
neuroprotection compared with SOD1 mutants in which EAAT2 expression was not 
manipulated (Guo et al., 2003). In addition, mutant SOD1G93A mice treated with a β-
lactam antibiotic that potently stimulates EAAT2 expression demonstrated delayed 
disease onset, slowed disease progression and prolonged life span (Rothstein et al., 
2005). 
Collectively, these studies indicate that excitotoxic levels of extracellular glutamate, 
resulting from selective impairment of the glial glutamate transporter EAAT2, are at 
least one of the causes of MNs degeneration in ALS. This knowledge implyes that 
the degeneration of MNs in ALS is not a genuine cell-autonomous process 
(Rothstein, 2009). 
 
Mitochondrial dysfunction 
Mitochondria are sophisticated organelles that require a complex regulation. Besides 
their ability to convert nutrients into ATP, mitochondria play an essential role in 
intermediate metabolism and in maintaining calcium homeostasis. However, 
mitochondria are also the main source of ROS and regulate the intrinsic apoptotic 
pathways. Thus, mitochondrial dysfunction can lead to bioenergetics failure, 
oxidative stress or apoptosis and results in cell death (Cozzolino and Carrì, 2012). 
Histological analysis in ALS tissue samples reveals an altered ultrastructure with 
swollen and vacuolated mitochondria populating MNs, muscles and intra-muscular 
nerves (Afifi et al. 1966; Atsumi, 1981; Siklos et al., 1996; Sasaki et al., 2007). 
This altered mitochondrial morphology was also confirmed in SOD1G93A mouse 
models (Dal Canto and Gurney, 1994; Kong and Xu, 1998; Higgins et al., 2003). 
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Impaired axonal transport 
MNs axons may reach up to one metre in length in humans and rely on efficient 
intracellular transport system. The main mechanism to deliver cellular components to 
their action site is long-range microtubule-based transport. The two major 
components of this machinery are the “engines” or molecular motors and 
microtubules, the “rails” on which they run (De Vos et al., 2008). Herein the 
molecular motors, it is possible to distinguish the kinesin family involved in the 
transport toward the synapses (anterograde), and the dynein family mediating the 
transport towards the cell body (retrograde). Classically, axonal transport is further 
divided in fast and slow transport on the basis of movement speed, although being 
both mediated by kinesin and dynein, the slower rate simply due to prolonged pauses 
between movements (Roy et al., 2000; Wang et al., 2000a). 
SOD1G93A transgenic mouse model of ALS show evidence of damage of both fast 
and slow, anterograde and retrograde axonal transports, as an early pathogenic event 
leading to the hypothesis that axonal transport impairment contributes to the disease 
process in a primary fashion and is not just an end-stage epiphenomenon (Zhang et 
al., 1997; Williamson and Cleveland, 1999; De Vos et al., 2007). 
How mutated SOD1 perturbs axonal transport is not fully understood, but it is likely 
that it involves several different pathways: damage to mitochondria, reduced ATP 
supply, altered phosphorylation of molecular motors of neurofilaments (De Vos et al., 
2008). However, no such findings have been observed in humans with ALS, even if 
one of the hallmark of the disease is the aberrant accumulation of neurofilaments in 
the cell body and proximal axons of MNs that can result in an impaired axonal 
transport. 
 
Protein aggregation 
A common feature of neurodegenerative disorders, intracellular aggregates, represent 
another candidate mechanism by which MNs degenerate in ALS. Aggregation occurs 
when a protein cannot reach its final and normal conformation, due to mutation 
and/or environmental triggers, that result in protein misfolding with following risk of  
intracellular inclusions. Whether such aggregated proteins play a key role in disease 
pathogenesis, whether they are simply a harmless by-products of the 
neurodegeneration process, or whether they could be beneficial to the cell by 
sequestering potentially toxic abnormal proteins, it is still under debate (Shaw, 2005). 
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The mutant SOD1 protein in transgenic mouse model of familial ALS, forms 
conspicuous cytoplasmatic inclusions in MNs and sometimes in astrocytes, which 
develop before the onset of motor dysfunction. SOD1 aggregates could produce 
cellular toxicity through several mechanisms: by sequestration of other proteins 
required for normal MNs function (Watanabe et al., 2001); by reducing the 
availability of chaperone proteins required for the folding and function of other 
essential intracellular proteins (Bruening et al., 1999) and by reducing proteasome 
activity needed for normal protein turnover (Allen et al., 2003); by aggregation on or 
within specific organelles, such as mitochondria, inhibiting their function. 
Regardless the still uncertainty role of protein aggregations in ALS, it is noteworthy 
that they can be identified in both sporadic and familial SOD1 related ALS, 
suggesting a shared pathogenic link (Rothstein, 2009). 
 
5. Oxidative stress 
Oxygen is essential for the normal function of eukaryotic organisms. Different 
tissues have different oxygen demands depending on their metabolic needs. The CNS 
represents only the 2% of the total body weight and accounts for more than 20% of 
the total consumption of oxygen (Halliwell, 2006). However, this metabolic activity 
also results in the generation of free radicals that may have damaging effects on cells 
when overwhelming antioxidant defences (Dröge, 2002). The CNS requires effective 
antioxidant protection since neurons have a life-long duration and they exhibit higher 
(about 10-fold) oxygen consumption compared to other tissues (Gandhi and 
Abramov, 2012). Oxidative stress is a condition in which the balance between the 
production of ROS and the antioxidant defence mechanisms is compromised, 
resulting in damaged cells by the excessive ROS. ROS may target several different 
substrates in the cell, causing protein, DNA, RNA oxidation and lipid peroxidation, 
modulating their function, actively contributing to the development of 
neurodegeneration (Gandhi and Abramov, 2012). These notions brought to the 
assumption that oxidative stress may be important in the aetiology of a variety of 
late-onset neurodegenerative diseases. 
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5.1. The role of oxidative stress in ALS 
Multiple pathological studies have reported the presence of increased oxidative stress 
in ALS CSF (Smith et al., 1998; Bogdanov et al., 2000; Simpson et al., 2004; Ihara 
et al., 2005) and post-mortem tissue (Fitzmaurice et al., 1996; Ferrante et al., 1997a; 
Shibata et al., 2001) compared to control samples. The measurements of oxidative 
stress is possible thanks to markers of, for instance, oxidized DNA (8-hydroxy-2’-
deoxyguanosine, 8-OHdG) and lipid peroxidation (4-hydroxynonenal). Interestingly, 
as mentioned before, also abnormalities in mitochondria, the main ROS generator in 
the cells, have been detected in both sALS and fALS post-mortem and biopsy 
samples from the spinal cord, nerves and muscles (Lin and Beal, 2006). 
Transgenic mouse and cell culture models of ALS based on mutant SOD1 
recapitulate the oxidative damage to protein, lipid and DNA observed in the human 
disease (Ferrante et al., 1997b; Andrus et al., 1998; Liu et al., 1998; Liu et al., 1999; 
Cookson et al., 2002; Poon et al., 2005). In particular, in SOD1G93A mice were 
reported increased levels of oxidized products in parallel with disease progression 
and mutant SOD1 was one of the most severely affected protein identified (Andrus et 
al., 1998). Moreover, WT SOD1 may acquire binding and toxic properties of mutant 
forms of SOD1 through oxidative damage since hydrogen peroxide (H2O2, the most 
common free radical-generating compound) treatment induced misfolding of WT 
SOD1, yielded the formation of its aggregates similar to those of mutant SOD1 
species and triggered microglia activation and death of cultured MNs derived from 
embryonic mouse spinal cord (Ezzi et al., 2007). Recently, it has been reported that 
in MNs-like NSC34 cells, a hybrid cell line produced by fusion of neuroblastoma 
with mouse MNs-enriched primary spinal cord cells (Cashman et al., 1992), 
oxidative stress induced by H2O2 led to cell death, with the SOD1G93A mutant cells 
displaying the greatest susceptibility to H2O2 compared to control cells at all the 
concentrations tested (Richardson et al., 2013). 
Although we have a certain knowledge about the involvement of oxidative stress in 
ALS disease, we still do not know whether it is a primary cause or merely a 
downstream consequences of the neurodegenerative process (Andersen, 2004). What 
is clear is that oxidative stress intersects with other cellular events in the emerging 
drawing of ALS aetiology leading to MNs death (Fig. 9). For instance, exposure to 
ROS was sufficient to reduce uptake of glutamate through its transporters of both 
glial and neuronal cells (Trotti et al., 1998; Rao et al., 2003), inducing excitotoxicity. 
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Cumulative oxidative damage over time may be responsible for the decreased 
mitochondrial efficiency and causes dissociation of SOD1 dimers to monomers with 
subsequent aggregation (Rakhit et al., 2004). ROS can also activate glial cells, 
resulting in release of further ROS and proinflammatory cytokines that activate 
neighboring cells that can be neurotoxic (Banati et al., 1993; Koutsilieri et al., 2002; 
Zhao et al., 2004). 
 
 
Figure 9. Oxidative stress exacerbates other MNs death mechanisms in ALS. ROS can (1) increase 
extracellular glutamate levels, (2) decrease mitochondrial efficiency, (3) increase endoplasmic 
reticulum (ER) stress, (4) catalyze aberrant oxidative reactions, (5) cause aggregation of neurofilament 
subunits, (6) activate microglia (Barber and Shaw, 2010). 
 
6. Neuroinflammation 
The CNS has been traditionally considered immunologically privileged in particular 
because it is surrounded by the blood-brain barrier (BBB). Current data suggest that 
the CNS is a highly immunological active organ, with complex immune responses. 
Peripheral immune cells can cross the intact BBB, neurons and glia actively regulate 
macrophage and lymphocyte responses with microglia being immunocompetent cells 
(Carson et al., 2006; Lampron et al., 2013). 
Neuroinflammation is characterized by activated microglia and astrocytes and 
infiltrating T cells at the site of neuronal damage (Appel et al., 2009), representing a 
typical feature in several neurodegenerative disorders (Carson et al., 2006). 
Microglia are of mesenchymal origin and are the resident macrophages in the CNS 
and account for 10% of the total glial cell population in the brain. They constantly 
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screen the extracellular environment and closely interact with astrocytes and neurons. 
Microglia can be activated by a range of signals (Hanisch and Kettenmann, 2007) 
and once activated they turn their morphology from ramified (resting microglia) to 
amoeboid (activated microglia) and secrete proinflammatory molecules such as 
tumor necrosis factor alpha (TNF-α), interferon gamma (INF-γ) and interleukin one 
beta (IL-1β) contributing to the inflammatory process, together with trophic and anti-
inflammatory factors that, on the opposite, contribute to the repair and limitation of 
inflammation. Microglia can thus exert a deleterious (M1) and a benign (M2) 
function, depending on their intrinsic properties, interaction with the cellular 
microenvironment and presence of pathogenic factors (Hanisch and Kettenmann, 
2007; Henkel et al., 2009; Michelucci et al., 2009). The M2/M1 distinction is not 
meant to represent a specific differentiation state of microglia, but as a spectrum of 
potential beneficial versus harmful responses and these phenomena may fall 
anywhere within this continuum (Liao et al., 2012). 
Astrocytes are ectodermal cells and are probably about ten times more numerous 
than neurons. They have many complex functions such as regulating extracellular 
neurotransmitter concentrations, exerting metabolic or ionic homeostatic functions 
and providing trophic support for surrounding neurons (Sofroniew and Vinters, 
2010). Astrocytes are not immune cells per se, but can, in specific conditions, 
contribute to the immune response (Farina et al., 2007). 
T-cells are also key contributors to this reaction since they infiltrate the CNS and 
modulate the neuroinflammatory reaction (Beers et al., 2008; Chiu et al., 2008). 
Summarizing, we should take caution regarding the multiple roles that immune 
system may have in both neurodegeneration and neuroprotection (Smith et al., 2012). 
An immune response could make disease more severe, however, it can also be 
protective (Schwartz et al., 1999). One possible explanation is that the overall effect 
of immune activation may be related to the timing of the response (McCombe and 
Henderson, 2011) meaning that another aspect that need to be considered, is whether 
neuroinflammation represents an event preceding cell death or a consequence of the 
disorders to determine if it is primary and part of the cause of the disease or 
secondary to the tissue damage (McCombe and Henderson, 2011). 
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6.1. The role of neuroinflammation in ALS 
ALS has been at time classified as a cell-autonomous disease, meaning that it is 
caused by mutant damage solely within MNs. It is now largely accepted that toxicity 
to MNs derives from damage developed within cell types beyond the MNs: the non-
cell-autonomous theory (Boillée et al., 2006a) (Fig. 10). The initial evidence for this 
assumption came from attempts to induce the disease when mutant SOD1 is 
selectively expressed only in MNs (Pramatarova et al., 2001; Lino et al., 2002) or 
astrocytes (Gong et al., 2000). None of these efforts produced MNs degeneration or 
death. A later study succeeded with mutant SOD1 expression restricted to neurons, 
however animals developed disease very late and the disease progressed slowly 
reaching lower degree of paralysis relative to lines expressing the same mutant 
ubiquitously (Jaarsma et al., 2008). Analyses of chimeric mice revealed that high 
expression levels of mutant SOD1 in most (Clement et al., 2003) or all (Yamanaka et 
al., 2008a) MNs is not sufficient to provoke cell-autonomous degeneration of 
individual MNs. In fact, MNs expressing mutant SOD1 could escape disease if 
surrounded by a sufficient number of normal non-neuronal cells. Conversely normal 
MNs surrounded by mutant SOD1 containing non-neuronal cells developed signs of 
abnormality, with the development of ubiquitinated intraneuronal deposits (Clement 
et al., 2003). 
Several studies demonstrated that suppression of mutant SOD1 synthesis selectively 
within MNs (Ralph et al., 2005;  Boillée et al., 2006a; Yamanaka et al., 2008b) or 
MNs and interneurons (Wang et al., 2009) extended animals survival by slowing the 
disease onset markedly, but was of no benefit at all in slowing the rate of disease 
progression after onset. In contrast, diminishing mutant SOD1 levels within 
microglia had little effect on early disease but sharply slowed later disease 
progression (Beers et al., 2006; Boillée et al., 2006a; Wang et al., 2009). Survival 
after disease onset was almost tripled (Boillée et al., 2006a). Noteworthy, 
introducing mutant SOD1-expressing microglia cells into control animals did not 
give rise to MNs disease, demonstrating that they are not sufficient to cause MNs 
death themselves (Boillée et al., 2006b). 
Astrocytes participate in this complex scenario: although restricting mutant SOD1 
expression in astrocytes is not sufficient for disease emergence (Gong et al., 2000), 
selective reduction of mutant SOD1 in astrocytes slowed disease progression and 
double the length of disease duration after onset (Yamanaka et al., 2008b). This was 
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accompanied by delayed microglia activation, demonstrating a functional cross-talk 
between mutant astrocytes and microglia (Ilieva et al., 2009). 
Mutant astrocytes also induced changes in their partner MNs. In cell cultures 
experiments, mutant SOD1 expression in astrocytes abrogated astrocyte capacity in 
inducing the up-regulation of the glutamate receptor subunit GluR2 in neighboring 
MNs, improving MNs vulnerability, due to the fact that GluR2 subunit containing 
receptors are Ca2+ impermeable (Van Damme et al., 2007). 
Taken together, mutant SOD1 expression in MNs determines the initial timing of 
disease onset and early progression, but very surprisingly does not contribute much 
to later disease progression, while mutant SOD1 within microglia and astrocytes 
accelerates disease progression. 
It is interesting that suppression of mutant SOD1 from a substantial proportion of 
Schwann cells not only failed to slow any aspect of disease, but it also generated a 
substantial acceleration of the late phase of disease (Lobsiger et al., 2009). On the 
other hand, modification of mutant SOD1 expression within muscles or endothelial 
cells does not affect ALS at any stage (Miller et al., 2006). 
 
 
Figure 10. Mutant SOD1 expression within different cell types has a diverse outcome in ALS. Mutant 
SOD1 in MNs dictates the onset of the disease without influencing its progression, while in microglia 
or astrocytes the opposite happens. Mutant SOD1 in muscles and endothelial cells does not affect 
ALS but, unexpectedly, in Schwann cells it was found to slow disease progression (Ilieva et al., 2009). 
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Activation of microglia and astrocytes is a prominent histological feature in the brain 
and in particular in the spinal ventral horn in ALS patients (Kawamata et al., 1992; 
Schiffer et al., 1996; Henkel et al., 2004; Turner et al., 2004) and in mutant SOD1 
transgenic mice (Hall et al., 1998; Alexianu et al., 2001; Henkel et al., 2006). In the 
mice, microglia activation is present before the onset of significant MNs loss or 
motor weakness (Henkel et al., 2006). Various inflammatory cytokines or enzymes 
are upregulated in the spinal cord or CSF of ALS patients such as IL-6, IL-1β, cyclo-
oxygenase 2 (COX-2) and prostaglandin E2 (PGE2) (Sekizawa et al., 1998; Almer et 
al., 2002) and in the spinal cord of mutant SOD1G93A mice like IL-1β, TNF-α, COX2 
and PGE2 (Elliott, 2001; Hensley et al., 2002). Among these factors, one particularly 
interesting cytokine is TNF-α, since it has been shown to be produced in higher 
levels by adult SOD1G93A microglial cells compared to the non-transgenic ones 
(Weydt et al., 2004) and administration of a TNF-α antagonist yielded a mild 
increase in survival in mutant SOD1G93A mice (West et al., 2004). The existence of 
both microglia activation and pro-inflammatory cytokine production before disease 
symptomatology indicates that biochemical changes induced by the immune system 
activation may be directly involved in MNs degeneration (Smith et al., 2012). 
Additional evidence implicating microglia in the pathogenesis of ALS arose from 
forcing the activation of the immune system in SOD1G93A mice via chronic 
administration of lipopolysaccharide (LPS), a well-known microglia activator: such a 
treatment exacerbated the disease (Nguyen et al., 2004). One of the direct toxic 
effects of activated microglia seemed to implicate nitric oxide (Zhao et al., 2004) 
suggesting an interplay between neuroinflammation and oxidative stress in mediating 
MNs degeneration. 
Moreover, mutated SOD1, released by MNs, is a potent activator of microglial cells 
(Urushitani et al., 2006), again emphasizing the cross-talk between MNs, microglia 
and potentially other non-neuronal cells that may cooperate to drive disease 
progression (Boillée et al., 2006b). 
The nervous and immune systems are engaged in an intense dialogue during ALS 
progress (Kerschensteiner et al., 2003). Microglia may adopt a protective or 
destructive phenotype at different times in the disease, which could depend on 
communication with other cell types (Evans et al., 2013). Recently, it has been 
highlighted that during the early slowly progressing phase of SOD1G93A ALS, 
microglia displayed a neuroprotective M2 phenotype, whereas during later stages it 
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adopted an M1 neurotoxic phenotype (Liao et al., 2012). Moreover, this beneficial 
effect in the early phase of the disease was enhanced by astrocytes suggesting that 
astrocytes may increase MNs survival through microglia and providing evidence for 
a microglia/astrocytes interaction involved in neuroprotection at early stages of ALS 
(Liao et al., 2012). Unfortunately, this response was substitute by the cytotoxic M1 
phenotype during the course of the disease and thus enhances the damage in 
SOD1G93A mice (Liao et al., 2012). Summarizing, inflammation may contribute to 
pathogenesis of ALS but it may also be a protective response. The difference in the 
overall effect of immune activation may be related to the timing of the response 
(McCombe and Henderson, 2011) and it may differ also according to age, gender and 
individual genetic variability. 
 
7. Excitability, network and disease: a vicious circle 
of degenerative pathways 
The link between neuronal excitability and network organization is evident: the 
intrinsic properties of neurons allow them to be incorporate in the circuit structure in 
their proper role, neurons electrophysiological properties define their functional 
properties. What is less immediate is the cross-talk between network and disease. A 
damage in the CNS due, for instance, to neurodegenerative disorders implies an 
impairment in the tissue architecture of neuronal networks both morphologically and 
functionally (Xu et al., 2011). This in turn reflects a worsening of the initial lesion, 
entering in a vicious circle of degenerative pathways. Hereafter, I will consider how 
these three features, neuronal excitability, network connectivity and 
neurodegenerative diseases are linked in a common and complicate interplay. 
 
7.1. MNs activity impairment in SOD1G93A mice 
Large α-MNs have low Ca2+-buffering capacity and are among the most vulnerable 
neurons (Tandan and Bradley, 1985; Mohajeri et al., 1998; von Lewinski and Keller, 
2005; Pun et al., 2006; Hegedus et al., 2008). Several studies have addressed, for 
example, MNs excitability and their intrinsic electrophysiological properties in 
health and SOD1G93A disease, by the use of different culture models or acute 
preparations. 
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The persistent inward current (PIC) generated by Na+ channels is a major factor 
influencing net neuronal excitability and in SOD1G93A is elevated months before 
symptom onset. This upregulation in the Na+ PIC has been demonstrated in 
embryonic and postnatal SOD1G93A lumbar MNs from acute slices (Kuo et al., 2004; 
Kuo et al., 2005), in postnatal SOD1G93A brainstem MNs in acute slices (van Zundert 
et al., 2008) and in cultured embryonic cortical MNs (Pieri et al., 2009). Na+ PIC 
upregulation may sustain the hyperexcitability state detected as increased firing 
frequency in SOD1G93A cultures compared to the control ones (Pieri et al., 2003a; 
Kuo et al., 2004; Kuo et al., 2005; van Zundert et al., 2008; Pieri et al., 2009) (Fig. 
11). 
In addition to the Na+ PIC, MNs also express Ca2+ PIC (Alaburda et al., 2002; 
Heckman et al., 2008), that has been demonstrated to be potentiated in MNs from 
SOD1G93A mice, in lumbar spinal slices (Quinlan et al., 2011). 
This higher excitability due to high PIC in SOD1G93A MNs, contributes to 
excitotoxicity and increases the metabolic demand exposing these cells to 
degeneration earlier than others. 
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Figure 11. G93A cultures display a significantly greater firing frequency compared to the control 
ones. (A) Membrane potential responses evoked by current injections in cortical MNs under current-
clamp conditions. (B) Plot representing the mean and SD of firing frequency in control and transgenic 
cultures illustrating that G93A MNs are characterized by a significantly greater excitability for all the 
injected current values compared to those in control (Pieri et al., 2009). 
 
Apart from intrinsic properties, also the synaptic ones have been investigated in 
SOD1G93A MNs. They might display altered channel permeability, receptor 
expression or receptor subunit composition. Within this framework, glutamate 
AMPA/kainate receptors have been widely investigated in disease models. SOD1G93A 
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mutation seems to alter AMPA receptor kinetics delaying their open time (Spalloni et 
al., 2004) and increasing their permeability to Na+ and K+ ions (Pieri et al., 2003b), 
thus inducing a greater depolarizing current due to AMPA activation, leading to 
activation of voltage-dependent Ca2+ channels with consequent major excitotoxic 
risk. 
From a pre-motor network perspective, MNs excitability is strongly modulated by 
synaptic inhibition, in particular fast Cl- dependent synaptic inhibition mediated by  
glycine and GABAA receptors. Collapse of the fine regulated Cl- gradient, results in a 
depolarizing response following glycine and GABAA receptors activation, inducing 
the instability of the neuronal network and its excitability (De Koninck, 2007). 
Regarding this topic, GABA applications in SOD1G93A cultures induces a large Cl- 
influx in MNs leading to its intracellular accumulation and to an efficient 
repolarization of the membrane potential, each of which enlarge the Ca2+ influx 
through AMPA receptors. This hypothesis is also supported by the observation that 
the treatment of SOD1G93A mice with the GABAA agonist muscimol shortened their 
survival (Van Damme et al., 2003). Furthermore, SOD1G93A MNs had more than 
doubled increase of α1 GABA receptor subunit expression level (Carunchio et al., 
2008) that is related to an higher Cl- influx and is involved in the regulation of CNS 
excitability (Kralic et al., 2002). These results support the hypothesis that MNs 
exhibit an over-inhibition rather than an over-excitation during the progression of 
ALS disease (Schütz, 2005). 
In another study, the decreased mRNA expression of glycinergic receptors (GlyRs) 
α1 subunit in SOD1G93A MNs, resulting in diminished expression of surface GlyRs, 
was proposed to be the cause of the significantly smaller current densities of glycine-
evoked currents and glycinergic miniature inhibitory postsynaptic currents (mIPSCs) 
in SOD1G93A MNs compared to control (Chang and Martin, 2011). Moreover, 
mIPSCs in transgenic cultures demonstrated slightly faster decay kinetics that could 
be attributable to different expression of synaptic GlyRs channels or, alternatively, to 
a faster clearance of glycine from the synaptic cleft (Chang and Martin, 2011). These 
data suggested that MNs in ALS, displaying a reduced glycinergic innervations, 
result in impaired synaptic inhibition. 
As this devastating disease selectively degenerate MNs, is quite obvious to find 
information regarding MNs studies. However, it would be interesting to investigate 
whether more global changes in spinal networks are present, and whether this would 
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include altered both excitatory and inhibitory neurotransmission in the interneurons 
that synapse onto MNs, trying to understand if their death could be linked to a 
malfunction of the premotor network. 
 
7.2. Interneuronal network activity impairment in SOD1G93A mice 
Brain regions are interconnected as a network, thereby strongly influencing each 
other (Bullmore and Sporns, 2009; van den Heuvel et al., 2009a). Studies using 
complexity theory demonstrated that the organization of the brain network or 
connectome plays a crucial part in healthy brain functioning (Bassett et al., 2009; Li 
et al., 2009; van den Heuvel et al., 2009b). As the brain is a complex system of 
interacting regions, local degeneration of MNs in ALS may have a widespread effect 
on the brain network and viceversa: network impairment may be the principal cause 
of MNs death. Interneuronal networks in the spinal cord modulate MNs activity. 
Interestingly, it is now widely accepted that in ALS there is a substantial loss of 
spinal interneurons (Schütz, 2005; Stephens et al., 2006) and that this may precede 
MNs loss (Fig. 12) (Grieshammer et al., 1998; Kablar and Rudnicki, 1999; Lim et al., 
2000). 
Based on these premises we focused our study on the impact of SOD1G93A mutations 
in the maturation of spinal ventral premotor circuit to unmask potential synaptic 
rearrangements which may contribute to the early-stage development of the disease. 
 
 
Figure 12. Schematic drawing of loss of interneurons contacts on MNs in ALS spinal cord. In the 
normal network, MNs (green) activity is strictly controlled and modulated by interneurons (red). In 
ALS transgenic mice the spinal cord undergoes network failure early in disease resulting from 
degeneration and loss of interneurons and abnormalities in MNs activity (Martin and Chang, 2011). 
 
 51 
 
Network activity in SOD1G93A spinal circuits presents an increased tendency towards 
synchronous bursting, suggesting an overall increase in excitability of premotor 
interneurons or a change in their synaptic connectivity (Jiang et al., 2009). 
Pre-symptomatic transgenic mice already display a specific loss of glycinergic 
innervation onto MNs, whithout detectable changes in GABAergic or cholinergic 
innervations (Chang and Martin, 2009; Sunico et al., 2011). In symptomatic 
SOD1G93A mice there was a marked reduction in the immunoreactivity for glycine 
transporter 2 (GlyT2, a marker for glycinergic interneurons) and for the two isoforms 
of glutamate decarboxylase GAD65/67 (markers for GABA interneurons; Hossaini et 
al., 2011). Such reduction are usually restricted to the ventral horn, ultimately 
suggesting a failure in the inhibitory synaptic control converging on MNs (Hossaini 
et al., 2011). 
Alterations in the recurrent inhibitory circuit established between Renshaw cells and 
MNs have been found in SOD1G93A mice in the late presymptomatic period, a 
potentially a significant contribution to the disease onset (Wootz et al., 2013). 
All in all, MNs in embryonic/neonatal SOD1G93A mice display substantial alterations 
in their morphology, intrinsic electrical properties and synaptic inputs (van Zundert 
et al., 2012), involving the premotor circuits that shape and define MNs 
characteristics. These studies strengthen the hypothesis that adult-onset ALS is, at 
least in part, the outcome of processes initiated during early stages of development. 
 
7.3. Oxidative stress and synaptic activity 
Experimentally induced oxidative stress is toxic in many regions, if not all, of the 
CNS and such toxicity can be replicated in cultured tissue. Exposure to H2O2 
concentrations ranging from 0.1 to 4 mM resulted in a marked decrease in the 
number of surviving neurons (Shimazu et al., 1999; Huang et al., 2008; Posser et al., 
2008; Viera de Almeida et al., 2008). On the contrary, glial cells seemed to be highly 
resistant to free radical induced injury (Raps et al., 1989; Sagara et al., 1993; Makar 
et al., 1994; Huang and Philbert, 1995). For example, in a study in mouse striatal 
cultures, astrocytes not only were highly resistant to H2O2-induced injury, but they 
were also neuroprotective, removing H2O2 from the culture media (Desagher et al., 
1996). More recently, this well-established view of oxidative stress-resistant glial 
cells has been contradict: H2O2 caused massive cell death in hippocampal 
organotypic cultures and surprisingly, the rates of cell death as well as the degree of 
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injury were more pronounced in glial cell body regions of the slices. 
Immunohistochemical analysis identified these glial cells as astrocytes (Feeney et al., 
2008). These findings suggest that during oxidative damage, glial impairment may be 
an important mechanism. 
What is less clear is the oxidative stress impact on neurons synaptic activity, since 
the in vitro data are mostly contradictory. The effects of ROS on neuronal synaptic 
transmission have been studied especially in hippocampus, due to the observation 
that free radicals might play a role in the pathogenesis of epilepsy in vivo. Many 
attempts tried to demonstrate the epileptogenic action of ROS in vitro, some of them 
largely unsuccessful. For example, H2O2 (3.3 mM) hyperpolarized hippocampal CA1 
and CA3 pyramidal neurons (Seutin et al., 1995). In addition, in the presence of iron 
salts, H2O2 (2.94 mM) was reported to markedly decrease synaptic efficacy 
impairing the ability of CA1 neurons to produce action potentials and to decrease 
synaptic release of glutamate (Pellmar, 1987). In another study, H2O2 at millimolar 
concentrations suppressed spontaneous population bursting in the CA1 region of the 
neonatal hippocampus (Garcia et al., 2011). These effects can hardly account for a 
putative epileptiform effect of free radicals observed in vivo. In contrast, other 
studies support the theory that an immediate consequence of H2O2 exposure might be 
inhibition of redox-sensitive glutamate transporters (Trotti et al., 1998) with further 
pathological consequences including hyperexcitability and even cell death: H2O2 
(300 µM) produced an excitatory effect on CA3 pyramidal cells in rat hippocampal 
slice cultures by decreasing inhibitory postsynaptic potentials (IPSPs) (Muller et al., 
1993); enhanced NMDA receptor activation following H2O2 exposure has also been 
reported (Mailly et al., 1999; Avshalumov and Rice, 2001).  
In spinal cord slices, H2O2 affected glutamatergic synapses enhancing excitatory 
postsynaptic potentials (EPSPs) through an increased release of glutamate and/or an 
inhibition of the uptake of glutamate (Lin et al., 2003) and produced a reversible and 
concentration-dependent increase in the GABAergic miniature postsynaptic currents 
(mPSCs) frequency through Ca2+ release from stored-pools (Takahashi et al., 2007). 
However, this prolonged effect could result in GABAergic inhibitory synaptic 
depression with a long-term enhancement of the overall excitability. Such 
concentration dependent and biphasic behaviour of H2O2 has been observed in 
synapses as different as the neuromuscular junction (Giniatullin and Giniatullin, 
2003) and the CNS hippocampal ones (Kamsler and Seg
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Exposure to another ROS donor, t-BOOH (2 mM), inhibited GABA release through 
presynaptic mechanisms in the spinal dorsal horn and this effect was reversible when 
ROS were scavenged (Yowtak et al., 2011). 
It is of particular interest that H2O2 (2.5 mM) reduced the inhibitory 
neurotransmission in thalamocortical circuits in both thalamic and cortical neurons 
and, noteworthy, it did not cause significant changes of excitatory postsynaptic 
responses to brains slices without thalomocortical connectivity, instead 
hyperexcitability was evident when slices preserved thalomocortical connections 
(Frantseva et al., 1998). This suggests that H2O2-mediated augmentation of cortical 
postsynaptic responses requires intact thalamocortical circuitry and it might in part 
explain the elusive character of free radical excitatory action in in vitro studies, 
where neuronal circuitry is not intact (Frantseva et al., 1998). In vitro experiments 
are generally at best limited by the local circuitry, whereas free radical-induced 
effects might be a network phenomenon, further supporting organotypic slice 
cultures as a good model to test how oxidative stress could modify the synaptic 
activity in the complex spinal cord network. 
 
7.4. Neuroinflammation and synaptic activity 
Fine-tuning of neuronal activity was thought to be a neuron-autonomous mechanism 
until the discovery that astrocytes are active players of synaptic transmission 
(Béchade et al., 2013). A single astrocyte can contact tens of thousands of individual 
synapses (Bushong et al., 2012) and has highly dynamic processes capable of 
altering the extracellular space (Theodosis et al., 2008). Activated astrocytes release 
gliotransmitters and are sensitive to neurotransmitters leading to the concept that 
astrocytic processes interact with pre- and postsynaptic neuronal elements (Araque et 
al., 1999; Haydon and Carmignoto, 2006). In fact, astrocytes are implicated in the 
regulation of neuronal excitability, synaptic transmission, plasticity and information 
processing (Pascual et al., 2005; Jourdain et al., 2007; Filosa et al., 2009; 
Henneberger et al., 2010; Ortinski et al., 2010) and since they are extensively 
coupled via gap junction and thanks to the gliotransmitter release, they can 
potentially synchronize the activity across extensive neural networks (Angulo et al., 
2004; Fellin et al., 2009). 
Similarly to astrocytes, microglia are involved in the regulation of neuronal activity 
contributing to the development, plasticity and maintenance of neuronal circuits. 
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During development ameboid microglia not only phagocytose the apoptotic neurons 
(Marin-Teva et al., 1999) but also promote programmed cell death (Marin-Teva et al., 
2011), while ramified microglia are implicated in adult neurogenesis (Choi et al., 
2008; Sierra et al., 2010) and in the integration of these new neurons into neuronal 
circuits (Ziv et al., 2006; Vukovic et al., 2012), highlighting that the traditional 
labeling of ramified microglia as “resting” is mistaken. A direct evidence is that 
microglia derived from exercised mice were shown to enhance the number of neural 
progenitor cells in cultured hippocampal neurons derived from sedentary mice 
(Vukovic et al., 2012) and, interestingly, depletion of microglia from cultures 
derived from aged mice conversely reduced the age-related decline in neurogenesis 
(Vukovic et al., 2012) indicating that microglia can differentially regulate 
neurogenesis and implicating these cells in the maintenance and plasticity of 
neuronal circuits (Wake et al., 2013). 
To properly generate mature brain functions neurons need to be correctly wired-up in 
neuronal circuits, a process that, as noted previously, occurs during development in 
an activity-dependent fashion (Lichtman and Colman, 2000; Hua and Smith, 2004). 
Microglia are accurate sensors of neuronal activity and react rapidly by modulating 
the physical contacts that their processes continuously establish with synaptic 
elements (Wake et al., 2009; Trembley et al., 2010). Interactions between microglia 
and neurons at synaptic sites have been directly visualized in vivo using two-photon 
microscopy: microglia made frequent but brief contacts with synapses in control 
conditions while when brains were made ischemic the duration of these contacts 
increased markedly (Wake et al., 2009), resulting in an higher turnover rate of 
presynaptic boutons and postsynaptic spines and lost of some synapses contacted by 
microglia. Thus, microglia is able to monitor the functional state of synapses, 
monitoring the healthy brain and rewiring neuronal circuits following injury. These 
considerations also imply that dysfunction of microglia may contribute to CNS 
disorders not only indirectly but also potentially directly (Wake et al., 2013). 
The ability of microglia to rapidly modulate synaptic activity was initially evaluated 
by treating cultured neurons or acute brain slices with microglia conditioned-medium 
that increased both the amplitude and duration of the NMDA-receptor induced 
currents (Moriguchi et al., 2003; Hayashi et al., 2006). Microglia stimulation can 
also modulate neurons activity: ATP leads to microvesicles shedding by microglia in 
a few seconds (Bianco et al., 2005) that increased mEPSCs frequency in cultures 
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hippocampal neurons (Antonucci et al., 2012), supposedly regulating the presynaptic 
vesicle release. This evidence brought the authors to the hypothesis that physical 
contacts or membrane exchange between microglia and neurons could actively and 
rapidly regulate neurotransmission. LPS stimulation of acute hippocampal slices 
induced a rapid and transient increase in the spontaneous AMPA PSCs frequency in 
CA1 neurons, an effect that did not occur in slices prepared from mice lacking 
microglia (Pascual et al., 2012). It was demonstrated that microglia activation 
resulted in ATP release that recruited astrocytes with the subsequent release of 
glutamate and increased excitatory transmission through metabotrobic glutamate 
receptors (Pascual et al., 2012). 
These are examples of the effects described as a result of microglia activation. 
Activated microglia can produce a broad spectrum of signalling molecules including 
cytokines, neurotransmitters and extracellular matrix proteins (Béchade et al., 2013). 
Among pro-inflammatory cytokines, TNF-α and IL-1β have received more attention. 
TNF-α is the prototypical pro-inflammatory cytokine due to its role in initiating the 
activation cascade of other cytokines and growth factors (Schäfers and Sorkin, 2008). 
TNF-α is able to modify synapses: in a process known as synaptic scaling, microglia 
detect low levels of neuronal activity and begin to release TNF-α that upregulate 
specific synapses to maintain a constant level of network activity (Turrigiano et al., 
1998; Stellwagen and Malenka, 2006). Blockade of TNF-α signaling prevented or 
reversed this effect (Steinmetz and Turrigiano, 2010). This indicates that TNF-α 
probably augments glutamatergic transmission throughout the CNS and one of the 
likely mechanisms responsible of this effect is the increase of the surface expression 
of AMPA receptors (Beattie et al., 2002; Stellwagen and Malenka, 2006). Moreover, 
TNF-α favours the insertion of a particular type of AMPA receptors, the ones that 
lack the GluR2 subunit (Stellwagen et al., 2005; Leonoudakis et al., 2008). This is 
important since these receptors allow calcium entry when activated and this can lead 
to changes in gene expression as well as cytotoxicity (Beattie et al., 2010). TNF-α 
also causes an increase in surface NMDA receptors expression (Wheeler et al., 2009) 
and endocytosis of GABAA receptors reducing the inhibitory drive (Stellwagen et al., 
2005). 
IL-1β activity has similar outcomes compared to TNF-α: it caused up-regulation of 
NMDA receptor-mediated calcium levels (Viviani et al., 2003) and decreased 
GABAA mediated potentials in hippocampal cultures (Wang et al., 2000b). 
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Both TNF-α and IL-1β impaired glutamate uptake and release by astrocytes, 
increasing excitatory transmission (Ye and Sontheimer, 1996; Hu et al., 2000). 
It is easy to conclude that based on TNF-α and IL-1β actions on glial cells and on 
synaptic glutamate and GABA receptors, these cytokines can cause profound 
changes in neurons excitability and possibly long-term transcriptional changes. 
Among the long-term changes affected by cytokines, both TNF-α and IL-1β inhibit 
neuronal plasticity, including long-term potentiation (LTP) and long-term depression 
(LTD), that occurs in hippocampal slices (Galic et al., 2012). 
It is possible to connect these effects in a common framework: pathological hyper-
excitability is associated with disturbances in learning, memory, neural plasticity and 
neurogenesis (Lowenstein et al., 1992; Katagiri et al., 2001), and microglia 
activation, with consequent cytokines production, is a phenomena that underlies all 
these events (Fig. 13), shedding light on neuroinflammation as a crucial player in 
brain homeostasis, network activity and in the resulting cognitive phenotype. 
 
 
Figure 13. Neuronal plasticity and excitability as a function of brain inflammation. Locally controlled 
and properly timed activation of immune processes is involved in increased neuronal excitability that 
underlies neural plasticity (section A). Any deviation from this physiological range results in 
pathological conditions: insufficient activation of immune parameters reduces excitability and 
suppresses neurogenesis and the induction of LTP (section B). On the other hand, intense brain 
immune activation can induce hyper-excitability of neuronal circuits that may elicit epileptic seizures 
(not necessarily, dashed line) associated with disturbance in learning, memory and neural plasticity 
(section C). If this immune over-activation is even more sever and/or chronic, excitotoxicity, 
apopotosis and neurodegeneration succeed, resulting in further cognitive impairments (section D) 
(Yirmiya and Goshen, 2011). 
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Similar results have been obtained in classical inflammatory disorders, such as 
multiple sclerosis (MS). Soluble inflammatory cytokines have been proposed as 
major determinants of neurodegeneration in MS as well as in its experimental model, 
namely experimental autoimmune encephalomyelitis (EAE). Inflammatory 
demyelination of the white matter of the CNS is the primary pathological hallmark of 
MS, whereas gray matter atrophy and neuronal degeneration predominate in the 
progressive forms of the disease (Geurts and Barkhof, 2008). It is now accepted that 
inflammation and neurodegeneration are intermingled rather than occurring in series 
in this disorder. Neurophysiological recordings have recently shown that in EAE 
mice glutamate-mediated EPSCs were enhanced during the early phase of the disease 
(Centonze et al., 2009), while GABAergic IPSCs were reduced (Rossi et al., 2011). 
Moreover, these effects could be mimic by cytokines exposure (such as TNF-α, IL-
1β and INF-γ) in control animals, further highlighting the link between inflammation, 
synaptic transmission and neuronal damage (Centonze et al., 2010). 
 
7.5. Cytokines influence on spinal cord slices 
In analogy to what described in the previous paragraph cytokine modulation of spinal 
synaptic circuits has not been explored until very recently. Superfusion with TNF-α 
(10 ng/ml) increased the spontaneous excitatory synaptic transmission in spinal 
lamina II neurons and, importantly, it was attributable to inhibition of ongoing 
inhibitory synaptic transmission (Zhang et al., 2010). In fact, TNF-α significantly 
increased the frequency of sEPSCs (Fig. 14) and following pharmacological block of 
the inhibitory synaptic transmission, TNF-α was no more able to change sEPSCs 
frequency suggesting that its effect was mediated by decreasing the inhibitory tone in 
the spinal cord. Indeed, TNF-α also significantly reduced the frequency of sIPSCs  
(Fig. 15) (Zhang et al., 2010). 
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Figure 14. TNF-α enhances excitatory synaptic transmission in spinal cord slices. (A) sEPSCs 
recorded (Vh = -70 mV) from spinal lamina II neuron before (a) and after (b) TNF-α application. (B) 
TNF-α increases the frequency, but not the amplitude, of sEPSCs (Zhang et al., 2010). 
 
 
Figure 15. TNF-α suppresses inhibitory synaptic transmission in spinal cord slices. (A) sIPSCs 
recorded (Vh = 0 mV) from spinal lamina II neuron before (a) and after (b) TNF-α application. (B) 
TNF-α decreases the frequency, but not the amplitude, of sIPSCs (Zhang et al., 2010). 
 
Consistent with these observations, TNF-α significantly decreased the number of 
current-evoked action potentials (APs) in tonic firing GABAergic spinal neurons 
(Fig. 16) (Zhang and Dougherty, 2011). 
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Figure 16. TNF-α decreases the excitability of tonic firing GABAergic neurons in spinal cord slices. 
(A) Representative current clamp traces of neurons responses to the same injected currents before and 
after the application of TNF-α. (B) Plot summarizing all the data of neuronal responses vs injected 
currents (Zhang and Dougherty, 2011). 
 
The authors suggested that TNF-α effects on spinal network activity were mediated 
by its receptor TNFR1 followed by the activation of neuronal p38 MAPK and they 
also observed that the inhibition of spontaneous APs in GABAergic neurons was 
accompanied with a reduction in Ih currents providing a cellular and molecular 
mechanism of spinal disinhibition induced by TNF-α (Zhang and Dougherty, 2011). 
In parallel, superfusion of spinal slices with IL-1β (10 ng/ml) increased the frequency 
of sEPSCs but, in addition, also their amplitude enhancing AMPA receptor- but in 
particular NMDA receptor-mediated glutamate currents (Kawasaki et al., 2008). 
Moreover, IL-1β reduced GABA- and glycine-induced currents with consequent 
significant decrease of sIPSCs frequency and amplitude (Kawasaki et al., 2008). 
These results indicate that both these cytokines are involved in the spinal neurons 
synaptic activity impairment, resulting in an increase excitatory/inhibitory ratio and 
probably leading to excitotoxicity or even neuron death. This underlies the necessity 
to investigate the cross-talk between the immune system and neurons using synaptic 
activity as a primary evaluation tool. 
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8. Inside the presymptomatic network activity: a 
hope for future therapies 
Neuronal loss is a hallmark of neurodegenerative disorders, but the clinical 
symptoms may reflect abnormalities in synaptic function and the loss of synaptic 
connections rather than loss of neurons (Brady and Morfini, 2010). Aberrant 
neuronal activity leads to synaptic deficits, disintegration of neural networks and 
failure of neurological functions (Palop et al., 2006). Brain regions are 
interconnected as a network, thereby strongly influencing each other (Bullmore and 
Sporns, 2009; van den Heuvel et al., 2009a) and this organization is part of a healthy 
brain functioning (Bassett et al., 2009; Li et al., 2009;  van den Heuvel et al., 2009b). 
Therefore, although early prevention of neuronal loss is clearly an important target in 
any therapeutic approach, a proportion of the deficits associated with 
neurodegenerative diseases might reflect reversible network dysfunction (Palop et al., 
2006), network intervention becoming a therapeutic opportunity. This kind of 
treatment could help to prevent progressive loss of neurons and, in the best case, 
might force the remaining neural circuits to compensate for lost or impaired circuits 
and improve overall network performance and neurological function, shifting the 
focus from neurons that are lost to those that survive (Palop et al., 2006). 
Brain networks are rather complex and can be impaired at different levels,  from 
molecular pathways to local micro-circuits in specific CNS regions (Fig. 17). 
 
 
Figure 17. Neurodegenerative disorders may affect neural activities at different levels. Networks 
impairment may result from dysfunction also of low-order levels, such as molecular pathways, 
signalling cascades, synapses modifications or neuronal subpopulations malfunction (Palop et al., 
2006). 
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Regarding ALS, modern neuroimaging techniques, such as diffusion tensor imaging 
(DTI), showed a reduction in white matter integrity in ALS patients (Sage et al., 
2007; Wong et al., 2007), and a significant reduction in the overall brain efficiency 
sustained by an impaired sub-network connectivity (Verstraete et al., 2011). This 
degenerative process was found to be widespread, but interlinked with the motor 
networks and previous studies suggested that functional connectedness of the motor 
network is correlated with a faster disease progression (Verstraete et al., 2010). 
Taken together, these findings propose ALS as a network disease. 
Another feature of ALS, and neurodegenerative diseases in general, is the usually 
late appearance in life of progressive neuronal degeneration. This means that it is 
characterized by a presymptomatic phase, likely lasting years, during which neuronal 
degeneration is slowly building up before the appearance of any clinical symptom 
(DeKosky and Marek, 2003) (Fig. 18). 
 
 
Figure 18. Symptomatic phase in neurodegenerative disorders occurs after a prolonged period of 
neuronal functional loss (DeKosky and Marek, 2003). 
 
This delay between the onset of neurodegeneration and the clinical symptoms 
manifestation can be probably explained since, although the final common steps in 
cell death pathways are shared between neuronal and non-neuronal cells (Hengartner, 
2000; Bredesen et al., 2006), there may be some essential steps in neurons death that 
are not present in non-neuronal cells (Raff et al., 2002). Neuron-specific features 
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may involve an extended period of time, often months or even years, in contrast with 
the rapid progression of apoptosis observed in non-neuronal cells (Jellinger, 2006). 
This is in large part due to the size and complex morphology of neurons with 
consequent regulation of synaptic function aspects during the early phase of neuronal 
degeneration (Mattson and Duan, 1999), bringing us back to the concept of these 
disorders as network diseases. 
The long-lasting presymptomatic phase indicates that a major goal of clinical 
research is to improve early detection of the diseases and of network dysfunction, 
allowing to stop the neurodegeneration temporal course or at least to slow the onset 
of clinical manifestations (DeKosky and Marek, 2003).  
In summary, neurodegenerative diseases, including ALS, are obviously characterized 
by neuronal cell loss, but this is just the final step. In the meantime, several 
molecular and cellular mechanisms can be affected resulting in synaptic activity 
dysfunction with consequent global network impairment. The detection of these early 
signs of network malfunction would be the key to enabling the transformation of 
clinical therapeutics from symptomatic to disease-modifying treatments (DeKosky 
and Marek, 2003). 
For these reasons, detect network defects in ALS in vitro model and identify which 
stress processes of the spinal tissue are involved in the eventual network impairment, 
is an essential condition to improve future therapies. Insults such as oxidative stress 
and neuroinflammation, both supported mechanisms causing ALS, should be 
considered as features to be tested since their impact on the spinal cord synaptic 
network has not been widely investigated. 
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Aim of the thesis 
 
In my thesis I focused on ALS and on two of the probable mechanisms involved in 
neurodegenerative diseases: oxidative stress and neuroinflammation. 
ALS has the common features of fatal neurodegenerative diseases: it is a late-onset 
disorder, it is characterized by the selective death of a subpopulation of neurons 
(MNs in the cortex, brainstem and spinal cord), it derives from a complex interplay 
between several pathogenic mechanisms (excitotoxicity, oxidative stress, 
neuroinflammation, protein aggregation, etc.) and, unfortunately, the only approved 
drug (riluzole) delays the patients survival of few months. 
Neuropathological results obtained from human ALS autopsy cases are surely 
valuable, but only for the terminal stages of the disease and we must inevitably rely 
on in parallel in vitro models that are important to find clues or to test hypothesis 
about the aetiology of ALS (Bär, 2000). In fact, in vitro cultures allow us to study a 
specific cell population or tissue under controlled conditions and to evaluate cell- or 
tissue-specific effects following a precise modification of their microenvironment. In 
ALS in vitro models we have the opportunity to analyze the MNs degeneration 
process in detail and even to test therapeutic attempts (Kato, 2008). 
In my PhD work I have exploited the organotypic cultures developed from 
embryonic mouse spinal cord that have been characterized in our laboratory and 
widely accepted as a good model to focus on premotor networks due to the easy 
access to interneuron microcircuit that this model provides via electrophysiological 
techniques. In addition, since the organotypic cultures are long-term in vitro systems 
enriched of a certain tissue complexity, reminiscent of organ features, they are a 
powerful tool for studying developmentally regulated changes of the tissue of interest. 
In the first part of my work I compared WT cultures with SOD1G93A transgenic 
cultures, a widely used transgenic model of ALS. In Avossa et al., 2006 our 
laboratory has already demonstrated with immunocytochemistry techniques that 
MNs, astrocytes and oligodendrocytes do not differ in terms of development, 
distribution and morphology in SOD1G93A spinal slices and in their WT littermates. 
Even though no signs of MNs degeneration was present, transgenic cultures were 
more vulnerable to AMPA-mediated excitotoxic treatment compared to WT ones, 
suggesting that environmental cues could exacerbate SOD1G93A MNs predisposition 
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to degeneration. Moreover, TEM analysis highlighted a significant increase in the 
ratio between inhibitory and excitatory synapses in SOD1G93A slices (Avossa et al., 
2006). A proposed explanation is that persistent glutamate transmission (Heath and 
Shaw, 2002) can induce a state of hyperexcitability in which compensatory 
mechanisms, such as favoring inhibitory vs excitatory synapses, will succeed. These 
changes in synaptic transmission may predate the following morphological 
alterations. We studied how these synaptic changes could shape the overall network 
activity, and we focused on the inhibitory component, in particular the glycine-
mediated transmission, that has recently received attention. The novel aspect of this 
model is represented by the possibility to test on healthy spinal MNs, genetically 
predispose to cell death, the interplay among stress conditions and motor and 
premotor circuits activity in an in vitro system integrated by glial cells (Avossa et al., 
2006). 
In the second part of my work, I isolated two fundamental mechanisms (oxidative 
stress and neuroinflammation) involved in the pathogenesis of ALS, to understand 
how they can also contribute to the etiology of the disease via synaptic alterations of 
the network excitability. A plus of our long-term cultures is that it is possible to 
mimic chronic conditions by incubating the slices with different medium (in my 
case: H2O2 for oxidative stress and a “cocktail” of cytokines or a microglia activator 
for neuroinflammation), to understand the dialogue between these stress key players 
and the synaptic premotor activity. 
Finding pre-symptomatic dysfunction in the spinal network activity in a genetic 
model of ALS and in parallel in controlled conditions that allow the investigation of 
a specific stressful treatment impact, may reach our major objective: understand if 
the combination of genetic predisposition and environmental factors triggers a 
common pathogenic cascade at early stages of spinal network development, 
compromising the long-term MNs viability, by means of altering synaptic 
transmission and thus initiating a permanent process progressively increasing tissue 
stress.  
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Methods 
 
1. Organotypic spinal culture preparation 
In the present work I have employed the organotypic slice cultures of spinal cord and 
DRG, developed from the embryonic mice. Spinal slices have been maintained in 
dynamic conditions thanks to the roller-tube technique, which allows a progressive 
spreading and flattening of the tissue, as firstly reported by Gähwiler (Gähwiler, 
1981). The following sections describe in details the main step of the culturing 
procedure. 
 
1.1. Mouse lines and breeding strategy 
I have used two different mouse lines. For a first set of experiments I have exploited 
the transgenic mice expressing a high copy number of the glycine 93 to alanine 
mutation of the hSOD1 gene (B6SJL-TgN(SOD1-G93A)1Gur; Gurney et al., 1994) 
and the non-transgenic females (B6SJLF1) purchased from the Jackson Laboratories 
(Bar Harbor, ME, USA). Hemizygous carriers male were bred to F1 hybrid females 
(C57BL6xSJL) and offsprings were identified by PCR. The non transgenic 
SOD1G93A littermates (WT) have been employed as negative control for the genetic 
background.  
In a following experimental section of my PhD project I have used the animal 
enclosure strain of mice (C57BL-6J). 
 
1.2. Genotyping 
For PCR analysis, genomic DNA was isolated from tails or from heads (adult and 
embryos, respectively) by adding 0.5 ml of proteinase K diluted in tail buffer (0.6 
mg/ml) and then incubating for at least 2 h in a termomixer set at 55°C and 1200 rpm. 
This procedure assures digestion of the tissue. The further addition of 500 µl of 
phenole while centrifuging at 12000 rpm for 10 min, allows the extraction of DNA. 
Then, 200 µl of this solution containing DNA, was transferred to another eppendorf 
and after the addition of absolute ethanole (EtOH, 400 µl), centrifuged for 5 min at 
12000 rpm, to allow precipitation of the nucleic acid. After a wash in 600 µl of EtOH 
70%, the samples were newly centrifuged at 12000 rpm for 5 min, then EtOH was 
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removed and DNA samples were solved in 200 µl of sterile water. The following 
primer pairs for PCR were used: 5’-CAT CAG CCC TAA TCC ATC TGA-3’ and 
5’-CGC GAC TAA CAA TCA AAG TGA-3’, which amplifies a 236 bp product 
from exon 4 of the SOD1 gene within the transgene construct; 5’-CTA GGC CAC 
AGA ATT GAA AGA TCT-3’ and 5’-GTA GGT GGA AAT TCT AGC ATC ATC 
C-3’, which amplifies a 324 bp product of the endogenous interleukin 2 gene, used as 
positive control for DNA amplification. 
 
1.3. Explantation 
Organotypic slice cultures were obtained from mouse embryos at 12-13 days of 
gestation (E12-E13). Pregnant mice were sacrificed and embryos extracted by 
caesarean section, leaved in their amniotic sacs and put into a Petri dish containing 
cold (+4°C) Gey’s balanced salt solution (GBSS, in mM: CaCl2 2H2O 1.49; KCl 
4.97; KH2PO4 0.22; MgCl2 6H2O 1; MgSO4 7H2O 0.28; NaCl 137.87; NaHCO3 2.7; 
Na2HPO4 0.84; glucose 5.55. The pH is 7.4 and the osmolarity 296 mOsm). From 
this point on the dissection was performed under a laminar flow hood in sterile 
conditions and under microscope (Olympus SZ40). The foetuses were freed from 
their amniotic sacs and put into another Petri dish with fresh cold GBSS. Their head, 
legs, tail and abdomen were cut away (Fig. 1) (the heads were conserved in the case 
of transgenic mice to permit the PCR analysis and therefore the identification of 
SOD1G93A or WT cultures). 
 
Figure 1. Mouse embryo at E12-E13. The three dashed lines represent the area in which the cut are 
applied to isolate the low thoracic and high lumbar region of the spinal cord. 
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The isolated backs of the embryos were cut into 275 µm thick transverse slices with 
a tissue chopper (McIlwain) (Fig. 2) and put into a new Petri dish with fresh cold 
GBSS. Slices were chosen from the low thoracic and high lumbar level. They were 
cleaned from the rest of the tissue to leave only the spinal cord with the two DRG 
attached and then maintained at +4°C for 1 h. 
 
 
Figure 2. Tissue chopper used to prepare the 275 µm thick transverse spinal cord slices. 
 
1.4. Embedding and incubation 
After 1 h, single slices were placed on glass coverslips (12 x 24 mm, 0.13-0.16 mm 
thick, Kindler) into a drop (20 µl) of chicken plasma (Rockland, USA) diluted 2:1 
with GBSS. Plasma was then coagulated by addition of a drop (30 µl) of thrombin 
(Sigma-Aldrich) to keep the slices in place (Fig. 3). 
          
Figure 3. Spinal cord with DRG attached isolated from the rest of the tissue at 0 days in vitro (DIV) 
and then placed into the clot of chicken plasma and thrombin on the glass coverslip. 
 
After 45-50 min, to allow the stabilization of the clot, the coverslips were places into 
plastic tubes (Nunc) filled with 1 ml of fresh medium (see below for the composition) 
and immediately put in the roller drum, which rotates at approximately 120 rph, 
contained in the incubator (Fig. 4). Rotation is essential for feeding, aeration and 
flattening of the cultures. In fact, slices are submerged in medium during half a turn 
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and covered with a film medium for the other half. Cultures were kept at 37°C with a 
concentration of 5% CO2. In these conditions organotypic cultures can be maintained 
for more than a month. Experiments were performed on spinal slices during the first 
3 weeks in vitro (WIV). 
 
           
Figure 4. Coverslips with slices are kept in plastic tubes containing nutrient medium and then tubes 
are inserted in the roller drum that permits their rotation. 
 
Lyophilized thrombin (Sigma-Aldrich) was diluted in distilled water (200 u/ml). 
Prior to use, glass coverslips were treated as follows: inserted into a holder, 
submerged in hydrochloric acid (HCl) 0.5 N for 24 h, then repetitively washed with 
distilled water and leaved in absolute EtOH for 30 min. Then coverslips were dried 
and sterilized at +120°C in an oven over night. 
 
1.5. Medium and medium change 
The standard medium consisted of: 67% Dulbecco’s modified Eagle’s medium 
(DMEM, Invitrogen, Italy), 25% fetal bovine serum (FBS, Invitrogen), 8% sterile 
water for tissue culture (Invitrogen), 5 ng/ml nerve growth factor (NGF, Alomone 
Laboratories, Israel) diluted in Hank’s solution and 1 mg/ml BSA. The pH is 7.35 
and the osmolarity 300 mOsm. (Hank’s solution in mM: CaCl2 2H2O 1.26; KCl 5.37; 
KH2PO4 0.44; MgCl2 6H2O 0.49; MgSO4 7H2O 0.4; NaCl 148.85; Na2HPO4 0.34; 
glucose 5.55. The pH is 7.4 and the osmolarity 296 mOsm). 
During the first six days in vitro (DIV) the medium contained a higher concentration 
of NGF (20 ng/ml), required for a healthy development of cells and cultures. After 
this period the old medium was replaced by a fresh standard one, with the addition of 
a mixture of antimitotics (Cytosine arabinoside 10 µM, Fluoro-deoxyuridine 10 µM, 
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Uridine 10 µM, Sigma) that allows preventing the exaggerated growth of non-
neuronal cells. After 24 h this antimitotics-enriched medium was replaced by a fresh 
standard one (without antimitotics and with low NGF), which was then replaced 
weekly (Table 1). 
 
Components 
Medium 1 
(during the first 
6 DIV) 
Medium 2  
(used at 7 DIV 
for 24 h) 
Medium 3  
(the standard 
one) 
DMEM 67% 67% 67% 
FBS 25% 25% 25% 
Distilled water 8% 8% 8% 
NGF 20 ng/ml 5 ng/ml 5 ng/ml 
Antibiotic-
Antimycotic 
1% 1% 1% 
Solution 100X 
Antimitotics 
- 10 µM - 
 
Table 1. Quantity of single components in the different medium used. 
 
1.6. Spreading and flattening of the slices 
While growing in vitro, slices undergo a progressive spreading and flattening, 
essential features for visualization of single neurons under optic microscopy. The 
spreading degree depends on the rotation speed, the origin of the explanted tissue and 
the initial thickness of the slices. In fact, soon after dissection, slices are too thick to 
allow the visualization of single cells. A fast rotation of the tubes allows the plasma 
clot and the damaged cells on top of the slices to be gradually washed, reaching a 
better access to individual neurons for electrophysiological recordings. The roller-
tube technique assures the preservation of the organotypic organization of the tissue 
while facilitating the identification of single cell types. Moreover, being a long-term 
preparation, the tissue can recover from the dissection trauma and easily adapt to the 
new in vitro environment. For all these reasons, the roller-tube technique is widely 
exploited to maintain organotypic slice cultures since, following this procedure, they 
are a suitable model for electrophysiological recordings and also for other technical 
approaches like imaging, immunofluorescence experiments, advanced microscopy 
investigation and long-term treatments.  
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Neuronal cells progressively mature and begun to produce electrical and synaptic 
activity, correlated to the development of single neuronal phenotypes and synaptic 
networks (Ballerini and Galante, 1998; Rosato-Siri et al., 2004). 
 
1.7. Spinal slices morphology 
The original structure of the spinal cord is preserved in organotypic spinal slices. 
After one and two weeks in vitro (named 1 and 2WIV) the slices appear as in figure 
5. The dorso-ventral orientation of the spinal cord is clearly recognizable by the 
presence of the dorsal root fibres (dorsal horn) and the central fissure (ventral horn). 
 
 
Figure 5. Bright field images of organotypic spinal slices just after the dissection (0DIV) and after 1 
and 2 weeks of in vitro growth (1 and 2WIV). Dorsal and ventral area are clearly identified by the 
DRG and the dorsal root fibres and by the ventral fissure (red arrows). It is also remarkable the 
progressive flattening of the tissue during the in vitro growth (kindly provided by Dr. Daniela Avossa 
and Prof. Laura Ballerini). 
 
Within organotypic spinal cultures different neuronal phenotypes develop and it is 
possible to visualize their morphology and also to monitor their in vitro growth, 
during the first 3WIV, through the employment of specific molecular markers 
(Avossa et al., 2003). It is also relevant that this spinal network is integrated with 
glial cells and even these non-neuronal cells can be identified by the use of specific 
antibodies. In organotypic spinal cultures all three glial cells type, astrocytes, 
oligodendrocytes (Avossa et al., 2003) and microglia are present. 
The heterogeneity of neuronal phenotypes includes MNs, interneurons and DRG 
cells. 
MNs are generally identified from their localization and morphology. In order to 
localize them, organotypic spinal cultures are stained using the choline 
acetyltransferase (ChAT) immunocytochemical technique (Avossa et al., 2003). 
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Positive neurons are localized on both sides of the ventral fissure and they are 
characterized by large, triangle-shaped soma (> 20 µm diameter) and multipolar 
dendritic prolongations. MNs have been demonstrated to display both excitatory and 
inhibitory postsynaptic potentials, which may be suppressed by application of 
inhibitors of the synaptic transmission (Streit et al., 1991). Mono- and poly-synaptic 
connections have been described between DRG and MNs (Streit et al., 1991; Galante 
et al., 2000), thus organotypic spinal cultures are a useful model to study MNs 
development and function. 
Ventral premotor interneurons represent a particularly important class of neurons in 
the spinal cord, since they are responsible for the motor patterns generation (Ballerini 
and Galante, 1998; Ballerini et al., 1999; Galante et al., 2000; Galante et al., 2001; 
Rosato-Siri et al., 2002). In organotypic spinal slices interneurons are visually 
identified on the basis of specific morphological criteria. They have an oval cell body 
with a diameter ≤20 µm and they are monopolar or bipolar cells, characterized by a 
widespread dendritic arborisation (Ballerini and Galante, 1998; Ballerini et al., 1999; 
Avossa et al., 2003; Furlan et al., 2005; Furlan et al., 2007). As emerged from 
intracellular electrophysiological recordings, in organotypic spinal cultures ventral 
interneurons display a spontaneous synaptic activity often characterized by 
distinctive synchronous temporal patterns (Ballerini and Galante, 1998; Ballerini et 
al., 1999; Rosato-Siri et al., 2004). 
During development DRG progressively flattened into monolayers and reconnect to 
the dorsal horns (Fabbro et al, 2012). DRG cells are easily recognized by they 
characteristic large (40-50 µm diameter) polygonal cell body (Avossa et al., 2003). 
By patch-clamp recording of these cells it was shown that DRG cells occasionally 
give rise to single action potentials that are not evoked by synaptic potentials 
(Ballerini et al., 1999). To test functional connections between DRG and spinal 
neurons, DRG cells can be electrically stimulated by a bipolar focal electrode and 
evoked mono and polysynaptic responses can be recorded from ventral interneurons, 
patched-clamped in whole-cell configuration and held at different membrane holding 
potentials (Galante et al., 2000). 
 
2. Immunofluorescence experiments 
Organotypic cultures were fixed with 4% paraformaldehyde (PFA) in phosphate 
buffer solution (PBS) for 1 h at RT, washed in PBS and incubated at 37°C for 30 min 
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in blocking solution consisting of 3% FBS, 3%BSA and 0.3% Triton-X 100 in PBS. 
Upon washing (in PBS), fixed slices were incubated over night at 4°C with primary 
antibodies. I have used the following primary antibodies: guinea pig polyclonal anti-
glycine transporter 2, GlyT2 (Millipore AB1773, 1:1000 dilution); rabbit polyclonal 
anti-glutamic acid decarboxylase 65, GAD65 (Santa Cruz Biotechnology sc-5601, 
1:50 dilution); mouse monoclonal anti-glial fibrillary acidic protein, GFAP (Sigma 
G3893, 1:200 dilution); rabbit polyclonal anti-ionized calcium-binding adapter 
molecule 1, Iba1 (Wako 019-19741, 1:400 dilution), mouse monoclonal anti-
microtubule-associated protein 2, Map2 (Sigma M4403, 1:200 dilution). 
Subsequently slices were washed in PBS and incubated with secondary antibodies 
for 2 h at 37°C. The secondary antibodies I have used are: Alexa 488 goat anti-
guinea pig (Invitrogen A11073, 1:400 dilution); Alexa 594 goat anti-rabbit 
(Invitrogen A11012, 1:250 dilution); Alexa 488 goat anti-rabbit (Invitrogen A11008, 
1:400 dilution; Alexa 546 goat anti-mouse (Invitrogen A11003, 1:400 dilution). 
Slices were imaged using a confocal microscope (Nikon Eclipse C1si, equipped with 
Ar/Kr and He/Ne lasers). The slice details were imaged at 20x and 63x magnification. 
Sections were acquired at different focal planes every 1.5-2 µm. The analyses were 
then performed using the ImageJ software (http://rsbweb.nih.gov/ij/) or the image 
analysis program Volocity edition 5.5. The colocalization was quantified by the 
overlap coefficient calculated in at least 3 fields, namely regions of interest (ROI), 
for each acquired image. 
 
3. Electrophysiological recordings 
Electrophysiological recordings were performed on visually identified ventral 
interneurons from slices at 1-3 WIV, by traditional patch clamp technique (Sakmann 
and Neher, 1984). For each experiment, a coverslip with the spinal culture was 
positioned on a recording chamber mounted on an inverted microscope (Eclipse TE 
200, Nikon, Japan). The slice was continuously superfused with standard Krebs 
solution (see below for the composition) at a flow rate of 5 ml/min and kept at room 
temperature (RT, 20-22 °C). Neurons were patch clamped with micropipettes pulled 
from thin-wall borosilicate glass capillaries (Clark) by a two steps puller (PC10 
Puller Narishige Group, Japan); tip resistance were 4-7 MΩ when filled with the 
intracellular solution (see below for the composition).  
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During the experiments, electrophysiological responses were amplified (EPC-7, 
Axopatch 1-D and Axon Multiclamp 700B) digitized at 10 KHz and stored for 
further analysis (pCLAMP software, version 10, Axon Instrument). Traces were 
filtered at 1 KHz with lowpass Gaussian filter prior the analysis. Membrane potential 
values indicated in this thesis were corrected for the liquid junction potential, 
estimated around -14 mV thanks to the acquisition software Clampex10 (Molecular 
Devices). No series resistance (Rs, when measured Rs < 15 MΩ) compensation was 
adopted since previous experiments have observed no distortion in synaptic events in 
these experimental conditions (Galante et al., 2000; Rosato-Siri et al., 2002). 
Passive properties were measured under voltage clamp configuration by stimulating 
cells with hyperpolarizing (-5 mV) square pulse of 100 ms duration and the area 
below capacitative transients was computed and normalized for voltage transient 
amplitude to calculate cellular capacitance; input resistance was obtained through 
Ohm’s law, by measuring the amplitude of steady state current generated by the 
voltage transient. 
In current clamp recordings, bridge balancing was continuously monitored and 
adjusted. Passive properties were measured by injecting a 100 ms lasting 0.01 nA 
negative current. The resulting voltage transient allows to determine the input 
resistance, valued by Ohm’s law, and the capacitance as the ratio between the voltage 
transient τ (fitted with a mono-exponential function) and the input resistance.  
 
3.1. Patch-clamp techniques 
The patch clamp technique allows high-resolution recording of the ionic currents 
flowing through the cells plasma membrane. Thanks to different patch clamp 
configurations it is possible to record and manipulate currents flowing through single 
channels or across the whole plasma membrane (Zhao et al., 2009). The patch clamp 
method is quite complex and laborious. Briefly, micropipette is leaned on the 
membrane of the cell to investigate. Then a slight negative pressure, normally 
obtained by suction, is applied to the internal of the pipette, so that the patch 
membrane gently inflects. At this point, measured resistance sharply goes up 
(reaching GΩ values) and the electrical noise is reduced. This is the so called cell-
attached configuration since the cell membrane is intact and it imposes very little 
perturbation on the cell under study. 
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Applying a further suction from the cell-attached configuration it is possible to cause 
the rupture of the cellular membrane, obtaining the whole-cell configuration. In this 
conditions the intracellular space is in continuity with the internal of the pipette, 
while the seal is maintained and the activity of the whole cell can be recorded. After 
the membrane patch is broken the resistance (generally around 250-400 MΩ) 
corresponds to that of the entire neuron and varies in according to the cell size. The 
whole-cell configuration allows conventional voltage-clamp (exploited to measure 
the ionic currents across the cell membrane while “clamping”, holding, the 
membrane voltage at a set level) and current-clamp (used to monitor spontaneous 
spiking activity) measurements to be performed on very small cells while the 
intracellular milieu is dialysed against the solution inside the pipette. 
Withdrawing the pipette from whole-cell configuration establishes the outside-out 
configuration which generally results in a resealing of the cell membrane so that the 
outside of the membrane faces the bath solution. This is indicated for studying, for 
example, receptors on the outer surface gated by extracellular ligands. 
On the other hand, pulling the pipette from the cell-attached configuration establishes 
the inside-out configuration that exposes the cytosolic side of the patch to the bath 
solution. This is particularly desirable for investigating ion channels that are 
regulated by intracellular mechanisms. These four patch clamp configurations are 
schematically represented in figure 6. In this thesis all recordings were performed in 
whole-cell configuration. 
 75 
 
 
Figure 6. Schematic illustration of the different configurations of the patch clamp technique: cell-
attached, whole-cell, inside-out and outside-out recordings. 
 
3.2. Solutions and drugs 
 
Extracellular solution (standard Krebs solution) 
While recording, cultures were continuously superfused with the standard Krebs 
extracellular solution containing (in mM): 152 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 
HEPES, 10 glucose. The pH was adjusted to the value 7.4 with NaOH and the 
osmolarity was 305 mOsm. 
 
 
 
 76 
 
Intracellular solution 
Micropipettes were filled with an intracellular solution, whose composition was (in 
mM): 120 K gluconate, 20 KCl, 10 HEPES, 10 EGTA, 2 MgCl2, 2 Na2ATP. The pH 
was adjusted to the value 7.35 with KOH and the osmolarity was 295 mOsm. 
 
Drugs 
The following drugs were bath applied through the perfusion system: 
- 6-cyano-7nitroquiloxaline-2,3-dione disodium salt (CNQX, 10 µM; Sigma, 
Italy), the antagonist of AMPA/kainate-type glutamate ionotropic receptors 
- SR-95531 (gabazine, 10 µM; Sigma), a specific antagonist of GABAA 
receptors 
- Strychnine nitrate (1 µM; Sigma), glycinergic receptors antagonist 
- Bicuculline methiodide (10 µM; Sigma), antagonist of GABAA receptors 
- Tetrodotoxin (TTX, 1 µM; Latoxan, France), to block voltage-dependent Na+ 
channels 
- DL-threo-β-benzyloxyaspartic acid (TBOA, 30µM; Tocris bioscience, UK), a 
non-specific blocker of glutamate transporters 
 
Cultures used for chronic treatments were incubated in medium containing the 
following molecules, prior the experimental recordings: 
- Hydrogen peroxide (H2O2, 500 µM for 12 h; Sigma; incubating medium was 
deprived of B27 supplement since it contains 5 powerful oxidizing agents: 
vitamin E, vitamin E acetate, superoxide dismutase, catalase and glutathione) 
- Lipopolysaccharide (LPS, 1 µg/ml for 4 or 6 h), the major component of 
Gram-negative bacteria outer membrane 
- Tumor necrosis factor alpha (TNF-α, 10 ng/ml for 4 or 6 h), a pro-
inflammatory cytokine 
- Interleukin 1 beta (IL-1β, 10 ng/ml for 4 or 6 h), a pro-inflammatory cytokine 
- Granulocyte macrophage colony stimulating factor (GM-CSF, 10 ng/ml for 4 
or 6 h), a pro-inflammatory cytokine 
The design of the experiments and the LPS, TNF-α, IL-1β and GM-CSF molecules 
were provided by our collaborator Dr. Clara Ballerini (Neurological Sciences 
Department, University of Florence, Florence, Italy). 
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Control cultures, namely untreated cultures, received the medium change for the 
same time period of treated cultures, without adding any other constituent a part from 
the standard ones. 
 
4. Data analysis 
The analysis of spontaneous postsynaptic currents (PSCs) and miniature postsynaptic 
currents (mPSCs) was performed using the Axograph X (Axograph Scientific, 
Molecular Devices) and/or the Clampfit 10 program (pClamp suite, Molecular 
Devices) both software exploit a detection algorithm based on a sliding template. On 
average 400 single PSCs and 200 mPSCs were analysed from each cell to obtain 
mean kinetic and amplitude parameters. From the average of these synaptic events, 
peak amplitude, rise time (from 10% to 90% peak amplitude) and decay time 
(expressed as τ) were calculated by fitting a mono-exponential function. 
Rhythmic activity (elicited by the application of strychnine and bicuculline) was 
characterized by inter burst period (IBP) and burst duration (BD). IBD is defined as 
the time between two consecutive burst, set at onset, while the duration is the time 
from the burst onset and 80-90% of its baseline recovery. Rhythm regularity was 
quantified by the coefficient of variation of IBP (CVIBP) and the coefficient of 
variation of BD (CVBD). The coefficient of variation is defined as the ratio between 
the standard deviation and the mean. It was calculated for IBP and BD of each cell, 
mediated on a sample of cells and expressed as percentage. 
In current clamp recordings, the firing frequency was determine as the ratio of 
detected APs and the time considered (expressed in seconds). APs threshold was 
calculated by the Axograph X threshold automatic function. 
Values are expressed as mean ± SEM, with n = number of neurons, unless stated 
otherwise. Statistically significant differences (p-values in the text and figure 
legends) were assessed by the two-tailed Students t-test, after validation of variances 
homogeneity by Levene’s test (for parametric data) and by Mann-Whitney (for non-
parametric data). In the case of percentage values, Fisher’s exact test of 
independence have been used. Statistical differences were considered significant at 
p<0.05. 
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Results 
 
1. Development of glycinergic control in spinal 
networks: the case of WT and SOD1G93A slice 
cultures 
The first set of experiments of my thesis is focused on the analysis of synaptic 
rearrangements prior of disease onset in a genetic model of ALS. In particular, I 
investigated glycinergic PSC changes along with the maturation of premotor circuit 
of the spinal cord. We used slice cultures developed from WT and SOD1G93A mice. 
Glycinergic synapses in the adult are widely distributed in the CNS, but the 
concentration of glycine in the spinal cord is far higher than elsewhere in the brain 
(Aprison and Werman, 1965) with the highest levels in the ventral horn. 
Glycine is the major inhibitory neurotransmitter in the mature mammalian brainstem 
and spinal cord (Werman et al. 1967) and the strength of glycinergic inhibition 
governs the rhythmic output of the motor system (Bracci et al., 1996a) suggesting 
that its alteration may play a pivotal role in a number of diseases ultimately involving 
motor control. 
Additional evidences support our decision to investigate the glycinergic transmission 
in the spinal cord. In fact, in a previous work by our lab (Avossa et al., 2006) we 
reported a synaptic rearrangement in SOD1G93A ventral horns, represented by a 
higher ratio between the symmetric and asymmetric synapses, traditionally thought 
to identify inhibitory and excitatory synapses respectively. 
Patched clamped interneurons in WT and SOD1G93A cultures slices were compared in 
terms of passive properties such as membrane capacitance and input membrane 
resistance that give a measure of cellular dimension and number of leak channels 
expressed on neuronal membrane, respectively. In SOD1G93A cultures at 2-3 weeks in 
vitro (WIV) we did not detect changes in recorded passive properties (Fig.1) for both 
membrane capacitance (64 ± 6 pF in n=56 WT, 63 ± 5 pF in n=52 SOD1G93A) and 
input membrane resistance (231 ± 32 MΩ in n=56 WT, 228 ± 22 MΩ in n=52 
SOD1G93A). 
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Figure 1.  Plot showing recorded interneurons passive properties for WT (n=56) and SOD1G93A 
(n=52) cultures. 
 
Next, we performed recordings (voltage clamp mode in whole cell configuration) 
from ventral interneurons at different time points of in vitro cultures growth, namely 
at 2WIV and at 3WIV. The glycinergic PSCs were isolated pharmacologically, upon 
the application of the AMPA/kainate subtype of glutamatergic receptor blocker 
(CNQX, 10 µM) and the GABAA receptor antagonist (SR-95531, 10 µM). Following 
the further addition of strychnine (1 µM), a selective glycinergic receptor blocker, 
the events disappeared confirming their glycinergic nature. In all the experiments 
shown and analysed the holding potential (Vh) was held at -70 mV (corrected for 
junction potential, see methods) while recording spontaneous activity and moved to  
-84 mV when measuring pharmacologically isolated PSCs mediated by glycine and 
GABA, to increase the Cl- driving force and thus the amplitude of the recorded 
currents. 
In both WT and SOD1G93A cultures glycinergic PSCs frequency and peak amplitude 
values increase along with the in vitro circuit maturation, indicating an enhancement 
in the glycinergic connection between ventral interneurons and this trend was 
similarly detected in the two culture (Fig. 2).  
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Figure 2. Glycinergic PSCs development in WT and SOD1G93A cultures. (A) Representative traces 
recorded in voltage-clamp mode in the presence of CNQX (10 µM) and SR-95531 (10 µM) from WT 
(black) and SOD1G93A (red) interneurons at 2WIV (top traces) and at 3WIV (bottom traces), Vh = -84 
mV. (B) Plots showing the average glycinergic PSCs frequencies and peak amplitudes for WT and 
SOD1G93A spinal slices. 
 
DIV WT (Hz) ±SE SOD1G93A (Hz) ±SE 
13-14 7.5 1.0 6.8 0.8 
15-16 9.1 1.2 9.1 1.5 
17-19 10.6 2.4 10.5 1.2 
20-22 10.9 1.2 12.3 2.3 
 
Table 1. Glycinergic PSCs frequency values for WT (n=30) and SOD1G93A (n=43) interneurons. 
DIV WT (pA) ±SE SOD1G93A (pA) ±SE 
13-14 38.1 6.8 33.0 5.6 
15-16 47.8 8.5 48.8 7.9 
17-19 50.1 6.3 51.8 4.2 
20-22 52.5 9.3 56.5 7.4 
 
Table 2. Glycinergic PSCs peak amplitude values for WT (n=30) and SOD1G93A (n=43) interneurons. 
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In table 1 and 2 are reported frequency and peak amplitude values respectively, for 
WT and SOD1G93A interneurons at each developmental stage in vitro. Even though 
SOD1G93A cultures closely resemble WT trend in increasing glycinergic PSCs 
frequencies and amplitudes during in vitro growth, their values at 20-22DIV are 
statistically significant compared to 13-14DIV (*p<0.05). 
 
We next analyzed glycinergic PSCs kinetic properties since it is well established that 
they undergo typical changes during their normal physiological maturation 
depending on the glycinergic receptors (GlyRs) subunits assemble (Lynch, 2009). 
GlyRs are ligand–gated Cl- channels, members of the cysteine (Cys) loop ion channel 
receptor family, composed by 5 subunits arranged symmetrically around a central 
ion-conducting pore (Betz and Laube, 2006; Lynch, 2009). So far, 5 different 
subunits have been identified: 4 α-subtypes (α1 – α4) and one β subunit. Functional 
GlyRs are formed by the association of one of 4 α-subtypes and the β subunit with a 
putative 2α:3β stoichiometry and also by homomeric α-subtypes assemble (Betz and 
Laube, 2006; Lynch, 2009). Electrophysiological studies have demonstrated that the 
expression of β subunits alone produces no glycine-gated currents (Bormann et al., 
2003) since biochemical evidence indicates that β subunits do not assemble as 
pentameric homomers (Griffon et al., 1999). Analysis of mRNA and proteins 
expression levels reveal that GlyRs in the foetal rat are predominantly α2 homomers 
(Becker et al., 1988; Malosio et al., 1991; Watanabe and Akagi, 1995) and its 
expression declines sharply between birth and postnatal week three, while expression 
of α1 and β subunits increases over the same period. The functional properties of the 
foetal and adult forms of the GlyRs subunits are clearly correlated with 
developmental changes in the inhibitory synaptic responses. The molecular switching 
from the α2 to the α1 GlyRs subunit may underlie shortening of the mean open time 
of GlyRs channels that results in a developmental shortening, similar in magnitude, 
of the decay time constant, or τ value, of glycinergic PSCs (Takahashi et al., 1992). 
The resulting fast IPSCs may ensure rapid motor control in the adult animal 
(Takahashi et al., 1992). 
As previously reported (unpublished results), I confirmed this temporary evolution in 
the spinal cultures. The decay time constant of glycinergic PSCs both in WT and 
SOD1G93A slices becomes progressively shorter during the in vitro growth (Fig. 3). 
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Figure 3. Glycinergic PSCs kinetic properties in WT and SOD1G93A cultures. (A) Representative 
traces recorded in voltage-clamp mode in the presence of CNQX (10 µM) and SR-95531 (10 µM) 
from WT (black) and SOD1G93A (red) interneurons at 3WIV, Vh = -84 mV. On the right note the 
scaled average of glycinergic currents. (B) Plot showing the mean glycinergic PSCs decay time 
constant for WT (n=20) and SOD1G93A (n=20) spinal slices during the in vitro development; note that 
the trend in the two cultures is similar but transgenic slices display faster glycinergic currents, highly 
significant at 3WIV (**p<0.01). The inset shows the absence of linear correlation between rise time 
and decay time constant for WT (n=11) and SOD1G93A (n=8) interneurons at 3WIV. 
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At 1WIV (data not shown) WT and SOD1G93A interneurons display similar 
glycinergic PSCs kinetic properties (the τ value was 15.8 ± 2.0 ms in WT and 16.1 ± 
2.2 ms in SOD1G93A, data provided by Dr. Vladimir Rancic). Starting from 2WIV 
these values begin to diverge and at 3WIV SOD1G93A glycinergic currents are 
significantly faster. Table 3 matches τ values for WT and SOD1G93A interneurons and 
the developmental stage in vitro. 
 
DIV WT (ms) ±SE SOD1G93A (ms) ±SE 
13-14 14.6 1.9 11.9 1.3 
15-16 10.3 1.3 8.6 2.1 
17-19 9.4 0.6 5.5 0.8 
20-22 8.2 0.7 4.8 0.2 
 
Table 3. Glycinergic PSCs τ values for WT (n=20) and SOD1G93A (n=20) interneurons. 
 
Moreover, we did not find any correlation between the rise time and the decay time 
constant (Fig. 3) excluding the possibility that the faster τ in transgenic cultures 
could be due to different recording conditions, location of synapses or electronic 
filtering. 
This result is intriguing and it is in line with recent observations (Chang and Martin, 
2011) posing light on the glycinergic system in the spinal cord during ALS 
progression. To elucidate the mechanisms underlying the different τ value in 
SOD1G93A cultures compared to the WT ones, we ruled out the possibility of 
differences in the control of intracellular chloride concentration. In fact, although we 
impose 24 mM Cl- from the pipette solution (see methods), the cytoplasmic 
subcellular control in concentration, in particular the clearance in proximity of 
synaptic sites may differ.  During development, chloride gradients evolve in function 
of the expression of chloride transporters. At early foetal period, the high expression 
of the sodium-potassium-chloride cotransporter (NKCC1) accumulates Cl- ions in 
neurons transforming GlyRs activation into a depolarizing signal (Flint et al., 1998; 
Kilb et al., 2002; Kilb et al., 2008) which in turn may activate calcium influx (Platel 
et al., 2005; Young-Pearse et al., 2006). In mature neurons, NKCC1 ceases to 
function, while the potassium-chloride cotransporter (KCC2) actively reduces the 
[Cl-]i, transforming the GlyRs activation into a hyperpolarizing stimulus (Lee et al., 
2005; Zhu et al., 2005). 
This issue is not only interesting regarding the maturation of inhibitory synapses, but 
also because the [Cl-]i affects the glycinergic PSCs τ value. It is clear that reducing 
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the [Cl-]i substantially speeds up the glycinergic currents decay time constant (Pitt et 
al., 2008). Taking together, variations in the expression of the chloride transporters 
alter the [Cl-]i and may subsequently modify the glycinergic PSC kinetics. 
To investigate transgenic culture changes in the [Cl-]i homeostasis, we recorded the 
glycinergic PSCs at different values of holding potential (Fig. 4). At 1WIV (data not 
shown) the chloride equilibrium potential is equal to the theoretical one for our 
recording conditions (see Methods), around -50 mV (data provided by Dr. Vladimir 
Rancic), but then there is a progressive shift towards more negative values (-55 mV 
and -60 mV at 2 and 3WIV, respectively) meaning that the chloride buffering 
becomes more efficient and chloride ions are extruded faster from the interneurons as 
cultures growth in vitro, as expected from the different developmental expression of 
chloride transporters. This behaviour was identical in WT and SOD1G93A cultures, 
excluding differences in chloride homeostasis as the cause of the glycinergic PSCs 
faster τ value in transgenic cultures. 
 
 
Figure 4. Chloride I-V curves for WT (black, n=22) and SOD1G93A (red, n=18) cultures at 2WIV and 
the 3WIV. Note the negative shift in the chloride reversal potential during the slices in vitro growth 
(these graphs were obtained pooling together interneurons recorded by me and by Dr. Vladimir 
Rancic) 
 
We further investigate the glycinergic miniature PSCs (mPSCs) to understand if the 
glycinergic currents kinetic differences between WT and SOD1G93A cultures were 
present also in events due to action potential independent synaptic release of glycine. 
We performed voltage-clamp recordings from ventral interneurons in the presence of 
CNQX (10 µM) and SR-95531 (10 µM), and then we added tetrodotoxin, TTX (1 
µM), a fast sodium-channel blocker. These miniature events result from the 
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stochastic release of single synaptic vesicles in the absence of any presynaptic 
activity and may help in clarifying the observed synaptic changes. 
The faster τ value in SOD1G93A glycinergic PSCs is detected also in mPSCs (Fig. 5; 
the τ value was 7.0 ± 1.4 ms and 6.9 ± 1.2 ms for PSCs and mPSCs respectively in 
n=14 WT and 5.3 ± 1.2 ms and 5.8 ± 1.1 ms for PSCs and mPSCs respectively in 
n=10 SOD1G93A). 
 
 
Figure 5. Glycinergic mPSCs kinetic properties in WT and SOD1G93A cultures. (A) Representative 
traces shown at high temporal resolution on the right recorded in the presence of CNQX (10 µM), SR-
95531 (10 µM) and TTX (1 µM) from WT (black) and SOD1G93A (red) interneurons at 3WIV, Vh = 
-84 mV. (B) Plot showing the mean glycinergic PSCs and mPSCs decay time constant for WT (n=14) 
and SOD1G93A (n=10) spinal slices at 3WIV; note that the faster decay time constant in transgenic 
glycinergic currents is maintained also in miniature events (**p<0.01; *p<0.05). At the two sides of 
the plot there are representative average scaled superimposed glycinergic PSCs and mPSCs for WT 
(black) and SOD1G93A (red) interneurons. 
 
In a set of experiments previously performed in our lab (by Dr. Giada Cellot) we 
already excluded that a different GlyRs subunit expression is involved in such 
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differences. Outside-out recordings from ventral interneurons were performed to 
analyse the conductance of single channel opening and the two main GlyRs 
assemblies present in the embryonic (α2 homomeric) and postnatal period (α1β 
heteromeric) are recognizable based on their characteristic conductances: around 100 
pS for α2 homomeric receptors (Takahashi et al., 1992; Bormann et al., 1993; Singer 
et al., 1998) and 40 pS for α1β heteromeric ones (Bormann et al., 1993; Burzomato 
et al., 2004). During the time window when whole cell patch clamp experiments 
showed the fastening of glycinergic decay time constant in transgenic slices, namely 
3WIV, in both WT and SOD1G93A cultures the developmental switch between the 
two different isoforms of GlyRs has already occurred in the majority of patched 
interneurons (Fig. 6; 77% and 89% for n=13 WT and n=10 SOD1G93A cultures 
respectively), indicating that a diverse GlyRs rate of maturation cannot be 
responsible for the observed glycinergic PSCs different kinetics observed in our 
experimental conditions. In the meantime, we also analysed the GlyRs subunit 
composition at an earlier stage of spinal slices development, namely 2WIV. 
Unexpectedly, WT cultures already displayed α1β heteromeric receptors (80%, 
n=40), as at 3WIV, while in transgenic cultures only half of recorded interneurons 
were characterized by the mature form of GlyRs (52%, n=42) (Fig. 6). These results 
highlighted the fact that transgenic cultures have a delay in their GlyRs maturation 
and, moreover, since these data are in conflict with the differences in glycinergic 
PSCs kinetic properties between WT and SOD1G93A cultures, they also indicate that 
alternative mechanisms are responsible for the glycinergic PSCs faster τ detected in 
SOD1G93A spinal tissue. 
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Figure 6. GlyRs subunit composition in WT and SOD1G93A cultures. (A) Representative traces 
recorded in outside-out configuration in the presence of CNQX (10 µM), SR-95531 (10 µM), TTX (1 
µM) and glycine (15 µM) from WT (black) and SOD1G93A (red) interneurons at 2WIV, Vh = -85 mV. 
(B) Plot showing the percentage of the heteromeric α1β GlyRs for WT (n=53) and SOD1G93A (n=52) 
spinal slices during their in vitro development; note that transgenic cultures still maintain the 
immature isoform of GlyRs in half of the cases at the 2WIV (*p<0.05). Courtesy of Dr. Giada Cellot. 
 
1.1. An alternative mechanism: GABA and glycine co-release impose 
glycine PSC τ in SOD1G93A  
The interplay between glycinergic and GABAergic components in the spinal cord is 
subjected to dynamic changes throughout development (Sibilla and Ballerini, 2009) 
with colocalization and release of glycine and GABA largely present in inhibitory 
synapses of different CNS areas, including the spinal cord. A work by Lu and 
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colleagues raised our interest addressing the possibility that GABA, co-released with 
glycine, could interfere with glycinergic PSCs properties. Analyzing the auditory 
brainstem nucleus, these authors discovered that GABA binds directly on the 
glycine-binding subunit of GlyRs. This displacement of glycine from its receptors 
decreases the channel gating properties dictating the fastening of glycinergic currents 
(Lu et al., 2008). To address a similar mechanism we decided to deplete the 
presynaptic terminals of GABA content and to compare the kinetic properties of 
glycinergic PSCs in WT and SOD1G93A before and after this depletion. We recorded 
glycinergic PSCs from spinal ventral interneurons in the presence of TBOA (Fig. 7), 
a broad-spectrum competitive antagonist of glutamate transporter (Shimamoto et al., 
1998) since GABA is generated from glutamate by glutamic acid decarboxylase and 
blocking glutamate uptake into nerve terminals reduces vesicular GABA content 
(Mathews and Diamond, 2003). GABA depletion, obtained via TBOA application 
(Lu et al., 2008) was mostly ineffective in n=7 WT slices (the τ value was 8.4 ± 0.9 
ms and 9.1 ± 1.0 ms before and after the perfusion of TBOA, respectively), but it 
significantly slowed down glycinergic PSCs in n=13 SOD1G93A cultures (the τ value 
was 5.7 ± 0.5 ms and 7.4 ± 0.8 ms before and after the perfusion of TBOA, 
respectively). This result supports the hypothesis that in transgenic cultures mixed 
synapses are still highly present at 3WIV in SOD1G93A spinal tissue, when compared 
to aged-matched WT. Co-released GABA displaces glycine from GlyRs and thus 
accelerates the glycinergic PSCs, narrowing the time window for effective inhibition. 
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Figure 7. Glycinergic PSCs kinetic properties in WT and SOD1G93A cultures following GABA 
depletion. (A) Representative traces recorded in voltage-clamp mode in the presence of CNQX (10 
µM), SR-95531 (10 µM) and TBOA (30 µM) from WT (black) and SOD1G93A (red) interneurons at 
3WIV, Vh = -84 mV. On their right it is visualized the scaled average of glycinergic currents.  (B) 
Plot showing the mean glycinergic PSCs decay time constant before and after the addition of TBOA 
for WT (n=7) and SOD1G93A (n=13) spinal slices at 3WIV; note that glycinergic currents are faster in 
transgenic cultures compared to WT ones (**p<0.01), but following TBOA perfusion this statistically 
significant data vanished. At the two sides of the plot there are representative average scaled 
superimposed glycinergic PSCs for WT (black) and SOD1G93A (red) interneurons before and after the 
addition of TBOA. 
 
We decided to further investigate the presence of mixed GABA–glycine terminals by 
using the immunodetection of different markers. 
The synthesis of GABA from glutamate depends upon two distinct isoforms of the 
glutamate decarboxylase, GAD65 and GAD67 (GAD65/67; Erlander and Tobin, 
1991). All GABAergic neurons in the CNS are thought to contain both isoforms of 
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GAD but they display different functional significance: the GABA generated by 
GAD67 is used for purpose other than neurotransmission such as functioning as a 
trophic factor for synaptogenesis during early development, protection after neuronal 
injury and regulator of redox potential during oxidative stress accordingly, GAD67 is 
usually evenly distributed throughout the neuronal cytoplasm (Pinal and Tobin, 
1998; Waagepetersen et al., 1999; Lamigeon et al., 2001), while GAD65 is 
concentrated at the nerve terminals where it synthesizes GABA for 
neurotransmission purposes (Martin and Rimvall, 1993). 
Also in the case of glycinergic transporters two different isoforms were 
characterized: GlyT1 that is the main regulator of glycine levels throughout the CNS, 
and GlyT2 with a more specialised role in maintaining terminal supplies of glycine 
for inhibitory glycinergic neurotransmission (Eulenburg et al., 2005). 
Therefore, inhibitory axon terminals were visualized by immunodetection of GAD65 
and GlyT2 to discriminate between GABA and glycine terminals, respectively,  or to 
localise co-expression at the presynaptic level (Dumoulin et al., 2001; Mackie et al., 
2003; Dugué et al., 2005). 
Even though local information of a protein is crucial to understanding its role in 
biological processes since the location and physiological function of a protein are 
closely related (Bolte and Cordelières, 2006), image-analysis methods for 
colocalization studies are afflicted by ambiguity and no single technique has been 
established as a standard method (Barlow et al., 2010). In our preliminary analysis 
we decided to quantify specifically the markers co-localization by measuring the 
overlap coefficient. The overlap coefficient (R) indicates an overlap of the signals 
and it can be split into two separate parameters (k1 and k2) that allow measure the 
contribution of each antigen to the colocalization areas (Zinchuk and Grossenbacher-
Zinchuk, 2009). Therefore, we analysed the overlap coefficient k1 regarding the 
green channel to determine the proportion of GlyT2 coincident with GAD65 over its 
total presence. Dr. Jummi Laishram collaborated to the design of these pilot 
experiments and acquired images by confocal microscopy and we used the plugin 
JACOP of ImageJ software and the Volocity software to analyze the images. 
In our preliminary analysis the ventral area of SOD1G93A slices at 3WIV displayed an 
apparently higher amount of terminals with colocalization of GlyT2/GAD65, when 
compared to WT cultures as shown in figure 8 (the overlap coefficient k1 was 0.117 
± 0.02 and 0.181 ± 0.07 in WT and SOD1G93A slices respectively, *p<0.05; 3 fields 
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observed for each slice, 100x150 pixels dimension; n=4 slices WT and n=4 slices 
SOD1G93A). 
 
 
Figure 8. Double immunostaining for glycinergic transporter 2 (GlyT2, green) and glutamic acid 
decarboxylase 65 (GAD65, red) of the ventral area of WT and SOD1G93A spinal slices at 3WIV. Scale 
bar = 10 µm (the immunofluorescence experiments were design and done in collaboration with Dr. 
Jummi Laishram and the confocal images were acquired by Dr. Jummi Laishram). 
 
2. Investigating the cross talk between stress, 
development and synaptic signalling: the C57BL/6J 
slice cultures 
As the principal aim of this thesis was to understand the dialogue between the spinal 
network activity and a general stress condition, in the following part of this research 
we used another strain of mice, without any genetic manipulation, that allowed us to 
test how microenvironment modifications could interfere with the spinal circuit 
organization. 
Firstly, we tuned the better conditions for the survival of spinal organotypic slices 
derived from C57BL/6J mice since it was the first time that we used them in our lab. 
Such a critical step required a larger amount of time: in fact, even though the in vitro 
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model is the same, we had to tune the adequate growth conditions, by enriching the 
medium with B27 (Brewer et al., 1993; Brewer et al., 1994; Brewer, 1995), a 
supplement designed for the long-term viability of primary CNS cultures (striatum, 
substantia nigra, cortex, septum, dentate gyrus and cerebellum) (Brewer, 1995). 
Successfully, this medium enrichment allowed us to significantly increase the 
survival of healthy spinal slices, confirmed by patch clamp recordings of visually 
identified ventral interneurons showing the usual spontaneous synaptic activity 
(figure 9). 
 
 
Figure 9. B27 supplement increased spinal organotypic cultures survival and health. Example of 
traces in voltage-clamp configuration showing the spontaneous activity recorded from C57BL/6J 
slices at 2WIV, Vh = -70 mV, without (top trace) and with (bottom trace) the addition of B27 in the 
culture medium. It is evident that in the presence of B27 spinal cultures are healthy and display the 
typical spontaneous circuit activity at this stage of in vitro development. 
 
When compared to previous recordings, the electrophysiological behaviour of WT 
and C57BL spinal slices is similar at all the considered stages (1, 2 and 3WIV) (Fig. 
10). During 1WIV, corresponding to the late embryonic stage in vivo, the spinal 
circuit generates a typical bursting activity separated by quiescent period that is 
replaced by an intense synaptic activity during 2WIV since the network stops to 
behave like a big synchronous oscillator (Rosato-Siri et al., 2004). This activity goes 
through further changes at 3WIV in which the frequency of PSCs is still increasing 
and bursts are present again displaying a higher pace, in fact both burst duration 
(BD) and inter burst period (IBP) are shorter compared to the ones observed at 
earlier stages (Rosato-Siri et al., 2004) (Fig. 10). 
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Figure 10. WT and C57BL cultures behaviour during in vitro growth. During development spinal 
slices undergo a maturation process regarding the network connectivity. WT (left) and C57BL (right) 
cultures display similar pattern of activity as shown by these traces recorded in voltage-clamp mode 
(Vh = -70 mV) at 1, 2 and 3WIV. 
 
During this period of assessment for these cultures, we also started to characterize 
the PSCs mediated by glycine neurotransmission to evaluate if it was a good 
candidate for our studies regarding the microenvironment changes impact on the 
spinal network. Considered the promising results in the in vitro ALS model, it 
seemed reasonable to start these new experiments investigating how the glycine drive 
could be subjected to an external interference. 
We analysed glycinergic PSCs properties, that were successfully isolated in 18/49 
recorded interneurons at 2 or 3 WIV. Glycinergic PSCs undergo the typical aging 
behaviour in terms of increased frequency and amplitude and faster decay time 
constant between the 2 and 3 WIV. The glycinergic PSCs frequency values were 
quite low, 2.0 ± 0.5 Hz (n=12) and 4.1 ± 0.9 Hz (n=7) at  2 and 3WIV respectively, 
while peak amplitude values were more similar to the ones detected for glycinergic 
PSCs in WT slices of the ALS genetic model, 32.1 ± 2.7 pA (n=12) and 46.3 ± 4.6 
pA (n=7) at 2 and 3WIV respectively (Fig. 11). These data mean that both 
glycinergic PSCs frequency and amplitude values increase during the in vitro growth 
of C57BL spinal slices, indicating the enhancement of glycinergic connection 
between ventral interneurons, as expected following the circuit maturation. 
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Figure 11. Glycinergic PSCs development in C57BL cultures. (A) Representative traces recorded in 
voltage-clamp mode in the presence of CNQX (10 µM) and SR-95531 (10 µM) from ventral 
interneurons at 2WIV (top trace, n=12) and at 3WIV (bottom trace, n=7), Vh = -84 mV. (B) Plots 
showing the average glycinergic PSCs frequencies and peak amplitudes for C57BL spinal slices. 
 
Also in these cultures the fastening of glycinergic PSCs was evident during the in 
vitro growth, starting from 9.6 ± 0.9 ms at 2WIV (n=12) and reaching 7.2 ± 1.1 ms at 
3WIV (n=7) (Fig. 12). Noteworthy, also the different developmental expression of 
chloride transporter is confirmed in C57BL organotypic cultures: the chloride 
reversal potential shifted from around -45 mV at 2WIV to around -55 mV at 3WIV 
(Fig. 12). 
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These results confirmed the previous findings, with the other strain of mice, 
supporting with further evidences these organotypic slices as a useful and 
representative model of spinal network development. 
 
 
Figure 12. Glycinergic PSCs kinetic properties and chloride I-V curves in C57BL cultures. (A) 
Representative average scaled isolated glycinergic PSCs recorded in voltage-clamp mode in the 
presence of CNQX (10 µM) and SR-95531 (10 µM) from ventral interneurons at 2WIV (n=12) and 
3WIV (n=7), Vh = -84 mV. (B) Plot showing the mean glycinergic PSCs decay time constant for 
spinal slices during the in vitro development. (C) Chloride I-V curves for C57BL cultures at 2WIV 
and 3WIV. Note the negative shift  in the chloride reversal potential during the slices in vitro growth. 
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3. Hydrogen peroxide (H2O2) treatment to challenge 
C57BL spinal neurons with controlled oxidative 
stress 
Reactive oxygen species (ROS), including hydrogen peroxide (H2O2), superoxide 
radical (O2-) and hydroxyl radical (OH-), are involved in molecular processes leading 
to neurodegeneration through the adverse effects of oxidative stress, a condition in 
which more ROS are produced than the cellular defence mechanisms can handle, an 
unbalance leading to neuronal apoptosis (Kamsler and Segal, 2004). In several 
neurodegenerative diseases such as AD, PD and ALS, oxidative stress has been 
proposed as one of the principal mechanisms involved in the impairment of the 
neurological system (Halliwell, 1992). In addition aged brains are exposed to higher 
concentrations of ROS than younger ones (O’Donnell et al., 2000), due to the 
breakdown in mitochondrial regulation of intermediate oxidation products occurring 
in senescent individuals (Lopez-Torres et al., 2002). A reduced control over ROS 
production in aged brains could lead to impaired neuronal function manifested as 
cognitive and/or motor decline, even prior to cell death (Kamsler and Segal, 2004). 
When H2O2 levels are under optimal regulation, cells use this molecule as a 
messenger involved in neuronal plasticity. In living cells the highest concentration of 
H2O2 has been measured in the striatum after an ischemic insult and was 100 µM 
(Hyslop et al., 1995). To note that in in vitro studies the concentrations used are 
higher than those expected to be present in living cells, in an attempt to accelerate 
and reproduce those processes occurring in vivo (Kamsler and Segal, 2004). It is 
assumed that the higher concentration in vivo of extracellular antioxidants may 
masks the real intracellular peak of ROS concentration under pathological conditions. 
This set of experiments was design to test the impact of oxidative stress conditions 
on spinal synaptic networks activity during in vitro maturation. To this aim we 
manipulated the H2O2 concentration in the spinal slice microenvironment. H2O2 was 
an appropriate molecular candidate behaving as messenger molecule at physiological 
concentrations and, in addition, we previously documented its effects on intracellular 
signalling, in particular on Ca2+ oscillations (Sara Sibilla, unpublished data). We 
exploited our long-term preparation to chronically (12 hours) incubate spinal 
explants with 500 µM H2O2, a concentration reported to cause a mild damage to the 
tissue (Pellmar et al., 1991; Posser et al., 2008). 
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We test by patch clamp (whole cell configuration, voltage clamp mode) recordings 
the passive properties of control (Ctrl) and H2O2 treated spinal interneurons, visually 
identified, localized in the ventral horn of spinal cultured slices. H2O2 treatment does 
not cause variations in membrane capacitance (51 ± 2 pF in n=43 Ctrl, 49 ± 2 pF in 
n=46 H2O2 cultures) and input membrane resistance (296 ± 21 MΩ in n=43 Ctrl, 321 
± 27 MΩ in n=46 H2O2 cultures) (Fig. 13). 
 
 
Figure 13. Plot showing recorded interneuron passive properties for Ctrl (n=43) and H2O2 treated 
(n=46) cells. 
 
We then analyse the frequency of spontaneous PSCs at different in vitro 
developmental ages. We found no differences between the two conditions as shown 
in table 4 and in figure 14. In both cases the frequency of spontaneous PSCs at 20-
22DIV is statistically significant compared to 12-14DIV (*p<0.05; **p<0.01). 
 
DIV Ctrl (Hz) ±SE H2O2 (Hz) ±SE 
12-14 17.5 5.4 17.4 2.4 
15-16 24.9 6.6 21.8 7.5 
17-19 26.1 4.9 25.2 3.1 
20-22 34.3 3.3 34.9 3.1 
 
Table 4. Spontaneous PSCs frequency values for Ctrl (n=50) and H2O2 treated (n=51) interneurons. 
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Figure 14. Spontaneous PSCs development in control and H2O2 treated cultures. (A) Representative 
traces recorded in voltage-clamp mode showing the spontaneous network activity from ventral 
interneurons at 3WIV in control (top trace) and H2O2 treated (bottom trace) cultures, Vh = -70 mV. 
(B) Plot showing the average spontaneous PSCs frequencies for spinal slices in the two conditions: 
control represented in black (n=50) and H2O2-treated cultures in red (n=51). 
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We further dissected the inhibitory component, focusing on GABA receptor 
mediated activity, that is prominent at this stage of in vitro growth, while the 
glycinergic mediated PSCs are more rare to isolate in these control cultures. In fact, 
the developmental course of GABA and glycine is strictly interconnected and mixed 
events, for example, may be difficult to identify (Jonas et al., 1998). GABAA 
receptor mediated currents are electrophysiologically distinguishable from glycine 
mediated ones due to their slower kinetics. We selected to focus our study at the 
older (3WIV) stage of in vitro growth. 
The GABAergic PSCs were isolated pharmacologically, upon the co-application of 
CNQX (10 µM) and strychnine (1 µM). Following the further addition of SR-95531 
(10 µM), the events disappeared confirming their GABAergic nature. 
Following the oxidative stress treatment GABAergic PSCs did not go through 
changes in their properties. Frequency values were 2.7 ± 0.6 Hz and 3.5 ± 0.7 Hz and 
peak amplitude values were 18.9 ± 1.8 pA and 22.4 ± 2.1 pA for control (n=9) and 
H2O2 treated (n=8) cultures, respectively. Also the kinetic properties were 
unmodified: τ values were 21.4 ± 2.4 ms and 20.8 ± 3.0 ms for control (n=9) and 
H2O2-treated (n=8) cultures respectively (Fig. 15). 
 
 
Figure 15. GABAergic PSCs τ values for control (n=9) and H2O2 treated (n=8) interneurons. No 
differences have been observed at 3WIV as shown by the plot and by the superimposed isolated scaled 
average traces. Controls are represented in black and H2O2-treated in red. 
 
In the absence of obvious changes in the inhibitory components we decided to 
investigate the appearance of disinhibited rhythmic bursts, induced by co-application 
of strychnine and bicuculline, that rely on the activation of the spinal premotor 
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network (Bracci et al., 1996b). Interestingly, the circuit responsible of this pattern of 
activity is preserved in organotypic spinal cultures (Ballerini & Galante, 1998; 
Ballerini et al., 1999), which has been highly characterized in our laboratory. 
Following the application of strychnine (1 µM) and bicuculline (10 µM) to 
pharmacologically block glycinergic and GABAergic receptors respectively, after an 
initial phase of irregular activity, a typical regular rhythm characterized by large and 
long-lasting bursts of inward currents appears, and continue unabated as long as the 
drugs are applied (Fig. 16). H2O2 treatment did not change the rhythmogenic ability 
of cultured spinal circuits, as we could not document differences in the mean burst 
duration (BD, Ctrl: 9.8 ± 0.8 s n=12 at 2WIV and 8.5 ± 1.0 s n=6 at 3WIV; H2O2 
treatment: 9.7 ± 1.3 s n=12 at 2WIV and 10.6 ± 1.1 s n=13 at 3WIV) or in the mean 
inter burst period (IBP, Ctrl: 16.9 ± 1.2 s n=12 at 2WIV and 12.6 ± 1.6 s n=6 at 
3WIV; H2O2 treatment: 16.9 ± 2.2 s n=12 at 2WIV and 15.3 ± 1.4 s n=13 at 3WIV). 
Also the average coefficient variation (CV) of the burst duration (CVBD: 28 ± 3% in 
control and 31 ± 9% in treated interneurons) and of the inter burst period (CVIBP: 26 
± 10% in control and 27 ± 8% in treated interneurons) was similar in control and 
H2O2-treated cultures. These values indicated a comparable regularity of the 
disinhibited burst rhythm established in spinal network. Tests were performed at 2 
and 3 WIV. 
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Figure 16. Disinhibited burst rhythm and AMPA-mediated PSCs in control and H2O2-treated cultures. 
(A) Representative traces recorded in voltage-clamp mode in the presence of strychnine (1 µM) and 
bicuculline (10 µM) from control (black, n=31) and H2O2-treated (red, n=28) interneurons at 3WIV, 
Vh = -70 mV. On their right it is present an enlargement of the traces to visualize the PSCs mediated 
by AMPA receptors. (B) Plots showing the mean BD and IBP of the disinhibited burst rhythm for 
control and H2O2-treated spinal slices during the in vitro development. (C) Plot representing the 
frequency of AMPA PSCs; note that at 3WIV this value is significantly higher in cultures subjected to 
the oxidative stress treatment (*p<0.05).  
 
Bursting activity is superimposed on a background of spontaneous intense synaptic 
currents mediated by the neurotransmitter glutamate interacting with its ionotropic 
receptors, the AMPA receptors. We analysed these excitatory PSCs (EPSCs) 
detected in the interburst intervals. AMPA PSCs are characterized by a fast kinetic 
that was not affected by the H2O2 treatment (the τ values were 2.3 ± 0.2 ms and 2.1 ± 
0.3 ms for control neurons, n=17 at 2WIV and n=14 at 3WIV respectively and 2.3 ± 
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0.2 ms and 2.2 ± 0.2 ms for H2O2-treated neurons, n=17 at 2WIV and n=11 at 3WIV, 
respectively). 
Also the amplitude of AMPA PSCs was similar in the two conditions: 26.6 ± 2.1 pA 
and 39.3 ± 4.0 pA for control neurons, n=17 at 2WIV and n=14 at 3WIV respectively 
and 31.7 ± 2.5 pA and 46.7 ± 4.2 pA for H2O2-treated neurons n=17 at 2WIV and 
n=11 at 3WIV respectively. 
On the contrary, the oxidative stress treatment affected the frequency of AMPA 
PSCs at 3WIV increasing it from 32.1 ± 4.5 Hz (n=17) in control slices to 45.7 ± 3.5 
Hz (n=14) in treated cultures (*p<0.05). At 2WIV this value was comparable 
between control (24.4 ± 2.5 Hz, n=17) and treated (26.8 ± 3.0 Hz, n=11) slices (Fig. 
16). 
In a sub-set of experiments we further analyse mPSC frequency at 3WIV following 
the application of TTX (1 µM). In these conditions we did not detected differences in 
the frequency of mPSCs between control (6.3 ± 2.7 Hz, n=6) and H2O2-treated (5.6 ± 
2.3 Hz, n=6) cultures. 
In the remaining set of experiments, where TTX was not added, the NMDA receptor 
mediated component of disinhibited bursting was further unmasked by adding 
CNQX (10 µM). The resulting burst rhythm had a slower pace and it disappeared 
with the further application of APV (20 µM), an antagonist of NMDA receptors. 
H2O2 treatment did not change the slow NMDA-mediated disinhibited rhythm of 
cultured spinal circuits (Fig. 17), as shown by the lack of differences in the mean 
burst duration (BD, Ctrl: 5.4 ± 0.6 s n=5 at 2WIV and 7.5 ± 0.8 s n=11 at 3WIV; 
H2O2-treatment: 5.5 ± 0.5 s n=4 at 2WIV and 8.5 ± 0.9 s n=13 at 3WIV) or in the 
mean inter burst period (IBP, Ctrl: 25.4 ± 2.9 s n=5 at 2WIV and 38.3 ± 4.1 s n=11 at 
3WIV; H2O2-treatment: 26.4 ± 3.4 s n=4 at 2WIV and 32.6 ± 2.7 s n=13 at 3WIV). 
Also the average coefficient variation of the burst duration (CVBD: 17 ± 3% in 
control and 16 ± 6% in treated interneurons) and of the inter burst period (CVIBP: 13 
± 5% in control and 13 ± 9% in treated interneurons) was similar in control and 
H2O2-treated cultures. This values indicated a comparable regularity of the NMDA 
burst rhythm in spinal network. 
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Figure 17. NMDA burst rhythm in control and H2O2-treated cultures. (A) Representative traces 
recorded in voltage-clamp mode in the presence of strychnine (1 µM), bicuculline (10 µM) and 
CNQX (10 µM) from control (black, n=16) and H2O2-treated (red, n=17) interneurons at 3WIV, Vh = 
-70 mV. (B) Plots showing the mean BD and IBP of the NMDA burst rhythm for control and H2O2-
treated spinal slices during the in vitro development. 
 
3.1. Cell excitability following the oxidative stress condition: 
analysing firing activity 
We found an increased frequency of EPSCs at 3WIV following the chronic 
incubation with H2O2. This difference was not reflected in changes in spontaneous 
heterogeneous PSCs frequency, rather it was unmasked in the presence of 
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pharmacological blockers of GABA and glycine mediated activity and when a 
regular rhythmic activity was established. In addition, the absence of changes in 
AMPA-mediated mPSCs apparently rules out other mechanisms, such as changes in 
transmitter release or presynaptic release sites/synapses following H2O2 treatment.  
Although the disinhibited rhythm in control and treated cultures was not altered 
either in frequency and duration we decided to evaluate whether a subtle change in 
cell excitability of spinal ventral interneurons was involved in the detected increase 
in EPSC frequency. We recorded the spontaneous activity, in the absence of any 
receptor antagonist, under current-clamp configuration to analyse the properties of 
action potentials (APs). Both resting membrane potential (RMP, -58 ± 2 mV in n=21 
control and -59 ± 1 mV in n=26 H2O2-treated neurons) and the APs threshold (-52 ± 
1 mV and -50 ± 1 mV in n=21 control and n=26 H2O2-treated neurons, respectively) 
were not affected by H2O2 treatment. Moreover, also their spontaneous firing 
frequency was analogous: 0.7 ± 0.2 Hz and 0.7 ± 0.1 Hz in control (n=21) and 
treated (n=26) ventral interneurons respectively (Fig. 18) meaning that the neuronal 
excitability was not changed following the oxidative stress treatment. 
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Figure 18. Firing activity of ventral interneurons in control (Ctrl) and H2O2-treated cultures. (A) 
Representative traces recorded in current-clamp mode showing the spontaneous firing activity of 
control (black, n=21) and H2O2-treated (red, n=26) interneurons at 3WIV, Vh = -74 mV. (B) Plot 
showing the mean frequency of APs in control and H2O2-treated spinal slices. (C) Plots representing 
the resting membrane potential (RMP) and the APs threshold of interneurons recorded in control and 
H2O2-treated. 
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4. Lipopolysaccharide (LPS) and cytokines (CKs) 
treatment to challenge C57BL spinal neurons with 
controlled inflammation 
Cross talk among immune and nervous signalling is now generally accepted 
(Kerschensteiner et al., 2003) and neuroinflammation is currently involved as a 
primary player in increasing numbers of neurodegenerative disorders (Carson et al., 
2006) with an uncertain role in balancing neuroprotection and neurotoxicity features. 
We decided to explore this dialogue between the CNS and the immune system 
challenging with artificial inflammation states cultured spinal cord slices. Before 
doing so we investigated for the first time the presence of microglia cells in slice 
cultures, being crucial mediators of CNS inflammation. Microglia cells have a 
mesodermal origin as monocytes and macrophages, therefore, they differentiate from 
the neuroectodermal derived astrocytes and neurons and they retain many of the 
features of macrophages throughout their lifecycle (Morris et al., 2013), such as 
survey and protect the surrounding tissue. This traditional role for microglia is 
overstepped by an emerging view of its activities. For instance, microglia is involved 
in the control of synaptic plasticity and this implies that microglia impairment or 
altered profile will potentially drive structural plasticity into harmful directions 
(Morris et al., 2013). 
To detect the presence of microglia in the organotypic spinal cultures, we performed 
immunofluorescence co-stainings for the ionized calcium binding adaptor molecule 1 
(Iba1), a microglia/macrophage-specific calcium-binding protein, the microtubule-
associated protein 2 (MAP2), an abundant neuronal cytoskeletal protein that binds to 
tubulin and stabilizes microtubules, and the glial fibrillary acidic protein (GFAP) an 
intermediate-filament (IF) protein highly specific for cells of astroglial lineage (Fig. 
19). These experiments allowed us to confirm that in our complex cultures also 
microglia cells are present, indicating these spinal slices as a useful model also to 
study the impact of the immune system modulation. 
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Figure 19. Double immunostaining for Iba1, a marker of microglia (green) and Map2, a protein of the 
cytoskeleton of neurons (red) on the left and double immunostaining for Iba1 (green) and GFAP, a 
marker of astrocytes (red) on the right of the ventral area of C57BL spinal slices at 3WIV. These 
confocal images confirm the presence of microglia cells in our spinal slices (experiments done in 
collaboration with Dr. Clara Ballerini, at the University of Firenze). 
 
Following the evidence of the presence of microglia cells in our organotypic cultures, 
we decided the protocols to mimic an inflammation state based on literature and on 
the experience of a partner laboratory (University of Firenze, Immune-neuro-lab 
directed by Dr. Clara Ballerini). The most well-known mechanism by which 
microglia perform its functions is via the release of various active molecules such as 
cytokines, CKs (Hanisch, 2002). Cytokines, are a functionally-connected group of 
peptides, phylogenetically very old (Beutler and Van Huffel, 1994), that operates in 
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networks and cascades, regulating the cellular activity. We chose, for our studies, 
three different cytokines, tumor necrosis factor-alpha (TNF-α), interleukin-1 beta 
(IL-1β) and granulocyte macrophage-colony stimulating factor (GM-CSF), that are 
known to be overexpressed in neurodegenerative diseases like ALS and that had 
already been tested also in spinal slices (Kawasaki et al., 2008; Zhang et al., 2010), 
but for the first time we used them in a mixture of typical pro-inflammatory 
cytokines. Since CK receptors are expressed in both microglia and neurons, we used 
also a protocol to dissect indirect effects due to microglia activation. We selected 
lipopolysaccharide (LPS), a large molecule found in the outer membrane of Gram-
negative bacteria that binds to its receptors, toll-like receptor 4 (TLR4), present only 
on microglia cells, promoting their activation with consequent inflammatory 
response. 
For both treatments, the mixture of CKs and LPS, we incubated cultured spinal 
explants for 4 or for 6 hours prior the experimental patch clamp recordings. The 
concentrations used are 10 ng/ml for the three CKs (Kawasaki et al., 2008; Zhang et 
al., 2010) and 1 µg/ml for LPS (De Paola et al., 2012). 
 
 
Figure 20. Plot showing recorded interneurons passive properties for Ctrl (n=83), LPS (n=96) and 
CKs (n=104) treated cells. 
 
Passive properties of recorded neurons were measured in both control and treated 
cultures to evaluate standard neuronal features and health. Both treatments (4 and 6 
hours were pooled together) did not cause variation in membrane capacitance (54 ± 3 
pF in n=83 Ctrl, 54 ± 2 pF in n=96 LPS and 56 ± 2 pF in n=104 CKs cultures) and 
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input membrane resistance (332 ± 24 MΩ in n=83 Ctrl, 333 ± 38 MΩ in n=96 LPS 
and 313 ± 31 MΩ in n=104 CKs cultures) (Fig. 20). 
We  performed our experiments at 2WIV and at 3WIV and we focused our analysis 
on the spontaneous EPSCs. We first analysed the frequency of spontaneous 
heterogeneous (mixed) PSCs. CKs treatments were tested at both time points of 
incubation: 4h and 6h. CKs treatments significantly increased the frequency of 
spontaneous PSCs at both 4 (*p<0.05 vs Ctrl) and 6h (**p<0.01 vs Ctrl), while LPS 
treatment slightly augmented it at 4h and this value became statistically significant 
following the 6h treatment (**p<0.01 vs Ctrl) (Fig. 21; the frequency value was 17.6 
± 1.9 Hz in n=17 control, 22.2 ± 2.4 Hz in n=34 LPS and 26.9 ± 3.8 Hz in n=12 CKs 
cultures at 4h and 16.0 ± 2.0 Hz in n=19 control, 25.6 ± 2.7 Hz in n=32 LPS and 30.8 
± 3.9 Hz in n=12 CKs cultures at 6h). These data also indicate that the effects 
summate with time of exposure: the longer the treatment, the greater the effect.  
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Figure 21. Spontaneous PSCs in control and treated cultures. (A) Representative traces recorded in 
voltage-clamp mode showing the spontaneous network activity from ventral interneurons at 3WIV in 
control (top trace) and CKs treated (bottom trace) cultures for 6h, Vh = -70 mV. (B) Plot showing the 
average spontaneous PSCs frequencies for spinal slices in the different conditions: control neurons 
(n=36) represented in black, LPS-treated (n=66) in red and CKs-treated (n=24) in blue. Note the 
significant increase in PSCs frequency following the neuroinflammation treatments (*p<0.05; 
**p<0.01). 
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Following the application of strychnine (1 µM) and bicuculline (10 µM) we isolated 
the glutamatergic component and we observed the typical bursting activity due to the 
pharmacologically block of the inhibitory counterpart. This disinhibited burst rhythm 
is profoundly affected only by the 6h treatment with CKs. In fact, both BD and IBP 
are significantly shorter when compared to the control cultures (*p<0.05) indicating 
that this neuroinflammatory treatment accelerated the disinhibited rhythm. The other 
treatments did not interfere with the rhythm drove by glutamatergic 
neurotransmission (Fig. 22; the BD value was 16.0 ± 1.8 s for n=15 control, 14.9 ± 
2.0 s for n=22 LPS and 14.0 ± 3.8 s for n=9 CKs slices at 4h and 16.2 ± 1.6 s for 
n=14 control, 14.7 ± 1.9 s for n=20 LPS and 9.7 ± 1.8 s for n=10 CKs slices at 6h; 
the IBP value was 24.7 ± 2.4 s for n=15 control, 21.7 ± 2.7 s for n=22 LPS and 20.1 
± 5.0 s for n=9 CKs slices at 4h and 24.9 ± 2.3 s for n=14 control, 20.2 ± 2.2 s for 
n=20 LPS and 15.2 ± 2.9 s for n=10 CKs slices at 6h). The similarity of the average 
coefficient variation of the burst duration (CVBD: 31 ± 2% in control, 33 ± 2% in 
LPS and 28 ± 3% in CKs interneurons at 4h and 30 ± 2% in control, 34 ± 3% in LPS 
and 28 ± 2% in CKs interneurons at 6h) and of the inter burst period (CVIBP: 25 ± 1% 
in control, 27 ± 2% in LPS and 21 ± 2% in CKs interneurons at 4h and 25 ± 2 in 
control, 29 ± 3% in LPS and 22 ± 2% in CKs interneurons at 6h) between control 
and treated cultures indicated a comparable regularity of the disinhibited burst 
rhythm established in spinal network. 
We thus analysed the AMPA receptor mediated EPSC isolated in the interburst 
intervals. These EPSCs were significantly changed in terms of frequency and 
amplitude values by the pro-inflammation medium (Fig. 23). Both LPS and CKs 
increased the frequency of EPSCs from 24 ± 2 Hz (n=14) and 24.4 ± 2.7 Hz (n=17) 
at 4 and 6h, respectively, in control cultures to 32.3 ± 3.1 Hz (n=27) and 31.3 ± 2.7 
Hz (n=28) at 4 and 6h, respectively, in LPS cultures and to 32.5 ± 4.3 Hz (n=11) and 
34.3 ± 3.9 Hz (n=11) at 4 and 6h, respectively, in CKs cultures. The AMPA PSCs 
peak amplitude instead was affected significantly (**p<0.01) only by the LPS 
treatment: its value was 29.8 ± 1.8 pA (n=14) and 29 ± 1.5 pA (n=17) at 4 and 6h, 
respectively, in control neurons, 39.8 ± 3.4 pA (n=27) and 39.3 ± 2.6 pA (n=28) at 4 
and 6h, respectively, in LPS interneuons and 34.8 ± 2.5 pA (n=11) and 31.5 ± 3.7 pA 
(n=11) at 4 and 6h, respectively, in CKs cells. EPSCs kinetic properties were 
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unchanged following all the neuroinflammation treatments compared to the control 
condition.  
 
 
Figure 22. Disinhibited burst rhythm in control and treated cultures. (A) Representative traces 
recorded in voltage-clamp mode in the presence of strychnine (1 µM) and bicuculline (10 µM) from 
control (top trace) and CKs treated (bottom trace) interneurons for 6h at 3WIV, Vh = -70 mV. (B) 
Plots showing the mean BD and IBP of the disinhibited burst rhythm for control and treated spinal 
slices: control cultures (n=29) represented in black, LPS-treated cultures (n=42) in red and CKs-
treated cultures (n=19) in blue. Note that the CKs treatment at 6h significantly accelerated the network 
rhythm (*p<0.05). 
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Figure 23. AMPA-mediated PSCs in control and treated cultures. (A) Representative traces recorded 
in voltage-clamp mode in the presence of strychnine (1 µM) and bicuculline (10 µM) from control 
(top trace) and LPS treated (bottom trace) interneurons for 4h at 3WIV, Vh = -70 mV. (B) Plots 
showing the average AMPA PSCs frequencies and amplitudes for control and treated spinal slices: 
control cultures (n=31) represented in black, LPS-treated cultures (n=55) in red and CKs-treated 
cultures (n=22) in blue. Note that LPS treatment increased both AMPA PSCs frequency and 
amplitude values, while CKs treatment enhanced just the frequency (*p<0.05; **p<0.01). 
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Figure 24. AMPA-mediated mPSCs in control and treated cultures. (A) Representative traces 
recorded in voltage-clamp mode in the presence of strychnine (1 µM), bicuculline (10 µM) and TTX 
(1 µM) from control (top trace) and LPS treated (bottom trace) interneurons for 4h at 3WIV, Vh = -70 
mV. (B) Plots showing the average AMPA mPSCs frequencies and amplitudes for control and treated 
spinal slices: control cultures (n=30) represented in black, LPS-treated cultures (n=54) in red and 
CKs-treated cultures (n=22) in blue. Note that LPS treatment increased AMPA currents amplitudes 
also in miniature events (*p<0.05; **p<0.01). 
 
When recording in the presence of TTX, mEPSC frequency was not changed by CKs 
or LPS treatments, while mEPSC amplitude values are larger following LPS 
treatment (Fig. 24; the frequency value was 3.1 ± 0.5 Hz (n=14) and 2.9 ± 0.6 Hz 
(n=16) at 4 and 6h respectively in control interneurons, 5.2 ± 1.1 Hz (n=26) and 4.6 
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± 1.1 Hz (n=28) at 4 and 6h respectively in LPS interneurons and 3.8 ± 0.5 Hz 
(n=11) and 3.6 ± 1.0 Hz (n=11) at 4 and 6h respectively in CKs interneurons; the 
amplitude value was 18.2 ± 1.2 pA (n=14) and 18.4 ± 1.0 pA (n=16) at 4 and 6h 
respectively in control slices, 23.6 ± 1.6 pA (n=26) and 22.1 ± 1.5 pA (n=28) at 4 
and 6h respectively in LPS slices and 20.4 ± 1.9 pA (n=11) and 19.6 ± 1.6 pA (n=11) 
at 4 and 6h respectively in CKs slices). mPSCs kinetic properties were not affected 
by the CKs or LPS incubations. 
 
4.1. Cell excitability following the pro-inflammatory condition: 
analysing firing activity 
We further performed current-clamp recordings to investigate the firing activity of 
spinal ventral interneurons. We did not measure any difference regarding neuronal 
RMP (-60 ± 1 mV for n=9 control, -59 ± 3 mV for n=11 LPS and -58 ± 2 mV for 
n=17 CKs internerons at 4h and -60 ± 1 mV for n=9 control, -59 ± 4 mV for n=4 
LPS and -60 ± 1 mV for n=16 CKs interneurons at 6h) and APs threshold (-49 ± 2 
mV for n=9 control, -51 ± 1 mV for n=11 LPS and -51 ± 1 mV for n=17 CKs 
interneurons at 4h and -49 ± 2 mV for n=9 control, -51 ± 1 mV for n=4 LPS and -52 
± 2 mV for n=16 CKs interneurons at 6h) when comparing the three groups of 
cultures. Similarly, spontaneous firing activity was not significantly altered by LPS 
or CKs incubation for either 4 and 6h (Fig. 25; the APs frequency was 1.1 ± 0.3 Hz 
for n=9 control, 0.8 ± 0.3 Hz for n=11 LPS and 0.7 ± 0.2 Hz for n=17 CKs 
interneurons at 4h and 1.2 ± 0.3 Hz for n=9 control, 0.4 ± 0.1 Hz for n=4 LPS and 
1.6 ± 0.3 Hz for n=16 CKs interneurons at 6h). 
We also characterized the distribution of spinal ventral interneurons based on their 
discharge pattern since it changes during slices in vitro development (Furlan et al., 
2007) and it could be subjected to modification also following a microenvironment 
perturbation or a stress condition. Firing patterns were induced by depolarizing 
current steps (500 ms duration; 0.2 nA amplitude) (Furlan et al., 2007). 
 116 
 
 
Figure 25. Firing activity of ventral interneurons in control and treated cultures. (A) Representative 
traces recorded in current-clamp mode showing the spontaneous firing activity of control (black) and 
LPS treated (red) interneurons at 3WIV, Vh = -74 mV. (B) Plot showing the mean frequency of action 
potentials (APs) release for control and treated spinal slices: control cultures (n=18) represented in 
black, LPS-treated cultures (n=15) in red and CKs-treated cultures (n=33) in blue. (C) Plots 
representing the resting membrane potential (RMP) and the APs threshold of interneurons recorded in 
the different conditions, control and treated slices. 
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We found the same categories of interneurons in all the conditions tested: tonic cells, 
which do not present accommodation and, therefore, continuously fire APs; irregular 
cells, without a defined and characteristic AP discharge pattern; transient cells, that 
generate a single AP only; adapting cells, which display accommodation following 
an early burst of APs (Fig. 26). Their distribution was all in all similar in the three 
conditions tested (control slices: 31% tonic, 8% irregular, 8% transient, 53% 
adapting; LPS slices: 41% tonic, 9% irregular, 18% transient, 32% adapting; CKs 
slices: 21% tonic, 10% irregular, 12% transient, 57% adapting), and together with the 
observed similarity in the RMP, the AP threshold and the spontaneous AP frequency, 
we can conclude that interneuron excitability is not changed due to 4h and 6h 
neuroinflammation treatments. 
 
 
Figure 26. Discharge pattern of ventral interneurons in control and treated cultures. (A) 
Representative traces recorded in current-clamp mode following a step of 0.2 nA for 500 ms showing 
the interneurons categories based on their discharge pattern, Vh = -74 mV. (B) Plot showing the 
distribution of the different types of interneurons at 3WIV for control and treated spinal slices: control 
cultures (n=26) represented in black, LPS-treated cultures (n=22) in red and CKs-treated cultures 
(n=42) in blue. 
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Discussion 
 
1. The faster glycinergic transmission in SOD1G93A 
slice cultures relies on increased GABA/glycine co-
release 
Glycine-mediated currents are altered in neurons derived from embryonic mice 
expressing the human mutated SOD1G93A. This is true for both dissociated spinal 
MNs (Chang and Martin, 2011) and, as we observed, for interneurons recorded from 
the ventral area of spinal organotypic cultures. In SOD1G93A MNs the current 
densities of glycine-evoked currents and glycinergic mPSCs are significantly smaller 
compared to control (Chang and Martin, 2011) probably caused by decreased 
expression of GlyRs as confirmed by immunofluorescence and quantitative single-
cell RT-PCR analysis. Another possible explanation is that reduced GlyRs 
functioning is secondary to loss of innervations from glycinergic interneurons 
(Chang and Martin, 2009). Therefore, this inhibitory insufficiency could be a MNs-
autonomous event as a MNs non-autonomous one in which the degeneration process 
involves neuronal networks that is exactly the focus of our interest. 
Glycinergic currents in spinal networks undergo a progressive fastening represented 
by the reduction of the decay time constant (τ) of synaptic currents during maturation. 
We also observed this characteristic in our spinal cultures in both WT and SOD1G93A 
slices, further confirming organotypic slice cultures as a representative in vitro model, 
but they display a different maturation profile since this developmental process is 
significantly steeper in SOD1G93A glycinergic PSCs and mPSCs. Faster decay 
kinetics of glycinergic mPSCs has been already observed in SOD1G93A MNs (Chang 
and Martin, 2011) and the authors suggested that one possibility could be a different 
expression of synaptic GlyRs channels. Providing a direct evidence for the kinetic 
properties of GlyRs with brief pulses of glycine onto MNs, no differences have been 
detected in the kinetic of glycine-evoked currents in SOD1G93A and control MNs 
(Chang and Martin, 2011), excluding the possibility of altered GlyRs subunit 
composition. We also explored this topic thanks to outside-out recordings to quantify 
the conductances of single channel opening by glycine. Even though we do not have 
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a direct vision of GlyRs subunits, each GlyRs assemble has a peculiar and defined 
conductance (Takahashi et al., 1992; Bormann et al., 1993; Singer et al., 1998; 
Burzomato et al., 2004) that allowed us to distinguish between embryonic slow α2 
homomeric receptors (100 pS) and postnatal fast α1β heteromeric receptors (40pS). 
The fact that at the stage in which we found significantly faster glycinergic currents 
in SOD1G93A cultures (3WIV) there is no correlation to a higher expression of GlyRs 
with faster kinetic properties, apparently rules out this hypothesis. 
The time course of glycinergic currents is strictly linked to the [Cl-]i: reducing the 
[Cl-]i substantially speeds up the decay of glycinergic currents (Pitt et al., 2008). The 
[Cl-]i is controlled by transporters (NKCC1 and KCC2), finely regulated during 
development, whose expression determine the glycinergic response. Pathological 
conditions that affect the [Cl-]i may result in neuronal activity impairment. For these 
reasons we decided to verify any changes in [Cl-]i during development of SOD1G93A 
and WT cultures as a possible cause of the observed differences in the glycinergic 
kinetic properties. In our experimental conditions (see methods) we always perform 
recordings with theoretical 24 mM of chloride ions in the recording pipette but, 
during the cultures in vitro growth, the mechanisms responsible of the chloride 
buffering increase, as expected, and at 3WIV, in both WT and SOD1G93A slices, the 
calculated [Cl-]i based on the chloride reversal potential is apparently lower, around 
15 mM, at least at the subcellular level of the recorded synapses. Noteworthy, this 
value corresponds to a glycinergic decay time constant of ~ 8 ms (Pitt et al., 2008) 
that resembles the one detected for WT cultures at 3WIV. 
These results are difficult to interpret, however we can assume that WT and 
SOD1G93A organotypic spinal cultures undergo developmental processes that allow a 
similar control in the GlyRs subunit composition and the [Cl-]i since at 3WIV they 
both display the postnatal form of GlyRs and a reduced [Cl-]i compared to the one 
imposed in the recording pipette. Therefore, another mechanism for the faster 
glycinergic currents in SOD1G93A should be involved. 
Apart from differences in the GlyRs assemble, that has been excluded, Chang and 
Martin also proposed a faster clearance of transmitter from the synaptic cleft as 
responsible of the impaired glycinergic kinetic properties in SOD1G93A cultures 
(Chang and Martin, 2011). We could not test the presence of faster clearance as a 
general mechanism that could reduce the effective time in which glycine interacts 
with its own receptors. We concentrated our efforts on the hypothesis that an 
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increased amount of GABA/glycine mixed synapses were present in SOD1G93A 
cultures. The presence of mixed synapses may be an advantage in fine-tuning the 
duration of post-synaptic responses depending on the affinities of different 
neurotransmitter for receptor sites (Lu et al., 2008). We exploited the protocol of Lu 
and colleagues to deplete GABA from presynaptic terminals by bath applying TBOA 
(Lu et al., 2008). These authors observed for the first time that since GABA is a 
partial agonist of GlyRs, reducing its intraterminal concentration slowed the decay of 
glycinergic synaptic currents in the auditory brainstem (Lu et al., 2008). Interestingly, 
in our experiments we observed that at 3WIV depleting GABA from presynaptic 
terminals weakly affected glycinergic currents in WT slices, while it significantly 
slowed down them in SOD1G93A littermates. This electrophysiological data strongly 
support the possibility of a higher amount of mixed synapses in SOD1G93A cultures 
compared to WT ones with consequent increased GABA/glycine co-release and 
impairment in glycine synaptic activity. 
We further support this hypothesis with preliminary data regarding the co-staining of 
GlyT2 and GAD65, two markers used to identify the presence of glycine and GABA, 
respectively, in the presynaptic terminals (Dumoulin et al., 2001; Mackie et al., 
2003; Dugué et al., 2005). Indeed, at 3WIV SOD1G93A cultures seemed to display 
more colocalized GlyT2/GAD65 terminals. 
In summary, we detected an impaired glycinergic current kinetic in the premotor 
network of SOD1G93A spinal slices and, in the absence of evidences regarding the 
GlyRs subunit composition and alteration in the [Cl-]i homeostasis, our data support 
the hypothesis of an increased GABA/glycine mixed synapses. These synaptic 
alterations have been identified at early stages of network development when 
neuronal degeneration and morphological defects are still not detectable (Avossa et 
al., 2006). These changes may represent early signatures of the SOD1G93A disorder 
that appear long before symptom emergence, thereby permitting an improved 
comprehension of MN disorders (Ben-Ari, 2008). 
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2. From a genetic model of a neurodegenerative 
disease to the assessment of environment 
contribution 
Recent evidences and our own observations suggest that the SOD1G93A model of 
ALS is characterized by synaptic malfunctions at premature developmental stages, 
potentially altering the following developmental programs (Ben-Ari, 2008). What is 
less clear is if these impairments are directly linked to the SOD1G93A mutation or 
indirectly to the tissue that is intrinsically predispose to be damaged. In order to gain 
insights into this issue, we decided to evaluate how synaptic activity in healthy tissue 
reacts to stress processes mimicking the pathogenic pattern. 
We used the organotypic spinal cord slices derived from embryonic C57BL/6J mice. 
We firstly set the spinal slice survival conditions and investigated their maturation 
profile in vitro compared to the previous model. These cultures are healthy and 
successfully develop in in vitro conditions but glycinergic activity is reduced by 
more than 50% in the ventral area of spinal slices. Therefore, the following 
investigations were focused on GABA transmission and/or on the excitatory 
component. 
 
2.1. Hydrogen peroxide (H2O2) treatment partially affected the 
spinal network 
The effect of ROS, such as H2O2, on neuronal synaptic transmission are highly 
variable depending on the model (dissociated cultures or brain slices) and on the 
protocol used (ROS-donor concentration, acute or chronic incubation). We provide 
an electrophysiological study regarding spinal cord slices treated chronically with 
H2O2. We thought that this approach could more closely reproduce prolonged, long-
term subtle microenvironment alterations. 
The treatment that we used (500 µM H2O2 for 12h) did not alter the dishinibited 
burst rhythm induced by strychnine and bicuculline perfusion. On the contrary, we 
detected an increased EPSCs frequency compared to untreated cultures. This 
difference is not replicated by mEPSCs indicating that the effect observed requires 
network activity. We excluded a higher overall neuronal excitability since firing 
frequency in control and treated slices were analogous, but we should underlie that 
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we recorded only spontaneous APs. These results brought us to the conclusion that 
changes in the spinal network activity following an oxidative stress treatment can be 
unmasked only in precise conditions in which the excitatory transmission is recorded 
in the presence of pharmacological blockers of synaptic inhibition. Noteworthy, we 
observed a subtle alteration regarding exclusively the EPSCs frequency that 
apparently did not affect the burst rhythm. This can be explained by the fact that 
bursts are due to synchronous activation of ionotropic glutamatergic receptors 
(Ballerini and Galante, 1998), both AMPA and NMDA receptors while spontaneous 
synaptic activity recorded during interburst period are exclusively AMPA-mediated 
events, in the recorded cell, due to recoding conditions. Moreover, strychnine and/or 
bicuculline perfusion differently affected the frequency of spontaneous synaptic 
events and the ability to induce bursting. For instance, strychnine alone increased the 
frequency of spontaneous synaptic events in rat organotypic spinal slices, an effect 
that was not related to the ability of this drug to induce bursting (40% of cells tested), 
while bicuculline consistentely evoked bursting (98% of cells tested) but differently 
regulated the frequency of spontaneous synaptic currents based on the cultures age 
(Ballerini and Galante, 1998). This indicates a dissociation between the network 
responsible for burst generation and the one producing the spontaneous activity 
recorded from a single interneuron (Ballerini and Galante, 1998). One possible 
mechanism by which H2O2 interfere with EPSCs is an enhanced presynaptic release 
probability by increasing Ca+ release from presynatpic stores (Takahashi et al., 2007) 
supporting the role of H2O2 as a retrograde messenger (Kamsler and Segal, 2004). 
Another hypothesis is linked to the inhibition of redox-sensitive glutamate 
transporters (Trotti et al., 1998). In both cases we should have found an increased 
frequency also in mEPSCs and a more widespread effect, involving also the 
dishinibited burst rhythm, due to an increase glutamate concentration in the synaptic 
cleft. Maybe the H2O2 concentration range in which it is possible to observe a 
synaptic effect without causing excessive neuronal damage is so subtle that it is 
difficult to detect more evident differences. Also for this reason we switched to 
another chronic microenvironment alteration, mimicking an inflammation state. 
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2.2. Lipopolysaccharide (LPS) and cytokines (CKs) treatment 
strongly affected the spinal network 
Pro-inflammatory CKs have been already tested on brain slices to evaluate their 
impact on synaptic activity since they are over-expressed in pathological conditions. 
Centonze and colleagues treated a microglia cell line with the so called Th1 mix 
composed of TNF-α, IL-1β and INF-γ that are known to peak during the acute phase 
of EAE, a mouse model of MS (Furlan et al., 1999). The treated microglia placed in 
contact with corticostriatal coronal slices, replicated the synaptic defects of EAE 
mice including a significant increased duration of sEPSCs (Centonze et al., 2009). 
Also TNF-α incubation alone (3h) mimicked the same synaptic alterations (Centonze 
et al., 2009). Moreover, activated microglia and TNF-α did not potentiate the effects 
of EAE induction on sEPSCs kinetic properties indicating that TNF-α release from 
activated microglia is a likely candidate for the detected synaptic deficits in EAE 
(Centonze et al., 2009). Based on these observations, we decided to chronically (4h 
and 6h) treat our spinal cultures with a mixture of  CKs, TNF-α, IL-1β and GM-CSF, 
known to be increased in the CSF of ALS patients, and to investigate the excitatory 
component. CKs treatment strongly impaired the spinal network: an increased global 
spontaneous activity was correlated with a higher EPSCs and burst frequency while 
the inhibitory counterpart was pharmacologically blocked. Both TNF-α and IL-1β 
(little is known about GM-CSF) have already been reported to increase the frequency 
of EPSCs in spinal cord and corticostriatal slices (Kawasaki et al., 2008; Zhang et al., 
2010; Rossi et al., 2012). We should exclude an increased glutamate release from 
glutamatergic nerve terminals (Kawasaki et al., 2008; Rossi et al., 2012) since the 
augmented frequency was not present in mEPSCs, but we are more incline in 
supposing an inhibition of ongoing inhibitory synaptic transmission (Zhang et al., 
2010), which is something that we would like to address soon. 
With the CKs treatment we were able to detect direct effects on neurons since they 
display CKs receptors. In parallel, we tested also an indirect inflammatory treatment, 
based on LPS incubation that interacts with its receptor (TLR4) present exclusively 
on microglia. It is evident that CKs and LPS engage in different molecular 
mechanisms. Also LPS treatment boosted both spontaneous activity and EPSCs 
frequency but this was not reflected in an impaired burst rhythm and, moreover, LPS 
was able to forcefully increase EPSCs also in miniature events suggesting an effect at 
the postsynaptic level. We can speculate about this topic: microglia activation by 
 124 
 
LPS results in the release of different molecules, including for instance TNF-α and 
IL-1-β, but also others such as IL-6 and nitric oxide (NO). It has been reported that 
NO is involved in synaptic plasticity phenomena, in particular facilitating the 
insertion or stabilizing AMPA receptors at synapses (Huang et al., 2005). Therefore, 
LPS may act directly on neurons by releasing CKs from microglia with the 
consequent effect observed with CKs treatment, but at the same time, microglia 
activation will result in further consequences by the release of a multitude of 
molecules which in turn may cause other synaptic defects. 
We should also add that following both CKs and LPS treatment the cell excitability 
was unchanged and also interneurons categories, based on their discharge pattern, 
were analogous. 
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Conclusions 
 
Since neurodegenerative diseases, such as ALS, are so complex and endowed with a 
multifactorial aetiology, parallel in vitro models are essential to isolate specific 
cellular events and determine the possible pathological causes. In this work we 
further confirmed organotypic slices as a good model to test the spinal network 
synaptic activity in both physiological and disease conditions due to the easy access 
to premotor interneurons with electrophyiological techniques and, above all, because 
these complex multi-layered tissues are long-term preparations. This is an essential 
feature to evaluate developmental and chronic cues and, moreover, their growth in 
vitro follows specific patterns in terms of neuronal and glial cells morphology and 
location, neuronal excitability and specific synaptic changes like the speeding up of 
glycinergic currents or the lowering of the chloride reversal potential. 
One of the principal findings of this work is that in SOD1G93A cultures, a typical 
model of ALS, the interneuronal glycinergic transmission is affected, resulting in an 
impaired communication with MNs and with the following motor program. Our data 
confirmed the hypothesis regarding an increased presence of mixed GABA/glycine 
presynaptic vesicles in which GABA narrows the effective time window for glycine 
inhibition. We should stress that these synaptic alterations were detected at early 
developmental stages (corresponding to the first postnatal period) in the absence of 
detected neuronal defects meaning that the SOD1G93A tissue is already displaying 
synaptic dysfunctions. 
Apart from the genetic predisposition that accounts for a small percentage of ALS 
patients, environmental factors are surely able to trigger neuronal degeneration and 
among them we decided to focus on oxidative stress and neuroinflammation since 
both of them are reported to be involved in ALS pathogenesis. Unfortunately, we 
could not investigate glycine neurotransmission since the cultures used for these 
experiments (C57BL) seemed to display a more immature network with a lower 
percentage of glycine synaptic contacts, at least in the ventral interneurons we 
recorded from. However, we unmasked that microenvironment modifications, both 
chronic oxidative stress and neuroinflammation treatments, altered the excitatory 
component increasing the frequency of EPSCs. While this difference was quite 
subtle following H2O2 incubation and not correlated with other network impairments, 
 126 
 
a neuroinflammation state was able to profoundly affect this feature and, in general, 
also the overall spinal circuit activity. Moreover, involving directly (CKs) or 
indirectly (LPS) neurons response resulted in further differences: CKs accelerated 
the disinhibited burst rhythm probably because of the strong increase in EPSCs 
frequency, while LPS augmented the amplitude of EPSCs and mEPSCs suggesting a 
postsynaptic alteration. 
These results expanded our knowledge about the dialogue between stress conditions, 
both genetic and environmental factors, and the premotor spinal network and we may 
speculate that these changes in synaptic transmission could cooperate in synergy, 
maybe at different stages of the pre-symptomatic phase in a neurodegenerative 
cascade, leading to the development of misconnected circuits that finally 
compromise the long-term MNs viability.  
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